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Abstract 
A series of kinetically stable chirallanthanide complexes has been developed, with a view to 
developing responsive probes for use in analysis and in seeking chiral complexes exhibiting 
selectivity in their interaction with nucleic acids. 
Firstly a pH sensitive complex has been modified with the aim of tuning the pH range to 
which it responds to the physiologically useful regime. The synthesis was undertaken of 
relatively lipophilic 6-butylphenanthridinyl complexes. Their photophysical behaviour was 
investigated by absorbance and luminescence spectroscopy and the modulation of their 
emission examined in the pH range 4.5 to 7.5. 
In addition to their luminescent properties, enantiomerically pure chirallanthanide complexes 
permit chiroptical techniques to be used, allowing their interactions with other chiral species 
to be addressed (e.g. nucleic acids, oligonucleotides). 
The first series of enantiopure lanthanide complexes has been devised that show several 
interesting features in binding to oligonucleotides and nucleic acids. These macrocyclic tris-
and tetra-amide lanthanide (Eu, Tb or Yb) complexes contain an N-alkyl phenanthridinium 
unit that allows intercalation between the base pairs of the DNA Their binding to [(AT)6h, 
[(CG)6h and CT-DNA was monitored by changes in the ligand and metal based 
luminescence, and in the characteristic CD bands of the oligonucleotides. Binding affinities 
were assessed using intrinsic methods and the McGhee-von Hippel analysis. Marked 
differences have been observed in the binding of Eu and Yb complexes as a function of the L1 
and A helicity of the complexes, which is itself determined by the configuration of the remote 
amide substituents. Binding of the .1-Eu complex was over 50 times stronger to [(CG)6]2 
compared to [(AT)6h, while the left handed A-Yb complex showed a different pattern of 
selectivity. In the europium complex of a related heptadentate tris-amide ligand, the 
coordination of a DNA phosphate group to the lanthanide centre was suggested by emission 
and lifetime changes. 
Another series of chiral tetraamide complexes linked to the 6 position of the phenanthridine 
moiety was synthesised and studied. An additional stereogenic centre at carbon, alpha to the 
phenanthridine group was introduced with the aim of tuning the selectivity of binding. A set 
of four diastereoisomeric ligands was separated and their lanthanide complexes characterised. 
The binding of their Eu and Yb complexes was evaluated and differences between Eu and Yb 
complexes persisted. The additional chiral centre did not appear to modify the binding 
affinity of this series of complexes. Finally, a series of 6-phenanthridinyl complexes was 
investigated in which the phenanthridine N atom was directly bound to the lanthanide centre .. 
Their affinity for DNA was found to be relatively low, which may be related to their rigid 
structure. 
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Introduction 
Chapter 1: introduction 
The DeoxyriboNucleic Acid DNA represents the richest source of information within 
a living organism. The genotype of each cell locked into its DNA sequence encodes protein 
and enzyme synthesis. It is composed of two separated chains that are usually wrapped 
around each other to form the double helix. They are connected to each other by hydrogen 
bonding interactions between the base units. 
1-1 DNA 
1-1.1 : Building-blocks of DNA 
DNA can be regarded as a polymer made from four kind of monomers. The 
nucleosides, formed by a purine or pyrimidine base and a deoxyribose sugar, are linked to 
each other by a phosphate bridge. The four bases are Adenine, Cytosine, Guanine and 
Thymine (which is replaced by Uracil in the case of RNA), and are hydrogen bonded in a 
self-complementary manner, as shown in Scheme 1.1. In 1953, Watson and Crick proposed a 
model for the DNA structure with two strands in an anti parallel double helix with 10 base 
pairs per turn. The pairing of the bases by hydrogen bonding is strictly Cytosine-Guanine and 
Thymine-Adenine. 1 
Because the sugar molecules are asymmetric, each sugar-phosphate motif has a 
polarity denoted as -5' or -3'. Thus the two individual nucleotide chains have opposite 
polarity, and are complementary. The paired bases are stacked on the top of each other along 
the axis of the helix and allow strong Van der Waals interactions between them. Each base 
pair is rotated by 36° (in B-DNA) with respect to the next. The phosphate groups sit outside 
and with the sugar form the backbone. The conformation of the sugar ring, which can be C2' 
ENDO or C3' ENDO, as well the position of the glycosidic bond, SYN or ANTI, affects the 
geometry of the double helix.2 The bases at the axis of the helix can be approched through 
two deep spiral grooves, called the major and minor grooves. Their existence is due to the 
asymmetry in the base pairing. The phosphate groups and the sugars form the walls of the 
groove, and the bases the floor, producing a hydrophobic compartment. 
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3' 
3' 
Scheme 1.1: Arrangement of the nucleobases in the DNA double strand 
1-1.2 : Different kinds of he/ ix 
1-1.2.1: A, B, Z helices 
The most common form of DNA helix is the 'so-called' B-DNA. It is the one found at 
a relative high humidity, as expected for the aqueous milieu of the cell. But there also exists 
the A and Z forms. Although the B helix is indeed the form of DNA found in cells, the A 
helix is also important biologically. Double strand RNA always forms the A structure, and so 
do DNA-RNA hybrid duplexes. 3 The standard A and B forms can occur with most 
sequences, depending for example on the degree of humidity ; the A form is found at relative 
low humidity (65-75%) and B form at a higher humidity level (>92%). The conformational 
changes in the duplexes have been studied by X-ray,4 proton NMR5 and circular dichroism 
(CD).6 The three forms are distinguished by the size of their grooves and their helicity. 
B-ONA 
Direction of helix rotation 
Number of residue per turn (n) 
Rotation per residue (360/n) 
Rise in helix per residue (h) 
Pitch of helix (oh) 
Major groove 
Minor groove 
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Scheme 1.2: The 3forms of DNA 
A Form BForm ZForm 
Right Right Left 
11 10 12 (6 dimers) 
33° 36° -60° per dimer 
0.255 nm 0.34 nm 0.37 nm 
2.8 nm 3.4 nm 4.5nm 
Deep & Narrow Deep& Wide Shallow & Wide 
Shallow & Wide Same Depth & Width Deep & Narrow 
Table 1.1: Parameters ofpolynucleotides. 
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These structural parameters have been determined by NMR and X-ray crystallography. 
1-1.2.2: Unusual secondary structures 
Triplex and Quadruplex 
The first triple helix discovered was poly(U)-poly(A)-poly(U), containing two 
pyrimidine strands and one purine strand.7 Such a structure involves both a Watson-Crick 
pairing and a Hoogsteen-type base pairing. This is called H-form and can be found in any 
structure showing an 'all pyrimidine strand' and one 'all purine strand'. 
Evidence has also been found for a quadruple helix, involving runs of guanine 
nucleosides.8 The tetrad G-G bases are paired via a Hoogsteen model in the same plane, in 
anti-parallel or parallel arrangements. 
Hairpins and cruciforms 
Most RNA molecules are single strand but many have self complementary regions that 
form hairpin strustures : the bases sequence allow the chain to fold back on itself and form a 
base-paired antiparallel helix. Double hairpins are also called cruciforms. 
1-1.3: Stability of DNA 
The major polynucleotide secondary structures (A and B forms) are relatively stable 
under physiological conditions. Yet they must not be too stable because many biochemical 
processes require the double helix opening. This loss of secondary structure is called 
denaturation. The major factors which favour dissociation of the double helix, are the 
electrostatic repulsion between the chains (as they are charged equally), and the increase in 
the entropy factor. 
Nevertheless, the double helix is well held together by different kinds of interaction.9 
First there is the stacking of the aromatic bases, where one 1t-system overlaps with the next 
one, resulting in the stabilization of the helix. 10 Secondly, the hydrogen bonding between the 
bases is critical to the stability, even if the energy of stabilisation is low; this reflects the 
competition with water molecules. 11 The hydration of DNA is essential for the maintenance 
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of its structural activity. Permanent electrostatic effects, induced dipole interactions, and 
solvophobic effects may also play a role in the stabilization of DNA 12 
1-2 Binding to DNA 
Because of the features of their tertiary structure, the different forms of DNA do not 
interact in the same way with drugs. The hydrophobic part constituted by the bases is not 
accessible to the same extent in the three main cases of binding, depending on the size of the 
grooves. The interactions with the bases are favoured in the case where one of the grooves is 
wide enough to allow the molecule to bind to it. For each form of DNA the phosphate groups 
make up a polyanionic backbone on the outside surface allowing interaction with the aqueous 
milieu. The edges of the bases have hydrogen bonding potential, which is only partially 
satisfied by the pairing, and is therefore available for recognition by ligands. 
1-2.1 : Interest of binding drugs to DNA 
DNA controls the genotype of each cell and so, consists of a library where 'all the 
recipes' are stored. Without it, it would be impossible for cells to replicate themselves. This 
is the case not only for healthy cells but also for malignant cells. One approach to cancer 
therapy involves the use of cytotoxic agents, which reduce the proliferative drive to the 
tumour. 13 Many compounds with good tumour cell-killing activity have been discovered, but 
relatively few have found a clinical use because of the lack of discrimination between tumour 
and normal tissue. 
The mode of action of cell-killing drugs is believed to involve the binding to DNA inside the 
cell, to stop the replication process. Replication is the process wherein the DNA is read base 
after base, translated into a codon, which codes for a particular amino acid. 14 If one base is 
missing or is the wrong one, the resulting nucleic acid chain or peptide, in the protein 
synthesis, would be different, this is called mutation, 15 and may lead to the death of the cell. 
There are two ways for the cytotoxic agents to act : the first is to bind covalently or non-
covalently to the double strand and so block the RNA pathway to the replication, or more 
readily to cleave the strand directly. 
c 'hafllel I /nmx.IIICIJo/1 
1-2.2 : I ype.\ c?f hmdmJ! 
The aftimty of drugs for nucleic acids depends on the physicochemrcal charactensttcs 
of the ligands (usually a molecular weight less than 1000) as well as the \\ay the) fit around 
the DNA hell>. Therr charge, hydrophiltctty. and geometry are rmponant factors to consrder. 
The three main types of non-covalent interactions that have been rdentrfied arc rllustrated rn 
Scheme 1-3 
ElectrostatiC Groove bmdmg Intercalation 
Scheme 1-3 : Bmdmg mode.\ c?{\lna/1 molecule,· tu /) \ ·I 
1:'/ec:trosWtic inlemction · 
This type of binding is favoured in cases where a cationic ligand is clectrostattcallv 
attracted to the negatively charged phosphate groups found at the surface of the DNA heir\.. 
so fairly accessible The hgand displaces the counter ron (typtcally Na • or M g.; ) around the 
double strand. The type of catronic ligand ranges from simple aqua ions to charged orgamc 
ions or complexes, srnce each presents a positive charge. 1 he enerro of thrs attractron '>anes 
inversely with the distance and so this can be a longer-range mteraction Thrs force could 
therefore be an rmportant factor to direct the ligand to a given regron of the sequence 
CirocH·e bmdmg : 
The driving force for thrs rnteraction is the solvophohrc effect whtch tn turn ts related 
to the hydrophobicity of the ligand. The molecule adapts its conformation to sit along the 
groove, stabilized by Van der Waals interactions and hydrogen bonding, 11' and hrdden from 
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external solvent. Groove interaction involves the concave curvature of the inner surface of 
the drug molecule complementing the convex surface of the groove floor. This surface 
matching has been termed isohelicity17 since both the groove floor and the drug inner surface 
have twists in their curvature. This concept has been found useful in the design of new 
groove-binding agents. A great number of compounds showing a preference for AT regions 
have been classified as groove-binders, and bind exclusively to the minor groove of B-DNA. 
They do not significantly pertub DNA structure, in contrast to intercalative drugs. 
Intercalation : 
The intercalation process is characterized by the interaction of an extended electron-
deficient, planar aromatic ring system. The intercalation hypothesis, first proposed by 
Lerman, 18 suggests that the planar chromophore has been inserted between adjacent base pairs 
of the DNA. The resultant complex is stabilized by Van der Waals interactions between the 
aromatic ring of the chromophore and the n-system of the bases surrounding it. This results 
in an extension of the helix by 3.4 A, and a change in the helical twist. 19 Furthermore the 
intercalator becomes rigidly held and oriented with the planar moiety perpendicular to the 
helical axis. Another feature in intercalation is the 'neighbourhood exclusion principle', 
where the intercalation of two molecules adjacent to each other is strongly disfavoured. 17a 
1-2.3: Drugs which bind to DNA 
Ethidium bromide is probably the best known intercalating agent. 20 Its planar 
aromatic unit is able to slide between the base pairs and form a strong complex. 
Consequently the replication of the DNA is impossible and it is lethal for the cell?1 A 
fluorimetric method for determining DNA and RNA concentrations using the fluorescence 
enhancement of ethidium bromide on binding to double strand nucleic-acids was proposed by 
LePecq and Paoletti in 1966.22 
In the same family of intercalating drugs are acridine23 and proflavine. 24 They possess 
not only charged planar heteroaromatic rings but also amino groups able to form hydrogen 
bonds to acceptor sites on the DNA. Not all of the acridines are intercalative agents. The 
conditions of temperature and concentration can also affect the binding. At high 
concentration, the acridine dyes saturate the intercalative sites, after which they bind on the 
backbone surface. 
7 
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The synthetic dye HOECHST 33258 is widely used 'as a fluorescent cytological stain 
for DNA, because it binds strongly to AT-rich sequences from the minor groove. 25 This 
binding is stabilized by Van der Waals interactions between the two benzimidazole rings and 
the sugar (04'), and hydrogen bonds between benzimidazole NH groups and proximal 
Adenine (N3) and Thymine (02). This groove binder is base-pair selective, by specific 
hydrogen bonding with the bases in the bottom of the groove, and it is particularly selective 
for AT pairs in DNA 
As an example of these kinds of groove binders, Dervan et al. developed analogues of 
netropsin. The parent molecule contains a succession of pyrrole and imidazole rings 
interacting with the bases by specific hydrogen bonds, which targets specifically a sequence 
by formation of a third helix sitting in the minor groove. 26 These polyamides, because they 
have a higher affinity and specificity than naturally occuring DNA binding proteins, have the 
potential to control gene expression. 27 
Actinomycin D is an intercalative antitumour drug which has also attached amino-acid 
side chains. It acts as a groove binder. 28 The peptide chains reside in the DNA groove, while 
the heterocyclic unit stacks between the base pairs. This is an example of an intercalator 
appended with a groove binding tail. 
Sar Pr~ "N-Me-Val 
I I 
Ethidium Bromide 
Proflavine 
Actinomycin 
Hoechst 33258 
Scheme 1.4: Small molecules interacting with DNA 
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Transition-metal complexes : 
Numerous studies of DNA interactions with chiral tris-chelate complexes ML3 have 
been inspired by the possibility of discriminating DNA handedness. 29 ML3 complexes are 
shaped like three-bladed propellers, and have two enantiomeric forms, right-(.1) and left-(A), 
that might be expected to interact differently with DNA The nature of the polyaromatic 
ligands determines the type of interaction that the complex can make with the double helix. 
Furthermore, due to their metal-ligand charge transfer transitions (MLCT), providing a 
spectroscopic handle, osmium(II), rhenium(!), rhodium(III) and ruthenium(II) complexes are 
very sensitive luminescent reporters of DNA in aqueous solutions. 30 The best documented 
examples of such complexes are ruthenium tris-phenanthroline [Ru(phen)3] 2+ and the mixed 
complex [Ru(phen)2(dppz)]2+ (Scheme 1.5). 
6-(Ru(phen)3]2+ b-(Os(phen)2(dppz)]2+ 
Scheme 1.5: Chiral transition-metal complexes 
Much work has been done on ruthenium(II) tris-(1,10-phenanthroline) complexes and 
its binding to various kinds of DNA helix. The first conclusions postulated following 
photophysical studies,31 and concerning the 'enantioselective binding' to right handed DNA, 
were that the two opposite enantiomers display two different binding modes with different 
affinities : one involving intercalation and the other, surface binding. In contradiction to these 
conclusions, Norden has shown using NMR, LD and CD experiments32 that there is no 
preferential intercalation of the .1-enantiomer over the A to B-DNA, and so no discrimination 
0 
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of DNA handedness. Both enantiomers have been found to be groove-binders with similar 
strengths as a function of the base-pair composition. 
The two enantiomers of [Ru(phen)2(dppz)]2+, presenting an extended aromatic system, 
bind with comparable strengths to DNA, by intercalation of the (dppz) chelate wing inserted 
between the base-pairs, but with no enantiospecificity. 268'33 A lot of reports34 on the binding 
of these complexes with DNA have appeared describing the interaction using different 
methods. The precise definition of from where the intercalation occurs, i.e. from the major or 
minor groove, remains unresolved. 
A large series ofruthenium,35 rhenium,36 rhodium,37 cobalt or osmium26b'38 complexes 
have been synthesized, aiming to study DNA binding, and for some of them, photocleavage 
of the double strand. The increase in the ligand surface area, for example from 
phenanthroline (phen) or bipyridine (bpy), to dipyridophenazine (dppz) or phenanthrene-9,10-
diimine (phi) leads to a substantial increase in intercalative binding affinity. 
Another large heterocyclic surface used for DNA interaction is the electron-poor 
aromatic porphyrin ring system. It has been known for some time that porphyrins bind to 
DNA but the mode of binding is still debated. 39 Spectroscopic data indicates that porphyrins 
bind to CG-rich regions intercalatively, while they take on an external binding mode 
interacting with AT -rich regions. 40 The nature of porphyrin intercalation has been defmed 
from the crystal structure of a hexamer with a copper meso-subsituted porphyrin. 41 Often 
porphyrins intercalate by flipping out a cytosine from the oligonucleotide helix. In these 
conditions, the intercalation of such metal complex represents a substantial perturbation of the 
DNA helical structure. A feature of metalloporphyrins is their use as cleavage agents by oxo-
transfer on DNA bases (usually guanine). 
Cis-Platin42 provides a typical exemple of a covalent interaction with DNA which 
blocks replication and translation process. But the first step is an electrostatic attraction of a 
doubled charged complex with the backbone of the DNA. This drug is clinically used in the 
treatment of ovarian and testicular cancer. 
1() 
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1-3 Techniques used to study conformational changes in DNA upon binding 
The study of the interaction of a drug with DNA is crucial in understanding how this 
could act as therapeutic agent. Relatively few techniques are available to visualize how the 
non-covalent binding of a small molecule can affect the DNA helix. The elucidation of the 
structure of such a drug-DNA complex has been a goal for many researchers, from physical 
chemists to biologists. 
1-3.1 : X-ray crystallography 
Fibre diffraction provided many answers concerning the structure of DNA, but also 
concerning its inter3:ction with drugs by relating the structure to the function. X-ray 
crytallographic studies43 of a DNA-drug system provides a lot of help in understanding how 
the drug interacts with DNA. They help to define the nature of the binding interaction which 
may be linked to the mode of action of the drug, and where along the oligonucleotide the 
ligand binds. The binding geometry and the ratio of ligand bound can as well be deduced 
from a fibre diffraction study of a crystal. Because it gives a view of the ensemble, X-ray 
structures can visualize the effects of the binding on the structural properties of the helix : its 
length, twist, and bending. 
This technique of investigation probing the interaction between a ligand and DNA 
expanded in the late 1970's, with the development of solid phase oligonucletide synthesis, 
providing pure defined oligonucleotide sequences for crystallisation attempts. The structure 
of the first fully base-paired full turn of double helix to be determined by a single crystal 
method, was that of the sequence d(CGCGAATTCGCG) at 1.9 A resolution.44 
However a limitation to this technique is the conditions under which the crystals were grown. 
To obtain crystals of an oligonucleotide requires most of the time, a different system of 
counter-ions, a different humidity level, or a different temperature than the physiological 
milieu. This means that the 'picture' of the interaction from the X-ray structure may differ 
from the actual milieu. 
Crystallographic studies have concentrated on the intercalative and minor-groove 
categories of complexes: The first drug-DNA crystal structures to be determined were of 
11 
Chapter 1: Introduction 
simple intercalating molecules, typified by the acridine, proflavine. 23 The structure showed 
the planar chromophore sandwiched between the two base-pairs of the dinucleotide duplex. 
The study was unable to address issues of conformational change beyond the immediate 
intercalation site. Intercalation at the centre of an extended sequence was also observed for 
the antibiotic actinomycin, showing it to interact at the central GpC site of the sequence 
d(GAAGCTTC). The two cyclic pentapeptides lie in the minor groove, showing as well a 
predicted set of hydrogen bonds between the threonine of the side chain and the two central 
guanines. 27b 
Many studies have been carried out on the intercalation of meso-substitued porphyrins 
with DNA. In particular, the crystal structure of Cu-TMPy with the sequence d(CGTACG)40 
shows that hemi-intercalation of the bulky ring displaces a cytosine residue from the helix. 
Other structural studies have focused on groove-binding drugs like pentamidine or 
berenil defining their specificity to bind to AT -rich sequences of B-DNA. 45 It appears from 
the crystal structures of these drug-DNA complexes that hydrophibic interaction with 
hydrogen atoms from the nucleotide backbone are in a large part responsible for the AT-
selectivity of these drugs. 
Only two covalently-linked drug-DNA complexes crystal structures have been 
reported.46 That of clinically-important antitumour drug 'cis-platin' has the platinium linked 
to two adjacent guanines of a dodecamer. Except for the one cited previously, no crystal 
structure of non-covalently bound metal complexes with nucleic acids have been reported so 
far. There is yet no structural data on any drug-DNA-protein ternary complex, raising the 
question of the relevance of structural studies on drug-DNA complexes alone. 
1-3.2: NMR Spectroscopy 
NMR spectroscopy is a method of choice to evaluate the binding of a ligand with 
nucleic acids, but also to know where exactly the interaction occurs along the oligonucleotide, 
with what geometry and affinity. High resolution NMR can afford very detailed information 
on various features, such as the electronic effects in the base-pairs induced upon binding, the 
structural changes of the backbone, or the hydrogen bonding the drug establishes with the 
bases or the sugar moieties. This technique is accessible to monitor ligand-DNA interactions 
because the kinetics of these reversible binding associations are slow compared to the time 
1? 
Chapter 1: Introduction 
scale of an NMR experiment. Binding of drugs to nucleic acids has been studied in various 
cases by NMR. 33b, 47,48 
Proton NMR shifts are directly linked to their structural and electronic environment, 
and consequently provide informations on the type of binding involved in a drug-DNA 
interaction. Shifts to lower frequency in the aromatic protons of the intercalated molecule 
result from the anisotropy cone of the stacked aromatic bases, which is generally associated 
with an intercalative binding mode. I8a,b,33b In contrast, a molecule bound in a groove does not 
induce such dramatic electronic changes ; its binding is mainly governed by hydrogen bond 
formation between the drug and some adjacent bases, which is reflected by the shift to higher 
frequency of NH or OH protons involved in hydrogen bonding. Shifts to higher frequency in 
the phosphorus NMR spectrum of the phosphodiester backbone are indicative of a substantial 
perturbation of the sugar-phosphate backbone, that accompanies intercalation.33b 
The NOE experiment being a probe for measuring distances between two nuclei in 3D 
space, can be very informative concerning the environment of the drug and the DNA68'3lb,36c: 
this can reflect, how closely nucleobase or sugar nuclei approached the drug-protons. 
Line width measurements may also be used to study the conformation of nucleic 
acids : this reflects the magnetic spin-spin interactions with nearby proton, nitrogen, and 
phosphorus nuclei. For exchangeable NH and OH protons the increased line width may 
reflect differing exchange rates with solvent and is a measure of the relative stability of the 
local duplex structure. The saturation recovery method is particularly useful for evaluating 
the exchange rates ofNH and OH protons. 
1-3.3: Circular and Linear Dichroism 
Circular Dichroism (CD) and Linear Dichroism (LD) are important chiroptical 
techniques that provide information about molecular structure and about interactions between 
chiral molecules49 : CD is the difference in absorption between right and left circularly 
polarized light, and LD is the difference in absorption of light linearly polarized parallel and 
perpendicular to an orientation axis, as shown in Scheme 1.6. 
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CD= At-Ar 
LD = A11 - A1_ 
Scheme 1. 6 : Definition of CD and LD 
In monitoring the interaction between small molecules and DNA, CD and LD appear 
to be very sensitive techniques to probe the changes in conformation of chiral 
macromolecules, such as DNA or peptides. Furthermore CD experiments deal with the 
solution phase, which is suitable to study changes in conformation, in contrast to the way that 
crystallization may modify the structure, especially for DNA. Another advantage is that the 
shorter timescale (10-15s-1) and the lower concentration are more advantageous for CD than 
withNMR. 
The origin of the CD absorption bands in double-stranded oligonucleotides is the n-+ 
1t* transitions from the achiral purine and pyrimidine bases, linked by the chiral sugar 
moiety, each ofwhich is part of a chiral biopolymer. 5° In this way, the conformation ofDNA 
at different temperatures51 or at high concentration of various salts52 may be identified. For 
example, the B to Z transition in the conformation of DNA is accompanied by a dramatic 
change in the CD spectrum.53 The spectrum ofB-form DNA shows a negative band at 250 
nm and a positive one at 280 nm, while the spectrum of Z-form presents a positive band at 
265 nm, and a negative one at 290 nm. 
The application of the CD technique to study DNA structure has been extended to 
intercalating54 and non-intercalating DNA binding agents associated in most cases with 
induced CD bands. 55 These effects permit a characterization of the binding mode. 
The intercalation of ethidium bromide into DNA has been studied by CD56 : the 
spectra show characteristic induced CD bands between 300 and 360 nm, outside the DNA 
spectral range. With actinomicin, intercalation has also been studied by CD,57 as well as its 
competition with other intercalative agents, or its sequence specificity. 
For a series of porphyrin derivatives, drastic changes were obtained in the ultraviolet 
region of the CD spectra of DNA upon binding, which was accompanied by a characteristic 
induced CD band in the visible region. In addition to an intercalative binding mechanism, an 
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external binding mode has been suggested, based on the positive band in the visible region, 
associated with a selective interaction on dA-dT sequences.58,39c 
The binding of non-intercalating ligands can also be investigated by CD. A dA-dT 
base pair preference for the binding of Hoechst 33258 was suggested by extensive CD 
studies, in addition to several other measurements which have contributed to the elucidation 
of the groove binding mechanism. 59 
An additional feature of nucleic acid structure that is particularly relevant in LD 
studies is the relative orientation of the bases to each other. Variations in the LD spectra upon 
binding with drugs can be used as a proof of an intercalative binding mode. 
The use of CD or LD to investigate the type of DNA binding involving chiral metal 
complexes, including UV-active ligands has been extensively reviewed. 31b,32a,JJb,JSd-f 
1-3.4 : Electrospray Mass Spectra me try 
In recent years, mass spectrometry (MS) has been introduced as a sensitive and 
specific tool for the analysis of specific, non-covalent complexes involving biopolymers. The 
use of MS to probe the interaction between oligonucleotides and drugs became possible 
owing to the development of extremely mild techniques of ionization, such as electrospray 
ionization (BSI) and pneumatically assisted BSI or ionspray (IS), which allowed the 
preservation of even weak interactions during the transfer of ions from the liquid to the gas 
phase, and the subsequent mass analysis of the whole complex.60 This promising 
development in MS avoids the use of a viscous environment, as in F AB or solid matrices in 
MALDI, and allows the direct analysis of biological samples. 
The goal of such an experiment is to determine the stoichiometry of the binding, and it 
may allow an evaluation of the affinity of similar drugs with a given oligonucleotide. 
However this type of experiment is not able to give any information about the binding mode, 
because it is simply related to the relative stability of the system in solution. In the detection 
chamber of a mass spectrometer, the stability of the ion-complexes in the gas phase cannot be 
assumed to be the same as in solution. 
The groove-binder distamycin has been studied by ionspray spectroscopy with a 
dodecamer and the stoichiometry of binding was shown to involve both 1 :1 and 1 :2 complex 
formation. The stoichiometry of intercalation of daunorubicin in a hexamer has also been 
investigated. 61 
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1-4 Luminescence 
1-4.1 : General features 
Photoluminescence62 is the emission of energy from an electronically excited state of 
an atom or a molecule following the absorption of light. The emission can be subdivided into 
\ fluorescence and phosphorescence (Scheme 1. 7). The radiative process which occurs 
between the singlet excited state S1 and the ground state So is termedjluorescence and lasts 
for 10-9 -10-6s. In the case of phosphorescence, emission of light is preceded by inter-system 
crossing (ISC) from the singlet excited state to the triplet excited state. The subsequent 
transition which arises from a triplet-to-singlet transition (different spin multiplicity), is 
characterised by a small natural radiative rate constant (i.e. long lifetime of 10-4-1 s). The 
excited state can also be deactivated by non-radiative de-excitation pathways, such as internal 
conversion (I C) or vibrational quenching. 
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Scheme 1. 7: Simplified Jablonski diagram 
1-4.2 : Luminescence of lanthanides ions 
l Vibrational relaxation 
Most of lanthanides are known to luminesce, particularly in the solid state. 
Lanthanide(III) ions contain partially-fitted 4f shells and so, are paramagnetic, except La and 
Lu which are diamagnetic. Their luminescence properties are characterised by sharp emission 
bands, that is due to the transitions between the lowest lying orbitals, which have a 4f 
11'> 
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electronic configuration. According to the Russell-Sanders coupling scheme, the f-f 
transitions of the lanthanides are spin-forbidden (~S * 0, Laporte parity rule).63 However this 
scheme fails in the case of heavy ions, because of the large spin-orbit interactions. In 
consequence the extinction coefficients associated with these transitions are very small (of the 
order of 1 M-1cm-1). · 
The luminescence spectra of lanthanides exhibit very sharp emission bands, which are related 
to the small ligand field effect to which the 4f electrons are subjected. Another feature of 
certain f-f transitions in lanthanide ions is their sensitivity in intensity or shape towards the 
environment, they are called hypersensitive transitions.64 Such transition, like 5D0 ~ 7F2 (~J 
= 2), or 5D0 ~ 7F4 (~J = 4) of Eu3+ can be used to study the composition of the first 
coordination sphere. 
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Scheme 1.8: Energy levels of selected lanthanides ions 
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The relatively long lifetimes are directly related to the observed small line widths. 
The splitting of the energy levels of the lanthanide ions results in many possible transitions 
between the different states after excitation of the ion (Scheme 1.8). Therefore the emission 
spectrum of a lanthanide ion consists of a series of distinct frequencies each corresponding to 
the transition from the lowest excited state to one of the sub levels of the ground state ; these 
frequencies are characteristic of each ion. The most intense luminescence band is usually 
used to determine the luminescence lifetime of the lanthanide ion. The luminescence lifetime 
't is defined by Equation 1.1 : 
I(t) = Ioexp (-t/'t) (Eq. 1.1) 
where I(t) and 10 are the luminescence intensities at t = t and t = 0, respectively. 
Monitoring the emission at a given emission wavelength, while scanning the excitation 
wavelength, gives information about the transitions from the ground state, which populate the 
emitting state, either directly or via higher-lying energy levels. 65 
Deactivation of luminescent excited state 
The luminescent lifetimes in aqueous solutions for the emissive level of Eu typically 
lie in the range of the 0.1-2.0 ms. Other non-radiative processes involving vibrational energy 
transfer can decrease the lifetimes. The high energy vibrational oscillator can couple 
vibrationally to the excited states of the lanthanide ions, and efficiently deactivate the 
luminescent state. It is well known than 0-H, N-H and C-H oscillators quench the excited 
states energy. However 0-D oscillators are at least 100 times less efficient than 0-H 
oscillators, and so measurements of excited state lifetimes in H20 and DzO can be used to 
find the hydration state, q, of a lanthanide complex.66 
Europium luminescence 
Of all the lanthanide ions Eu3+ is the most commonly studied for its luminescent 
properties. The main luminescent transitions of Eu occur between 5Do and 1F1 levels. The 
more intense emission bands generally arise from the transitionS, no --+ 7f 1 at 590 nm and 
5Do-+ 7F2 at 610 nm. 
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710 
Scheme 1.9: Typical luminescence spectrum of an Eu(JJI) complex. 
The 5D0 ~ 7F 1 transition has magnetic dipole character, and so is essentially 
independent of the ligand environment but is very sensitive to the symmetry of the complex. 
In the case of 5D0 ~ 7F2 , its nature being predominantly electric dipolar, this transition is 
hypersensitive to the ligand environment. It is very weak or even not visible if the Eu ion lies 
on an inversion centre. As the level 7F0 is non-degenerate, only a single transition is allowed 
to this state, the allowedness of the transition being a sensitive function of the complex 
symmetry. 
1-4.3: Sensitised emission 
As discussed before, the main drawback of lanthanide luminescence is the lack of 
efficiency of direct excitation because of the low molar extinction coefficients (E = 1 M-1.cm-
1). A way to overcome that problem is using an antenna as a relay to absorb energy and 
transfer it to populate the excited states of lanthanides. A two component system combines a 
lanthanide ion binding subunit with a suitable aromatic chromophore ('antenna'). 
The sensitiser absorbs the excitation energy at an appropriate wavelength, and transfers this 
excited state energy directly to the lanthanide excited state, resulting in sensitised emission. 67 
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The first step in sensitised emission involves the absorption of the excitation light by 
the sensitiser, as a result the sensitiser is excited to its singlet excited state (S,) The second 
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excited state (T1) of the sensitiser. This triplet state can populate a lummescent state of the 
lanthanide ion by energy transfer. The excited lanthanide can then emit l1ght at longer 
wavelength as it returns to the ground state. 
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The efficiency of the luminescence from the lanthanide IS detennined by the following 
processes: 
• Light absorption by the antenna (high extinction coefficient at the excitation 
wavelength) 
• Efficiency of intersystem crossing : <Prsc 
• Efficiency of energy transfer from the antenna to the lanthanide : llEr 
• Efficiency of lanthanide luminescence : <PLn 
The quantum yield as the product of these steps is given by equation 1.2: 
<Poverall = <Prsc •llEr • <PLn (Eq 1.2) 
The quantum yield for emission from the excited lanthanide ions ( <PLn) is usually high as long 
as vibronic quenching by XH oscillators is minimised. The efficiency of the intersystem 
crossmg IS very high for diarylketones, but more modest for planar aromatics such as 
phenanthrenes. 
Energy transfer is the process by which the excited state of a molecule or ion relaxes 
its energy to a lower-lying state. Such a process requires an electronic interaction between the 
donor (antenna) and the acceptor. Two mechanisms have been postulated to occur: 
• A coulombic predominantly dipole-dipole interaction via the electromagnetic field 
renders energy transfer from the sensitiser to the acceptor; this is called the Forster 
mechanism68 and represents an action at distance. 
• The exchange interaction occurs via overlap of the electronic orbitals, and hence 
requires closer contact. Simultanously an electron from the excited sensitiser is 
transfered to the acceptor, while a ground state electron from the acceptor goes back to 
ground state of the sensitiser ; this is called the Dexter mechanism69. 
The energy transfer is often accompanied by competing quenching processes, and 
therefore it can be difficult to detennine the efficiency of the energy transfer process. 
1-4.4 : Ligands for lanthanide ions 
The coordination properties of lanthanides ions are associated with the nature of the 4f 
valence electrons which are located in the inner orbitals and are therefore not directly 
accessible for bonding. The lanthanide contraction is at the origin of the; gradual increase in 
')1 
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effective nuclear charge and oxidation potential, and a contraction of the ionic radius along 
the lanthanide series (La3+ to Lu3+). The 'hard acid' character of lanthanide ions favours an 
electrostatic interaction with ligands containing 'hard donor atoms', such as oxygen, nitrogen 
or fluoride. The high charge density of a lanthanide(III) ion enhances the binding with 
polyanionic ligands such as carboxylates, phosphinates or phosphates. The coordination 
number and the geometry of their complexes is rather flexible in comparison to the constraints 
imposed by the ligand-metal orbital overlap in many transition-metal complexes. Lanthanide 
ions commonly present a coordination number from 7 to I 0, with 8 and 9 coordination 
number predominating. The potential use of such complexes as luminescent probe for 
immunofluoroassays 70 requires a high thermodynamic and kinetic stability in aqueous 
solution. 
The vibrational quenching of lanthanide ion luminescence also initiated an interest in 
coordinating ligands able to encapsulate and shield the lanthanide centre from the deactivating 
effect of coordinating OH oscillators ( eg. H20, alcohols ). 
A class of ligands often cited comprises some acyclic polyamino polyacetic acids like EDT A 
or DTPA, 71 but the main drawback of these complexing agents was the relatively low kinetic 
stability of their complexes to be good candidates for immunofluoroassays. Various acyclic 
ligands using pyridine, or 2,2' -bipyridine72 present a chromophore which can act as a 
sensitiser for the lanthanide ion they complex, and they have the advantage of shielding the 
metal centre efficiently from the solvent, although their hydrophobic nature limits their 
solubility in aqueous media. 
To overcome these effects of poor kinetic stability or solubility in water, macrocyclic 
ligands such as cryptands and azacrowns, have been developed and have been shown to form 
thermodynamically and kinetically stable complexes with lanthanides. Their ability to 
encapsulate the lanthanide ion inhibits deactivation by solvent oscillators. Furthermore, the 
functionalisation, especially with carboxylate pendent arms, can increase their solubility in 
aqueous media, and by increasing the number of donor atoms more stable complexes are 
obtained. Expansion of ligand denticity allows scope to introduce a sensitiser to improve 
luminescence properties. 
In the case of cryptands, the donor atoms are already somewhat preorganized for 
complexation, and this can result in a completely shielded metal centre. The original [2.2.1] 
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cryptand73 consisting of three oxyethylene bridges which, when replaced by bipyridine units74 
afford useful antennae to increase the luminescence from the bound lanthanide ion. 
Porphyrins are other biological compounds that form lanthanide complexes of special 
interest. Two texaphyrin complexes are undergoing clinical trials ; a gadolinium compound is 
an effective radiation sensitiser for tumour cells, whilst the corresponding lutetium compound 
that absorbs light in the far-red end of the the visible spectrum is in phase II trials for 
photodynamic therapy for brain tumours and breast cancer. 75 
In the aza-crown class, many derivatives of DOTA (1,4,7,11-tetraazacyclododecane-
N,N' ,N' ',N'' '-tetraacetic acid) exist where the pendent carboxylic arms have been replaced 
by phosphate, phosphinate, amide or ester groups. The different coordinating arms have an 
influence on the luminescence spectra of their europium complexes spectra, which 
demonstrates the effect of varying the symmetry around the metal centre76. 
1-4.4.1 : Cyclen as a ligand system 
Macrocyclic octadentate ligands derived from a 1,4,7,11-tetraazacyclododecane ring 
( cyclen) have received attention as a result of their ability to form stable and non-labile 
complexes with metal ions, especially lanthanide cations. In particular, one of the most 
successfulligands, DOTA, whose Gd(III) complex is widely used as a contrast agent for MRI 
and biomedical applications, has been investigated through the whole fblock series. 
1-4.4.2: Isomerism ofDOTA complexes 
The X-ray characterization of Ln3+ complexes of DOTA reveals that the eight 
coordination sites, four nitrogens and four oxygens, provided by these ligands, are arranged in 
two parallel squares, twisted by an angle <p. There are two limiting structures defined by the 
value of this twist angle : a square anti prismatic geometry is associated with an angle of ea. 
40°, while a value of nearer 29° defines the twisted square anti prismatic isomer. These 
isomeric structures emanate from the minimum energy values of the ring N-C-C-N torsion 
angles (±60°) and the side arm N-C-C-0 angles (±30°). The enantiomeric ring conformers 
are referred to as (8888) and (').),:A.t...) (Scheme 1.12),77 while the interconversion of t1 (right-
handed) and A (left-handed) isomers proceeds via arm rotation (Scheme 1.13). 78 
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Scheme 1.12 : Equilibria between 8 and /!.forms of the eye/en ring 
by cooperative ring inversion 
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Scheme 1.13 : Equilibria between the L1 and A isomers 
following arm rotation in DOTA type complexes. 
These two elements of symmetry therefore give rise to four stereoisomers related as two pairs 
of enantiomers, which may interconvert in solution via ring inversion 8888 ~ J..) .. )..'A or arm 
rotation (A ~ .1). The former motion occurs typically at a rate of 50s-1 (298K) in water 
(Scheme 1.14). 
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1-4.5 : Sensitiser 
The efficiency of the photosensitisation process depends on the properties of the 
sensitiser to make a practical luminescent probe. Even when the energy transfer from the 
organic chromophore to the lanthanide ion is only moderately efficient, it may still offer a 
considerable advantage over direct excitation. The selection of a suitable antenna 
chromophore should be based on the following points : 
• The triplet energy level of the antenna should preferally be 2000 cm-1 above the 
luminescent level of the lanthanide to ensure that the energy transfer process IS 
effectively irreversible under ambient conditions. 
• A high extinction coefficient in the UV-visible region with possible excitation at 
wavelengths greater than 340 nm (to avoid quartz optics and overlap with the 
absorption region of biological aromatic compounds). 
• The singlet excited state should not be readily oxidized, to avoid the quenching of the 
excited state lanthanide by electron transfer (oxidation potential E0 for Eu3+ /Eu2+ = -
0.35V for the aqua ion and ea. -1.1 V for typical complexes). 
• An efficient intersystem crossing from the antenna singlet excited state to the triplet 
excited state. 
1-5 Luminescent probes using lanthanide ions 
1-5.1 : General features 
Lanthanides are valuable spectroscopic probes because of not only the drastic changes 
they bring to the NMR spectra of their ligands, but also their luminescence properties. 
Furthermore, calcium and lanthanides possess very similar ionic radii, and are likely to 
occupy the same type of coordination sites in biological macromolecules. Lanthanides can 
enter into reaction with biologically active compounds, replacing ions of calcium, and due to 
their specific spectroscopic properties, can serve as probes providing information on these 
molecules and the biological processes occuring in them. 80 The main advantage of lanthanide 
luminescent probes is their high sensitivity, allowing them to act as both structural and 
analytical probes in physiological media. 
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centre or in the local environment of the sensitiser. Three parameters can be morutored to 
signal binding of an analyte . emission intensity, lifetime and polarizatiOn The most 
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absorbance of the ligand) and an efficient energy transfer process from the ligand to the 
lanthanide ion. 
Lanthanide chelates are employed in different commercially available fluoroimmunoassays: 
DELFIA (Dissociation-Enhanced Lanthanide FluorolmmunoAssay) and FIAgen (FiuoroimmunoAssay). 82 
In Durham, lanthanide probes based on variously substitued cyclen including 
triphosphinates, tetraamides and tricarboxylates81 (Scheme 1.16), have been developed with 
the aim of signalling anion binding, pH, p02, metal ions or the interaction with biomolecules, 
such as nucleic acids. 
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Scheme 1.16: Selected R~sponsive Lanthanide Complexes developed in Durham 
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Sensing pH involves two approaches : the first is the protonation-deprotonation of the 
antenna before energy transfer, that may modulate the luminescence from Eu(III) or Tb(III) 
ions, e.g. for (1)83 and (IV). 84 The second involves the coordination of the fourth pendent arm 
to the lanthanide which is sensitive to pH in the range of 5.5 to 7.5, e.g. (ll). 85 
The luminescence intensity and the shape of the emission spectrum m diaqua 
complexes, e.g. (DI), is also affected by the presence of anions. Carbonate, acetate, 
lactate/citrate, malonate and phosphate each can bind to the lanthanide centre displacing water 
molecules and perturbing the lifetime and emission intensity. 86 Halides have also been shown 
to act as efficient quenchers of the antenna fluorescence and lanthanide luminescence in (1). 
In Tb complexes of (I) the sensitivity to molecular oxygen is reflected by quenching of 
emission; this could be useful to determine p02 in aqueous solution.87 
The presence of nucleic acids is signalled by an enhancement of the luminescence 
intensity of (V), where the porphyrin unit sensitizes the Yb3+ ion complexed by a chiral 
tetraamide cyclen. 88 
The complex (VI) has been developed with the aim of responding selectively to 
changes in zinc concentration occuring at physiological pH, by modulation of Tb 
luminescence. 89 
1-5.2: Lanthanide probes of nucleic acids 
The literature of lanthanide-nucleic acid interactions is sparse when compared with 
lanthanide-protein studies. The effects of the aquated lanthanide ions on the structure of 
oligonucleotide duplex have been studied by many research groups. 90 Energy transfer from 
nucleic acids to the Tb(III) ion has been studied to investigate the geometry of the binding of 
ions to the nucleobases, and by extension the selective detection of base mismatches in a 
given oligonucleotide. 91 Cleavage of the DNA strand by lanthanide ions is also a well 
documented area of research. 92 
Lanthanide chelates have recently been shown to be promising probes for the structure 
and the composition of polynucleotides. An example of the use of lanthanide complexes for 
the detection of nucleic-acids is the technique involving a ternary complex of Tb(ID) with 
diethylenetriarnidepentaacetic and p-aminosalicylic acids bound with single-stranded DNA. 93 
In such a system, the intensity of Tb(III) emission increases with increasing concentration of 
?0 
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DNA An other method proposed for the direct determination of nucleic acids involves an 
Eu(III) complex of terpyridine-bis(methyleneamine )tetraaacetic acid,94 and on agarose gel, an 
Eu(III) complex ofBCPDA was employed. 95 
Sensitised emission from Eu(III) and Tb(III) has also found application in the 
detection of single/doubled strand nucleic acids contaning guanine, thiouridine or xanthine by 
liquid chromatography. 96 The suitable energy levels of excited states of these bases allow an 
energy transfer from the bases to the lanthanide ions. 
Sammes et al. developed one of the first method for the direct in situ identification of 
mutations in a target strand of DNA 97 The probe is composed of a complemantary sequence 
of bases that can hybridise with the target DNA and to which is attached at one end, a short 
linker molecule bearing a chelated europium ion. The chelator used is EDTA which binds 
quite strongly to the europium ion, but does not fill its coordination sphere. A second 
component is a sensitiser that works with further encapsulation around the metal ion to which 
is attached a phenanthridinium intercalating group (Scheme 1.17). The emission from the 
europium shows a decrease in intensity when the probe is bound to the mis-match compared 
to the matched (complementary) sequence. 
Target DNA DNA probe Duplex Intercalation 
1.Hybridation of probe with target 
2.1ntercalatorfinds the site where Eu binding can occur; active complex 
Scheme 1.17: Sammes probe 
hv 
' hv' 
An other example of oligonucleotide-europium complex conjugate has been developed 
by Baker et al. aiming the selective cleavage of the phosphate bond for an anti-sense activity 
in cells. 98 The Eu(III) ion is complexed by a trishydroxyethyl substituted cyclen linked to the 
1() 
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oligonucleotide (Scheme 1.18). The cleavage is alleged to occur by nucleophilic attack of the 
phosphate linkage by the Eu complex. Details are lacking however and the ligand is unlikely 
to form very stable complexes with Eu at ambient pH 
Scheme 1.18: Oligonucleotide Eu-conjugate 
Hurskainen et al. have developed an europium-labelled DNA probe, usmg a 
derivatised N,N' -biscarboxymethylaminomethylpyridine chelate.99 The Eu chelate was 
introduced on transaminated /.DNA, and the hybridisation assays were carried out on the solid 
phase. The advantages of their detection method is the use of time resolved fluorescence to 
quantify and interpret easily the probe response over a range of target DNA and at a fairly 
high probe concentration (up to 500 ng/ml). 
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Because the growth of tumour cells often is accompanied by variation in local pH, 
signalling a change in acidity in human body is an important feature of cancer diagnosis 
(Scheme 2.1 ). Consequently the design of a pH probe which responds precisely to that pH 
range (typically 6.8-7.5) is critical for potential uses such as micro-scale pH measurements. 
Chemically robust single-component luminescent sensors are thus needed for studying this 
and related changes in ionic concentrations in living cells. 
pH 7.4 
pH 6.9 
Healthy cell Tumour cell 
Scheme 2.1: Intra and extra cellular pH in a healthy and tumour cell 
2-1: Previous work on pH sensors. 
In 1997, Parker et al. designed various macrocyclic lanthanide complexes, involving 1,4,7,10-
tetraazacyclododecane ( cyclen) bearing a phenanthridine chromophore which acted as a 
sensitiser for the bound lanthanide ion (Scheme 2.2). 1 
(I) Ln = Eu 
(Il) Ln = Tb 
Scheme 2.2: Phenanthridinium lanthanide conjugates 
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This chomophore was chosen for its property of allowing excitation in biological media: it is 
possible to excite the sensitiser at wavelengths of over 350 nm minimising the associated 
background fluorescence from excited biomolecules. The sensitising chromophore serves a 
dual function: its singlet or triplet excited states may be reversibly perturbed by changes in the 
local environment, in particular pH changes leading to the protonation of the phenanthridine. 
These monoamide triphosphinate complexes are kinetically stable in aqueous media, and exist 
as one major stereoisomer in water. Upon protonation the phenanthridinyl absorption 
spectrum exhibits distinctive changes: the three absorption bands visible at neutral pH become 
only two in acidic conditions, increase in intensity and shift to longer wavelengths, from 350 
nm to 370 nm (Scheme 2.3). Consequently, the Eu(III) luminescence sensitised at 370 nm by 
the phenanthridinyl group increases by a factor of over 500 by protonation of the antenna. 
The fluorescence spectrum from the phenanthridine group also undergoes changes as the 
phenanthridinyl nitrogen is protonated: the intensity increases by 300% and there is a shift to 
longer wavelength of 40 nm. The variation in the intensity of the phenanthridine fluorescence 
(Aern = 405 nm, Aexc = 320 nm) and of the Eu emission (.Aem = 594 nm, Aexc = 370 nm) with pH 
allowed an estimate of the pKa of the singlet excited state of the complex. A value of 4.4 was 
found for both parameters monitored, which is, according to the literature, fairly similar to the 
pKa value of 4.45 reported for the phenanthridine ground state.2 
The Tb complex responds differently to acidic conditions3: the luminescence from Tb drops 
upon protonation of the phenanthridine (Scheme 2.4). The phenanthridine based fluorescence 
increases by a factor of three by pro to nation of phenanthridinyl nitrogen, as observed with (1). 
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The different behaviour displayed by the Eu(Ill) and the Tb(Ill) comple~es can be explamed 
by considering the energies of the appropriate excited states (Scheme 2 5 ). 
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Under acidic conditions the phenanthridine triplet state lies only 800 cm-1 above the 5D4 
energy level of Tb. Such proximity leads to efficient deactivation through thermally activated 
back energy transfer from the metal to the sensitiser at the expense of the lanthanide emission. 
Such a process does not occur in the case of Eu, owing to the larger energy gap between the 
two levels. When unprotonated the triplet state ofphenanthridine is 1500 cm-1 higher than the 
Tb 5D4 level; the rate of back energy transfer in the Tb complex is then very much reduced, 
and no longer competes effectively with the rate of intramolecular energy transfer and hence 
lanthanide emission. The excited state pKa of 5.75 for the Tb complex, as determined from 
the dependence of the metal luminescence, is close to the pKa value reported for the triplet 
state of phenanthridine itself (PKa (T1)=5.75). The complementarity of these two lanthanide 
complexes is evident in their potential use as luminescent pH probes. 4 
2-2: Modification of the phenanthridine chromophore 
The phenanthridine chromophore possesses very useful characteristics in its excited 
energy levels, thereby allowing the sensitisation of both Eu and Tb ions. Thus there is a 
relatively low lying first excited state and absorption of light at wavelengths of around 350 
nm occurs fairly efficiently (E > 103 M-1cm-1). Moreover there is a fairly small singlet triplet 
energy gap, allowing a fast rate of intersystem crossing to populate the triplet which, in turn, 
is sufficiently high in energy to allow intramolecular energy transfer to a proximate Eu or Tb 
ion. Furthermore the "switching" process operated by the protonation/deprotonation of the 
phenanthridinyl nitrogen occurs at pH 5.7, which is relatively close to the physiologically 
useful pH range (pH 5.5 to 7.5). Because the change at which this effect occurs is controlled 
by the modification of the molecular structure of the antenna, it was expected that substitution 
a to the nitrogen (i.e. at the 6-position) would perturb the pKa of the phenanthridine, without 
affecting its triplet energy too much. 
Therefore, a series of simple alkyl and both electron-withdrawing and electron-
releasing groups were considered. Initially the effect on the singlet and triplet energy levels 
was screened. 
2-2.1: Introduction of substituents in 6 position: synthesis 
Alkylation or arylation of the phenanthridine at the 6-position was expected to 
modulate the pKa of the sensitiser. The positive inductive effect of the butyl group should 
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raise the pKa, but could also affect the protonation equilibrium through a steric effect via 
steric inhibition of solvation of the phenanthridinium conjugate acid. Likewise a phenyl 
group could perturb the value in the required direction despite its small negative inductive 
effect. Amination has a negative inductive effect, but the lone-pair conjugation could increase 
. favourably the absorbance Amax· The introduction of an electron-withdrawing ester group was 
expected to lead to a decrease of the pKa, but was also likely to affect negatively the triplet 
energy. Cyanation should have a negative inductive effect, but the highly conjugated 
chromophore would absorb to longer wavelength. 
o:tsto), 
4 
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Scheme 2. 6: 6-Substituted phenanthridines 
Synthesis of 6-substituted phenanthridines 
6-Butyl and 6-phenyl phenanthridine were obtained following the Gilman procedure,5 
by nucleophilic attack of the appropriate lithium reagent at low temperature. The re-
aromatisation step was carried out using manganese (IV) oxide as an oxidising agent. 
4() 
Chapter 2: pH Responsive Lanthanide Probes 
A series of 6-substituted compounds was prepared by the nucleophilic substitution of 
chloride from 6-chlorophenanthridine. 6-Chlorophenanthridine itself was obtained according 
to the literature method,6 by reaction of phenanthridinone with phosphorus oxychloride in the 
presence of N,N-dimethylaniline. The next step involved the nucleophilic substitution of the 
chloride by cyanide, benzylamine, dibenzylamine, or a thiol, which allowed respectively 6-
cyanophenanthridine, 6-benzylaminephenanthridine, 6-dibenzylamine phenanthridine and 6-
thiophenanthridine to be obtained. The benzylamine and dibenzylamine substitutions were 
also carried out using only minor variations to the literature procedure. 7 6-
Aminomethylenamine phenanthridine 10 was prepared by reduction of 6-
cyanophenanthridine 9 using Pearlman's catalyst and hydrazine hydrate. 6-N-methyl-N-[2 
boroxyphenylmethyl] phenanthridine, 5, and 6-carboxymethyl phenanthridine, 6,_ were made 
available to the author and were given generously. The synthesis of 6-(N-chloroacetyl-1 '-
amino )-butyl phenanthridine 7 is detailed in chapter 4. 
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... 
015" 1) RLi,Et~.-?a·c ~ """' 2) Mn02,CH2CI2,r.t. h 
R=Bu, Ph 
1 
N:O~to~"' 1/ 
Thiourea, 
EtOH,so·c 
---'---~ ... 
KCN,~ 
1oo·c 
a~CN 
~u 
9 
8 
Q:{Sh " 
"""' 
.,.-,;:. 
3 R=H,R'=Bn 
4 R=Bn,R'=Bn 
Pd(OH)2,NH2NH2, 
MeOH,r.t. 
2 
Scheme 2. 7: Synthesis of substituted phenanthridines 
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2-2.2: Photophysical aspects of the chromophore 
The effect of each of these different substitutions on the pKa of the 6-substituted 
phenanthridine has been investigated by monitoring the variation of absorbance and 
fluorescence upon protonation. The changes in absorbance as a function of pH allowed the 
determination of the pKa of the ground state S0, for each of the substituted phenanthridines. 
The variation of fluorescence intensity with pH similarly allowed the determination of the 
singlet excited state (SI) pKa. The more representative value for a pH responsive probe is the 
pKa of the singlet because the variations in its population are echoed by changes in the 
emission of the lanthanide excited state following intramolecular energy transfer. The value 
of the pKa is obsviously crucial in the selection of the substituent group, but the energy level 
of the triplet excited state has also to be considered. 
The singlet state energies of neutral and protonated species can be established from 
their UV-visible absorbance spectra at room temperature. Their triplet state energies were 
measured from phosphorescence spectra, at 77K in a diethyl ether/pentane/ethanol glass. The 
values obtained for the various substituted phenanthridines are listed in Table 2.1. 
In order to identify an appropriate substituted phenanthridine for pH measurements, an 
increase in the pKa value was sought without affecting significantly the triplet energy. 
The butyl chain allowed the phenanthridine pKa of compound 1 to rise to 5 for the singlet 
excited state, and the singlet and triplet energies remain unchanged compared to those of the 
phenanthridine itself; both effects were considered suitable. The phenyl group, 2, had only a 
slight increasing effect on the pKa value compared to the butyl substitution, probably due to 
the small negative inductive effect of the aromatic ring. The effect on the energy levels was 
mmor. In the case of the amino-substituted compounds, their strong electron·donating 
character allowed the pKa to be raised up to 5.5 (only the pKa of 6·benzylamine 
phenanthridine was determined; it was expected to be fairly similar for compounds 4 and 5). 
This type of substitution had a dramatic effect on the triplet energy, raising it up to 23000-
24000 cm-1. This value is too high to allow an efficient energy transfer. The carboxymethyl 
substituted compound, 6, had a similar increasing effect on the triplet state energy. This 
would also tend not to favour energy transfer to the metal. Compound 7 had a pKa which was 
well beyond the useful range. In this case, steric inhibition of hydration of the 
phenanthridinium ion may play a part. The triplet energy of 6·thiolphenanthridine, 8, is 
slightly lower than the parent unsubstituted phenanthridine. 
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6-Substituted pKa (So) pKa (S1) E singlet (cm-
1) E triplet (cm-1) 
Phenanthridine Neutral Acidic Neutral Acidic 
Phenanthridine 3.4 3.6 28200 26300 22000 21300 
06 4.6 5 28600 26600 21600 21000 1 -"'-
_, N~ ::I 28200 25600 20700 
-<" 3.4 3.9 20500 1: 2 
~ CC6 5.5 5.5 28600 26600 23400 21700 3 
ooto;, - - 28000 - 23800 23600 
M~ CC{$ hOHb 
- -
28000 
-
23800 22600 
5 
ccts-· . 28000 20100 19900 - - -6 
ci?- 2.3 2.5 28200 25900 21800 21000 7 
CC{S". ~ 
- -
24300 - 19800 19800 
"" I s 
- - - -
21600 21400 
4.8 4.9 28600 26300 - -
* This may exist as the thioamide tautomeric form : 
Table 2.1 :Acidity constants and singlet excited state and triplet excited state energies 
for a series of 6-substituted phenanthridine 
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A cyano group (compound 9) being electron-withdrawing is not expected to increase the pKa 
of the phenanthridine nitrogen, but lowered the singlet energy, allowing excitation at 
wavelengths in the range 360-380 nm. The reduction of the cyano group in 9 provided a route 
to 6-aminomethylphenanthridine (compound 10). This amine possessed a pKa which was 
fairly similar to that measured for 6-butyl phenanthridine, consistent with a small electron-
releasing effect of the aminomethyl moiety. 
Taking all these facts into consideration, the more suitable substitution for increasing 
the pKa value without introducing too much modification of the photochemical properties of 
the sensitiser, i.e. singlet and triplet energies, is the substitution by a simple alkyl group, and 
the butyl substituent was considered the most appropriate. 
2-3: A pH probe based on 6-butyl phenanthridine 
The target complexes for pH sensmg are based on a cyclen macrocyclic ligand 
functionalised with three carboxylate or phosphinate pendent arms; such a ligand forms 
neutral complexes with lanthanide(III) ions. 
2-3.1: Synthesis of europium(!!!) and terbium(IIJ) complexes 
The synthesis, developed with the acknowledged assistance of Dr. Kanthi Senanayake, 
was based on a route established for the original unsubstituted phenanthridine probe,4 
introducing the butyl group in an early synthetic step. The first step involved the bromination 
of the phenanthridine ring (12), which occurs selectively in the 2 position with NBS. 4 The 
nucleophilic alkylation in the 6 position was undertaken using related method involving 
butylmagnesium chloride to avoid a putative bromide-lithium exchange in the case of the 
organolithium reaction. In an oxidative work-up step, the re-aromatisation of the ring was 
effected using manganese(IV) dioxide as an oxidising agent. Thereafter a nucleophilic 
substitution of the bromide (13) by a cyano group (14) was achieved using cuprous cyanide 
and the primary amine 15 was isolated after reduction with borane-THF. The peptide 
coupling with a-chloroacetic acid was carried out in THF in the presence of EDC and 
hydroxybenzotriazole, allowing the formation of 16. 
LI.LI. 
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NBS,CCI4, 
80°C, 12h. 
12 
1) BuMgCI,Et02 
-10°C,2h 
2) Mn02,CH2CI2, 
r.t.,12h 
CICH2C02H,EDCI 
HOBt,OOC, 1 h 
X 
15 
Scheme 2.8: Synthesis of the a-haloamide chromophore 
CuCN,DMF cX=Br 13 
1400C,2d X=CN 14 
The carboxylate ligand 18 was prepared by alkylation of the a-haloamide 16 with the 
tri-ester cyclen derivative 17, in which the tert-butyl protection was subsequently removed 
under acidic conditions (Scheme 2.9). 
17 
1) 16,K2C03,MeCN 
700C,4h 
2) 80%TFA-CH2CI2 
r.t. ,3h 
Scheme 2.9: Synthesis of the carboxylate ligand 18 
18 
The phosphinate ligand 23 was obtained after protection of three of the cyclen ring 
nitrogens using established methodology8 in which a molybdenum-tricarbonyl complex is 
formed, which leaves one amine free for the alkylation reaction with the phenanthridine a-
haloamide, 16. Subsequent phosphinoxybenzylation using formaldehyde in the presence of 
molecular sieves, followed by hydrolysis of the phosphoester led to the triphosphinate ligand 
23 (Scheme 2.10). The benzyl phosphinate ligand 23b was obtained in a parallel manner to 
the methyl phosphinate ligand 23a. 
23a: R =Me 
b: R = Bn 
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21 
j RP(OEt)2,CH20, 4A,THF,60°C,4h 
N Bu 
~ 
C{, ,....OEt 
R-lf \1\~N 
KOD,D20,r.t., 16h eN N) ~ 
EtO N N \ _jLJ \ o"~ I ... R R ,....P.::::-0 EtO 
22a: R =Me 
b: R = Bn 
Scheme 2.10: Synthesis of the phosphinate ligand 23a and 23b 
The last step involved the complexation of both ligands with lanthanide(III) salts in 
acetonitrile; for the monoamide tricarboxylate ligand 18, europium(III) (or terbium) acetate 
was used, and europium(III) nitrate was employed in the case of the monoamide triphospinate 
ligand 23. The neutral complexes 19, 20, 24 and'25 that formed were purified on a short 
alumina chromatography column. 
{ 
Eu3+ 19 
Ln lb3+ 20 
Scheme 2.11: Europium and terbium complexes 
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2-3.2: Luminescence properties of these complexes 
2-3.2.1: Determination of acidity constant 
Absorption spectra for Eu(III) and Tb(III) complexes were recorded in acidic (pH<2) 
and neutral media (pH>7). The protonation caused a marked shift to longer wavelength and a 
hyperchromism with an isosbestic point at 306 nm. Monitoring the changes in absorbance at 
365 nm as a function of pH allowed the ground state pKa to be determined (295K, I= 0.1 M 
NMe4N03). The pKa of the singlet excited state was also estimated by monitoring the change 
in fluorescence emission from the phenanthridinyl group. The pKa value determined by 
monitoring the changes in metal emission was the same as the one from fluorescence 
emission changes, previously described. 
~ Europium(III) tricarboxylate complex 19 
The absorbance spectra recorded for the europium complex 19 were typical of the 
phenanthridine group, showing a shift to longer wavelength of about 20 nm and a significant 
hyperchromism in acidic solution, compared to the spectra obtained in neutral conditions. A 
pKa of 5.4 was determined for the ground state of this 6-substituted complex, that is 1.2 units 
higher than for the analoguous unsubstituted complex (1), (described in part 2-1 ). 
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lnt. 
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Scheme 2.12: Variation of fluorescence intensity (Aem = 405 nm) as a function of pH for 19, 
showing the fit to the experimental data points (295K, 1 = 0.1 M NMe4N03, Aexc = 304 nm) 
t17 
The pH dependence of the fluorescence emission raised from the phenanthndine group 
( A.C"\c - 365 nm. Acm 405 nm) allowed an estimate of the pKa. of the smglct exc1ted state, and 
was found to be 5.6 (Scheme 2.12). Again this value represented an mcrease of 1 ~units from 
that observed for (I}. 
The phenanthridinyl group sensitised em1ssion from the metal foliO\\ mg e\cltatlon at 
365 nm. Therefore Eu emission spectra w•ere also recorded as a function of pH (l,e,. = 30-l 
nm, A~:~n = 580, 592 or 615 nm, IJJ = 0, I ,2) (Scheme 2.13) The vanat10n 1n mtens1ty \VIth pH 
of any of the europium emission bands ref1ected the singlet exc1ted state pKd value of 56. 
similar to that obtained from tluoresence data. In acidic conditions, the emission intensity 
showed a three fold enhancement compared! to the intensity in neutra l media P•c,, - 30-l run) 
The same effect was observed for the fluorescence accompamed by a sh1ft to longer 
wavelengths of20 nm. 
The data based on the experimental measurements fitted (usmg a non-linear lteratJ\·e least 
squares fitting procedure operating under Excel R software) allowed the establishment of the 
acidity constant 
Em 
lnt 
7,0E+06 1 
pH7 
6,0E+06 pH 2 
o.u~·us 
4,0E+06 
3.0E•06 
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1,0E+06 l O.OE+OO 
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A. I nm 
Scheme 2.13: I· uropmm emiSSIOn sensllised by phenuntlmdmyl exc:lltJium 
<IS u.fimci/On ofpHfor 19 (295K. Am 30-1 nm) 
= 
750 
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The europium emission spectra showed fairly precisely the different absorption bands 
corresponding to each transition from the 5D0 level to the ground state 7Fn manifold. It was 
observed that no changes occurred in the form of these bands, consistent with the absence of 
any change in the Eu coordination environment following ligand protonation. The variations 
in intensity observed at different pH values are simply due to the pH dependent perturbation 
of the phenanthridine chromophore itself Furthermore, the reversibility of the observed 
phenomenon also demonstrates the robustness of the system, which tolerates very low (- pH 
1) as well as quite high pH (- pH 12). No alteration of the coordinating or linking functions 
was observed. 
~ Terbium(ll/) tricarboxylate complex 20 
The ground state pKa was measured to be 5.5 from the pH dependence of the 
absorption spectrum, in reasonable agreement with the value of 5.4 obtained for the analogous 
europium complex. 
The emission based on the phenanthridine fluorescence was monitored to determine 
the protonation constant for the singlet excited state of the complex. A value of 5.3 was 
estimated after fitting of the increase in fluorescence intensity (A.exc = 304 nm, "-em = 405 nm) 
following variation of pH (Scheme 2.14 ). 
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Scheme 2.14: Variation of phenanthridine fluorescence intensity as a function of pH for 20, 
showing the fit to the experimental data points(295K, I= 0.1 M NMe4N03, Aexc = 304 nm) 
l!O 
C 'hap1er l. pH Ue.v>tJII\1\'t' I Wlfhwudl! Prnhn 
The analysis of the metal centred emission from the terbium comple\. sho\ved dtfferent 
behaviour as a function of the acidity of the medium. Firstly. the phenanthndme fluorescence 
(A..:m = 405 nm) decreased ''ith increasing pH, like the europtum analogue. from \\htch data a 
protonation constant of 5.6 was found . Secondly. the terbtum emtsswn (l,e,. 304 nm. 1-<C = 
545, 590 or 620 nm, .JJ 5,4,3) behaved in the opposite direction b} mcrease \\lth alkaline 
pH. A value of 5.6 was detennined by monitoring the 545 nm band associated \Vlth the '04 ~ 
7F5 transit ton (6./ = -1 ). Scheme 2 15 illustrates how the ligand fluorescence based emission 
and the metal based emissiOn vary in opposing senses dependent upon the acidity of the 
medium. 
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Scheme 2.15 : 1 'a nut 1011 of emt\,, Wn a.\ a junctwn (l pH f(,r l'h carhux.l·latl.! cwnplex 20 
(295K. 1 0.1 1\f N.\lep\'03, An·( 3{J.Imn) 
The reason for this mversion is that the triplet excited state le,·eJ of the protonated 
phenanthridine group is also populated by a back energy transfer process from the proximate 
terbium 50~ excited state. This process competitively deactivates the terbium '04 level 
(20500 cm ·I). Under neutral conditions, the unprotonated phenanthridine tnplet state ts 
higher in energy, and therefore can populate the Tb excited level without significant back 
c 'haptef 1. pH Nt!.'f"'ll'l\''' I omhanJ£1t·f'mht!' 
energy transfer, leading to terbium emission bands. This process IS the same as that reported 
with the onginal unsubstltuted complex U. -l 
87000 11500 
.,lll. 
XXx ... 
I 
X 
77000 A X 
Tb 7500 
X Eu X .i. 
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Scheme 2./6. ( 'umplemf!ntanty ufthe two hmtlwmde c:omplexe.\ 19 (X) unci 20 ( A. ) 
/(Jr pi I .\ensmg (A,."' 30-1 nm; A.,m 6 I 5 nm .for 19; A-..,111 5-15 nmtor 10) 
The two complexes Eu and Tb complexes exhibit opposite and complementary 
behaviour when they are submitted to variations in pH (Scheme 2. I 6 ). The exctted state pA-" 
was estimated to be 5.6 (±0 1) in each case. 
r /~·umptZmt(/1 I) rnphosphmate complexe.\ 
The pKa of the phosphinate complexes was also investigated Both met h) I and be~ I 
phosphinate europium complexes 24 and 25 showed the same beha\ iour, suggesting that the 
nature of the phosphorus ltgands does not affect the behav10ur of the sw1tchmg process The 
singlet state pKa value for these complexes was found to be 5 35 m each case. The pAd \alues 
determined by monitoring changes in the europium emission intensity O•..:m = 590 nm, .11 = I J 
gave the same value of 5.4 (±-0.1 ). 
"' 
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2-3.2.2: Lifetimes and quantum yields 
The lifetimes in H20 and D20 for the decay of the Eu excited state in unsubstituted 
phenanthridinyl monoamide triphosphinate complex I had revealed the presence of one water 
molecule bound to the lanthanide. 9 For the complexes prepared in this study the coordination 
number at the lanthanide ion was not expected to change, given that the coordinating pendent 
arms are the same. Lifetimes in H20 and D20 have been measured for complex, 19, aiming 
to identify the coordination number (Table 2.2). 
Neutral 1.48 0.41 
Acidic 1.49 0.40 
Table 2.2: Radiative rate constants (ms-1) for complex 19 (295K) 
An estimation of the hydration state, q, for 19, using Eq 2.1, gave a value of 0.92, 
meaning that one water molecule binds the europium whatever the pH of the solution. 
qEu = 1.2 [(kH2o-krno)-0.25-0.075x] (Eq 2.1) 
where x is the number of proximate NH oscillators which when equidistant are assumed to quench in an 
equivalent manner. 
To quantify the efficiency of sensitised emission, the overall quantum yields for 
sensitised emission in 19 were measured in H20 and D20 under neutral and acidic conditions 
(Table 2.3). 
(j)l)2Q 
Neutral (pH 7) 0.014 0.055 
Acidic (pH 2) 0.062 0.25 
Table 2.3: Quantum yields (±20%) for the europium complex 19 (295K) 
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The values obtained in D20 were consistently about three times larger that in H20, 
reflecting the deactivating effect of vibrational quenching by OH oscillators. This is also 
revealed by the higher rate constant for luminescence decay in H20. 
As explained in part 2-1, the protonation of the phenanthridine nitrogen inhibits the 
quenching of the singlet excited state, leading to higher (j)em value in acidic media. In both 
H20 and D20 the quantum yields for complex 19 were four times larger in acidic media 
compared to the values obtained under neutral conditions. This reflects the ease of energy 
transfer from the excited triplet state of the ligand, when the sensitiser is protonated. Because 
the protonation !owes the triplet energy level by 600cm·1, the energy transfer is favoured, and 
the emission from the europium becomes more efficient. 
It was also of interest to compare the efficacy of sensitised emission in the case where 
the phenanthridine is substituted by a butyl group, e.g. complex 19, with the original 
unsbstituted complex I. As was described earlier, the butyl substitution allowed the increase 
of the acidity constant of the complex; the emission quantum yields could also be affected by 
such a chemical modification. The values of the quantum yields in H20 are listed in Table 
2.4. 
(j)em (j)em 
Eu-1 0.011 Eu-19 0.014 
[Eu-I]H+ 0.03 [Eu-19]H+ 0.062 
Table 2.4: Quantum yields in H20 for complexes I and 19 
Very similar trends are noticed for both complexes. The efficiency of sensitised 
luminescence in the neutral complexes did not show any differences in term of yield. The 
values are very similar. When the quantum yields in acidic media are compared, complex 19 
seems to be more efficient by a factor of 2 over its unsubstituted analogue I (measured under 
the same conditions). This gain in efficiency is likely to be due to the decrease in the triplet 
state energy of the phenanthridinium antenna caused by the alkyl group substitution. As 
listed in table 2.1 (page 43), the triplet state energies, respectively under neutral and acidic 
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conditions, are 400 cm-1 and 300 cm·1 higher in the case of the phenanthridine compared to its 
substituted analogue. 
As a reminder the energy of the triplet state of phenanthridine was found to be 22000 and 
(21300}* cm-1 and for 6-butylphenanthridine, 21600 and (21000/ cm-1. Because the butyl 
group lowered the energy levels of the ligand, the quantum yields are likely to be increased by 
a more efficient energy transfer step, which has led to a more efficient overall lanthanide 
luminescence. In support of this argument, a recent study by Latva et al. 10 examining over 40 
europium complexes revealed that the highest quantum yields were obtained for complexes 
where the triplet state of the sensitiser lies between 21000 cm-1 and 22000 cm-1. 
The distance between the sensitiser and lanthanide ion is an important feature involved 
in the efficiency of the energy transfer process in the case of a Forster mechanism. This is 
reflected to the efficiency of the quantum yields as defined by Eq. 2.2. 
cpem = ( cpT YJET)(ko 'tobs) (Eq. 2.2) 
where <i>T is the quantum yield for the triplet formation 
11ET is the efficiency of the energy transfer process 
k0 is the natual radiative rate constant for the 5D0 state of the Eu complex 
'tobs is the observed lifetime for europium decay 
In the case of the Forster mechanism, the efficiency of the energy transfer process is 
proportional to the inverse of the distance to the sixth power, given by Eq. 2.3. 
1 
[1 + (r/ro/] 
(Eq. 2.3) 
where kET is the rate of energy transfer 
ku is the radiative decay of the donor 
knr is the non-radiative decay of the donor 
r is the separation between the donor and the acceptor 
r0 is the distance at which the energy transfer is 50% efficient 
In these two complexes the distance between the phenanthridinyl donor and the 
europium ion is believed to remain unchanged. Consequently the difference between these 
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two systems only involves the photophysical aspects of the chromophore, i.e. the energy 
levels of its excited states. 
A recent study carried out at Durham, 11 investigated the efficiency of the energy 
transfer as a function of the distance donor-acceptor in phenanthridinyl europium complexes, 
and revealed that efficient overall quantum yields can be found even if the phenanthridinyl 
chromophore is more than 5 A distant from the europium centre. 
Summary 
To conclude, the substitution of a butyl group at the 6-position of the phenanthridine 
allowed the pKa of the probe to be increased to 5.6, being consequently more suitable for pH 
sensing closer to the physiological range. The photophysical properties of the europium and 
terbium complexes were not significantly affected by this substitution. Furthermore in terms 
of efficiency of the sensitised emission, this substitution has a positive effect, allowing the 
complex to exhibit a stronger luminescence. 
Recent studiesi have been carried out immobilising such responsive complexes in a 
sol-gel matrix and studying their behaviour as a function of pH. The pKa values obtained 
were all about 1.2 to 1.5 units higher than those found in homogenous solutions. They thus 
fall in the range 5.4 (unsubstitutued) to 7.2 (6-butylphenanthridinium complexes), well suited 
to the analysis of biological samples. The higher pKa may be simply be related to the 
enhanced polarity of the sol-gel medium. 
* In italic characters are given the values for the protonated species. 
; This work has been carried out by Stephanie Blair in Durham. 
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2-Phenanthridinyl Based Ligands 
for DNA Interaction 
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The phenanthridine unit was shown to be an efficient sensitiser for lanthanide ions 
using the appropriate ligand system. The previous chapter was devoted to the interactions of 
various analytes, especially protons, with a phenanthridinyl conjugate. Changes in the local 
environment of the phenanthridine group can also affect the singlet and triplet energy levels 
of the phenanthridine which are reported by variations in the luminescence intensity, lifetime 
and quantum yield. 
As a matter of fact, the molecular structure of the phenanthridine ring system is the 
same as that of ethidium bromide, which suggests that it could be incorporated in a lanthanide 
complex system with the aim of interacting with the DNA helix. Since 1970, ethidium 
bromide has been known to be a very efficient DNA intercalator, endowed with very 
interesting fluorescence properties toward intercalation between nucleobases. 1 Conjugation 
involving the two amino groups in position 3 and 8 of the aromatic ring defines its 
photophysical properties (Scheme 3.1 ). Because of this conjugated and relatively poor 
electron system, ethidium bromide is able to slide between the base pairs of the DNA helix 
and to form a strong complex. 2 
Scheme 3.1: Ethidium bromide 
Upon intercalation, the electron transfer from the nucleobases to the electron deficient 
ethidium bromide gives rise to a marked hypochromism and a red shift in its absorption 
spectrum. The enhanced fluorescence from ethidium bromide, which has been monitored to 
evaluate the affinity of the binding,3 occurs as a result of reduced hydrogen-bonded solvent 
quenching interactions in the excited singlet state. 
A chiral phenanthridinium lanthanide complex presents not only the interesting 
intercalative properties of a conjugated extended ring, but also possesses the appropriate 
energy levels to sensitise effectively europium, terbium or ytterbium, complexed in a chiral 
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cyclen derivative. Monitoring the interactions of such a series of complexes with various 
oligonucleotides allows DNA structure to be probed. 
3-1 Bases 
3-1.1: Description of the chiral complexes 
The introduction of a stereo genic centre 8 to the ring N imparts considerable rigidity to 
the complex and leads to formation of an enantiopure complex. In the Eu, Tb and Yb 
complexes, the configuration of the chiral centre in the amide moiety determined both the 
macrocyclic ring configuration (8 or f.. in each 5-ring chelate) and the helicity of the layout of 
the N-substituents (d vs. A). 
The functionalisation of the cyclen with three chiral amide arms defined two cationic 
enantiomeric lanthanide complexes. These tetra-amide complexes can also adopt either a left-
handed A or a right-handed d configuration which is determined by the chirality of the three 
amide N-substituents of the cyclen (Scheme 3.2). The (R) and (S) amide arms give rise 
respectively to the A and the d configuration. The d and A lanthanide complexes give rise to 
equal and opposite CPL spectra. 
(RRR)-A-[Lnl 1, 4+ (SSS)-A-[Lnl 1"]4+ 
Scheme 3.2: Enantiomeric 2-Phenanthridinium complexes 
An example is given by the behaviour of the terbium complex: CPL spectra were 
recorded in methanol (298K) and the observed dissymmetry factors, ~m, were +0.17 ('Aem = 
545 nm) for (RRR)-[TbL1at+ and -0.17 for (SSS)-[TbL1bJ4+ (Scheme 3.3). Analysis of the 1H 
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NMR spectra for (RRR)-[EuL1at+ revealed only one set of shifted ring protons (Hax) at +29.8, 
+29.0, +28.4 (1:2:1) ppm. Such behaviour is consistent with the preferred adoption in 
solution of a single stereoisomeric species and by analogy with the behaviour defined for the 
related (RRRR) tetra-amide lanthanide complexes,4 the (RRR)-[LnL 13] 4+ complexes exist as 
the (I ... ) ... :)..'A)-11 stereoisomer in solution . 
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Scheme 3.3: CPL (left) and CD spectra (right) of Ll and A-[TbL1/+ complexes 
The phenanthridine moiety linked through the 2-position to the chiral macrocycle, 
allows the extended aromatic surface to slide deeply into the DNA helix. In addition to the 
triply charged lanthanide centre, the methylation of the phenanthridine produces an extra 
positive charge on the intercalative moiety, enhancing electrostatic attraction. The 
independent motion of the phenanthridinyl amide arm allows the complex to adopt a suitable 
geometry during complexation to the double helix, without profoundly affecting the 
macrocyclic complex. 
The presence of the phenyl substituent in the 6-position of the phenanthridine 
chromophore is not required for increased affinity during binding to oligonucleotides or DNA. 
Comparative titrations were carried out with N-ethylphenanthridinium iodide and N-ethyl-6-
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phenylphenanthridinium iodide binding to [(CG)6h. The absorbance spectra revealed no sign 
of enhanced conjugation between the phenyl substituent and the actual phenanthridine ring. 
Furthermore, the affinity of the N-ethyl-6-phenylphenanthridium iodide for the 
oligonucleotide was 'lower than that observed for the non-substituted compound. Thus, it was 
concluded that the phenyl ring has no significant influence on the intercalative binding. 
3-1.2: Interaction with oligonucleotides 
The interaction of such a chiral complex with the DNA helix is expected to be 
favoured for one enantiomer over the other. The DNA double strand being a chiral molecule, 
the association of the two enantiomers will give rise to a stronger diastereomeric complex, 
related to the principle of diastereomeric resolution. The A- and B-forms of DNA are right-
handed helices, while the Z form is left-handed. The oligonucleotides chosen for studying 
these interactions are twelve deoxyribonucleotide units long, e.g. a succession of 6 pairs 
Cytosine-Guanine ( dC-dG)6 or 6 pairs Adenine-Thymine ( dA-dT)6. The duplex form is the 
strongly favoured structure in aqueous solution for these "short" oligonucleotide chains. 
The driving force for the interaction of such complexes with DNA is related to their 
ability to intercalate the DNA via the phenanthridinium unit, and the recognition of the path 
of the helix via the chiral macrocycle. The backbone of the DNA is polyanionic due to the 
phosphate bridges pointing at the surface, which produces an electrostatic attraction for any 
positively charged species. This last feature is involved in the first step of the associative 
interaction, i.e. the approach of the complex close to the DNA 
3-1.3: Photophysical aspects of the interaction 
Several parameters can be examined to characterise the interaction, and a study of 
changes to both the ligand and the DNA duplex can give information. Firstly the tertiary 
structure of the DNA double strand is expected to undergo changes in its length, degree of 
unwinding, helical twist or in its electronic parameters. Secondly, the ligand, especially when 
it is a lanthanide complex, is able to signal changes in its proximate environment, through 
perturbations to the antenna fluorescence or the metal luminescence. 
The intercalation of the phenanthridinium moiety between the nucleobases can be 
signalled by a hypochromism and a red shift in its absorbance spectrum. The red shift is an 
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essential element to prove the intercalation of the ligand between the bases of the DNA: the 
excited states of the phenanthridine chromophore are lowered. This stabilisation is due to 
charge transfer from the nucleobases and this gives rise to an absorption of light at higher 
wavelengths. The fluorescence from the ligand is expected to be quenched by electron 
transfer from the nucleobases. This effect is often observed when aromatic fluorophores 
interact with DNA Consequently the luminescence from the lanthanide being affected as the 
photophysical characteristics of the sensitiser change. Such changes are also directly related 
to the interaction between the sensitiser and the DNA aromatic bases. 
As well as these traditional absorption techniques, chiroptical measurements, 
particularly Circular Dichroism gives information about the behaviour of the DNA during 
binding, about the helix, and by extension, about how a small molecule can determine such 
conformational changes. 
The use of mass spectroscopy was also investigated to study these interactions, and 
allowed an evaluation of the stoichiometry ofthe binding. 
3-1.4: McGhee and von Hippel method of binding constant determination 
The titration data obtained in these studies were analysed using the McGhee and von 
Hippel method,5 which allows an estimation of the apparent binding constant and the size of 
the binding site, by relating the spectroscopic data to the concentration of oligonucleotide 
added. This method of analysis, in contrast to Scatchard method, was the first to account for 
the fact that a binding site might span more than one lattice point. The equilibrium binding 
constant establishing the strength of a ligand for a given oligonucleotide is defined as Eq 3.1: 
Lb 
K=--
LrSr 
where Lb is the concentration of bound ligand 
L1 is the concentration of free ligand 
S1 is the free site concentration 
(Eq 3.1) 
Free ligand + Empty binding site 0 Bound ligand 
The total site concentration is determined in the case of the Scatchard method by Eq 3.2, 
1'>1 
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Sror= CMY n 
where CM is the concentration of DNA duplex 
So the relation expressing K is defined by Eq 3. 3 : 
r 
---=--rK 
n 
(Eq 3.2) 
(Eq 3.3) 
But this analysis is too simplistic when the macromolecule can be considered as a lattice. The 
McGhee and von Hippel method takes account for the fact that a binding site may span more 
than one lattice point. In this method, the expression of Kbecomes Eq 3.4: 
r r [ n-r ] 1/n-1 
- =K(l--) 
L1 n n - (1-n) r 
(Eq 3.4) 
The starting point for the determination of equilibrium constant from spectroscopic data is 
usually given by Eq 3.5: 
(Eq 3.5) 
where pis the emission intensity of the ligand at a chosen wavelength 
a is a constant over the range of binding ratios being considered 
If all of the ligand is bound, L1is assumed to be zero, so Eq 3. 5 becomes Eq 3. 6: 
p =a/ Lrot (Eq 3.6) 
where L101 is the total ligand concentration 
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The first step of the analysis is the determination of a. Because it is not always possible to 
get data for either low or high binding ratio limits, the binding constant K from Eq 3.1, can be 
written as shown in Eq 3. 7. 
ap 
K (Eq 3.7) 
(Stat - ap) (Ltat- ap) 
Rearranging Eq 3. 7 gives Eq 3.8: 
LtotStot 
Ltat = - Stot + ap- K 1 (Eq 3.8) 
ap 
So for two different total oligonucleotide concentration, 1S101 and kS101 , but the same 
concentration of ligand (complex), Eq 3.8 becomes Eq 3.9: 
(Eq 3.9) 
Or equivalently 
k . ~ k . j CM- 1CM = Ltol CM/ p - 1CMI P1 +a 
l-P1 a l-P1 
(Eq 3.8) 
So in the plot, the ideal straigtht line has a slope of L101 I a and an intercept of na. 
k . 
CM- 1CM 
y= versus x= -------
The determination of a allows us to relate, for each point, the concentration of bound ligand, 
Lb, and then the concentration of free ligand, LJ. 
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The second step in the analysis following Eq 3. 6, is to plot r I LJ versus r allowing the 
determination of the binding constant K, as the intercept on the y axis, and n, the number of 
bound ligand per duplex, as the intercept on the x axis. 
N.B: An example illustrating such a method is given in Appendix. 
3-2 Interaction of 2-phenanthridinium L1 and A complexes with 
oligonucleotides 
3-2.1: Affinities towards [(CG)6]2 and [(AT)6}2 
The affinity of the europium and ytterbium complexes for a given oligonucleotide, 
[(CG)6h and [(AT)6h was determined by monitoring changes in the absorbance and 
fluorescence spectra of the ligand upon addition of oligonucleotide. The advantages of using 
spectroscopic data for determining the binding affinity K include the short time scale of the 
experiment, meaning that the system does not have to be stable for any great length of time, 
and our ability to probe a signal due only to the bound ligand. The enantiopure complex of 
europium or ytterbium was solubilized in aqueous solution buffered at pH 7.4 (10 mM 
HEPES, 10 mM NaCI) at a concentration of 30 !JM and the HPLC-purified commercial 
oligonucleotide solution was used without any further operation. 
3-2.1.1: Binding of Europium complexes Ll and A[EuL1/+ 
3-2.1.1.1: Absorbance spectroscopy 
The affinity of the .1 and A [LnL1t+ complexes for [(CG)6h and [(AT)6h was 
investigated by absorbance and luminescence spectroscopies. 
With the europium (SSS)-.1 and (RRR)-A complexes, two isosbestic points at 304 and 
378 nm were observed in the absorbance spectra of the phenanthridinium moiety upon 
addition of oligonucleotide [(CG)6h and [(AT)6h (Scheme 3.4). The same trend was 
observed with Calf Thymus DNA, which is composed by 42% ofCG base pairs. 
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The characteristic features of an intercalative binding mode. i.e. a pronounced 
hypochromism, a red shift and a long wavelength tail were noticed in each case. The 
hypochromism at 320 nm was measured and was more intense by a factor of two for both ~ 
and A complexes with [(CG)6h compared to [(AT)6h The spectra at saturation of 
oligonucleotide showed a shift to longer wavelengths of I 0 nm, independent of the 
oligonucleotide used. The size of the red shift did not vary with the configuration of the 
complex remaining the same in each case within experimental error. 
3-2./. 1.2: Luminescence speclroscopy 
The fluorescence of the N-alkyl phenanthridinium moiety (A.,xc = 378 nm, Aem = 4 I 5 
nm) was monitored as a function of added oligonucleotide. and the observed variations 
allowed the affinity of the binding to be quantified by analysis with the McGhee and von 
Hippel method. 5 The quenching of the phenanthridinium fluorescence (ALm = 415nm) by the 
charge transfer between the phenanthridinium and the DNA bases was also followed by the 
decrease of the long-Jived europium luminescence, following addition of the oligonucleotide 
(Scheme 3.5 ). 
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The changes in Eu luminescence were monitored with parallel results to those 
observed for the fluorescence data analysis as shown in Scheme 3.6. 
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The variation in intensity was slightly greater for the fluorescence (A.m~ = 410 nm) than 
for the europium emission (Aem = 612 nm, i.e. t'iJ = 2), so the former data set was used for the 
semi-quantitative analysis. Furthermore it seems more appropriate to monitor directly the 
changes undergone by the phenanthridinium fluorophore 
The general fom1 and relative intensity of the europium luminescence spectra 
remained constant throughout the titration~ only a decrease in total intensity was observed 
upon addition of oligonucleotide. The europium transitions sensitive to the local environment 
(i .e. transitions AJ = 2, AJ = 4) remained unchanged through the titration, indicating the 
coordination environment around the lanthanide was not distorted upon binding (Scheme 3 7 ) 
No significant change in the lifetime of the europium emission was observed from its 
val ue of0.55 ms in water in the absence of DNA, ruling out any direct quenching of the metal 
excited state by photoinduced electron transfer from the DNA bases. 
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The observed spectroscopic changes suggested that binding involved intercalation of 
the phenanthridinium chromophore between the base pairs ofthe oligonucleotide. 
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3-2.1.1.3: Circular dichroism spectroscopy 
To define whether the chirality of the complexes contribute to selectivity in binding to 
DNA, the interaction of these complexes with the oligonucleotides was also investigated by 
circular dichroism spectroscopy. This time the titrations were carried out differently. The 
effect of the binding of the complexes on the DNA structure was monitored by measuring the 
CD of the oligonucleotide as a function of added ligand (or complex). As the ligand was 
chiral as well, it gives rise to CD bands in the same range of the DNA absorption. 
Consequently there was a need to subtract the CD spectra of the ligand or complex from the 
spectra of the perturbed DNA The resulting difference spectra therefore allowed observation 
of the 'DNA-bound complex' only. 
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Scheme 3.8: Difference CD spectra of[(CG)6]2 in the presence of increasing ratios 
of A-[EuL1af+ (left) and of L1-[EuL1bf+ (right) (295K) 
NB: The thin plain line is the spectrum of the DNA alone. 
In the near UV region, the characteristic CD spectrum of the oligonucleotide [(CG)6h 
and of B-form of poly( dG-dC) exhibits a strong negative band at 250 nm and a positive band 
at 275 nm (thin plain line in Scheme 3.8).6 Upon addition of A-[EuL1at+ complex both bands 
decreased in intensity, and a shift of a few nm to lower wavelength was noticed for the 250 
nm band. The positive band almost disappeared with the saturation of the oligonucleotide by 
the complex. 
For the ,1.-[EuL Ibt+ complex, addition to d(CG)6 gave rise to an increase in intensity of 
the negative band, for which the maximum shifted to lower wavelength by 6 nm. The 
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positive band at 275 run decreased slightly upon the addition of complex. At 320 nm a new 
negative band appeared and reached a saturation point at a ratio of three complexes per 
duplex. 
With a different type of oligonucleotide [(AT)6h the CD titrations depicted a similar 
kind of event (Scheme 3.9). With the complex, both bands at 250 and 270 nm characteristic 
of d(A)-d(T) decreased upon the addition of complex. At 250 nm the intensity of the negative 
band became three times smaller while at 270 nm the positive band decreased by 50 %. 
With the t:\-[EuL1bt+ enantiomer, the addition of complex to [(AT)6]2 induced an 
increase of 40% of the 250 run negative band while at 270 nm the band decreased and shifted 
by 5 run to the red. 
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Scheme 3.9: Difference CD spectra for [(AT)6h upon the addition of the A (left) and Ll (right) 
Eu complexes (295K, pH 7.4, 10 mMNaCI, 10 mM HEPES). 
In the UV region, the CD spectra of [(CG)6h and [(AT)6h showed the characteristic 
features of B-DNA, and this overall form persisted even after addition of a considerable 
amount of complex, ruling out the B ~ Z transition which can occur in the presence of a 
highly charged metal complex. 7 
In the visible region, the CD signal arises exclusively from the phenanthridinium 
chromophore. This titration was processed in the same way as previously: the complex was 
added to the DNA, and its contribution was subtracted. Firstly, no absorption was observed 
,;o 
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as the DNA does not absorb in this region (thin plain line in Scheme 3.10). Upon binding to 
[(CG)6h and [(AT)6h (i.e. ratio [(CG6)2]/[ligand], [1;0.5]), a positive band increased in 
intensity at 370 nm which is the characteristic absorption of the phenanthridinium 
chromophore. This behaviour was observed for both the 8 and A complex (Scheme 3.10). 
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This positive 370 run band, only observed for the bound complex, was of the same 
form for both oligonucleotides, suggesting that the chirality of the phenanthridinium binding 
site must be similar for both [(CG)6h and [(AT)6h, as the sign of the induced CD was 
independent of the complex handedness. 
The stoichiometry of the oligonucleotide-Eu complex binding was further investigated using 
the method of continuous variation, by plotting the CD intensity at a precise wavelength 
versus the mole fraction of the complex. Discontinuities at 0.5 and 0.67 were found, 
consistent with stepwise formation of 1: 1 and 1 :2 complexes for each oligonucleotide 
[(CG)6h and [(AT)6]2. 
Both A-Eu and ~-Eu complexes displayed the same induced CD bands when they 
bound to the DNA Furthermore the spectra seem to show a saturation point at a DNA: ligand 
ratio of 1:3. 
3-2.1.2: Binding of Ytterbium complexes: L1 and A [YbL1/+ 
To evaluate the influence of the lanthanide, the interaction of ~ and A ytterbium 
complexes [YbL1] 4+ with [(CG)6h and [(AT)6h was also investigated by spectroscopic 
techniques and mass spectrometry. 
The absorbance spectra for this series of A complexes showed a red shift of 10 run and 
the hypochromism at 320 nm was measured to be 32 %, upon the addition of [(CG)6h- With 
the other oligonucleotide, [(AT)6h, the hypochromism of 24% was twice that observed with 
the A-Eu analogue although the shift of 8 nm to longer wavelength remained unchanged. 
With the ~-Yb complex, the titration monitored by absorbance revealed with each 
oligonucleotide a distinctive hyperchromism, but a small shift to the red was still noticed. 
The fluorescence intensity from the phenanthridinium moiety (A.exc = 378 run, Aern = 
415 run) decreased upon the addition of DNA With this series of complexes, it was not 
possible to monitor the ytterbium emission as the instrument was not sufficiently sensitive 
beyond 800 run. However the ytterbium luminescence changes were expected to be the same 
as those of the phenanthridinium fluorescence. 
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The surprising behaviour of .L\-Yb revealed by the absorbance spectral changes 
suggested that a different type of interaction may be occurring . However the fluorescence 
decay characteristics and the CD spectral changes exhibited the same features observed in the 
binding of the .L\-Eu complex. Both titrations of [(CG)6]z with A-[YbL Iat+ and .L\-[YbL 1b]4+ 
showed the same changes in the induced CD bands for the near UV region (Scheme 3.11 ). 
This suggests that the nature of the interaction of the complex with the oligonucleotide duplex 
is of a similar type for both the europium and the ytterbium complexes. 
3-2.1.3: Mass spectrometry 
The advantages of studying DNA interactions with short well-defined oligonucleotides 
relate not only to the ease of handling, but also to the potential application of mass 
spectrometry. Mild ionization techniques need to be employed to preserve the structure of the 
relatively weak non-covalent binding interactions. 
A different type of oligonucleotide was initially used to monitor the DNA interaction 
of Eu and Yb macrocyclic complexes. The Drew and Dickerson dodecamer 
d(CGCGAATTCGCG)z has already shown that it is stable towards electrospray ionization 
techniques. 8 However mass spectral analysis of the non-covalent DNA binding of a given 
ligand must be treated with caution since the gas phase stability may be quite different to the 
stability in a solvated environment. 
After assignment of the molecular peaks corresponding to the Drew and Dickerson 
oligonucleotide, i.e. monomer (M) and dimer (D), species with charges varying from -1 to -5, 
the .L\-[EuL Ibt+ complex (C) was added with a precise ratio of duplex to metal complex. In 
addition to their masses, the spectral profiles of the DNA-complexes exhibited an irregular 
shape compared to those derived from the oligonucleotide alone, where the presence of 
ammonium counter ions was clearly depicted in the fine structure of the spectral envelope. 
The molecular peaks were separated by 9 mlz units one from each other (e.g. M(NRt)/2). The 
major set of peaks were observed at 1853 rnlz (20%) for [D + 2C]5-, and at 2110 m/z (20%) 
for [D + et. There was no sign of peaks showing three complexes bound to the dodecamer. 
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The interaction of the isomeric A-[EuL Jat+ complex with. this dodecamer also showed the 
presence of such mass spectral peaks corresponding to two complexes bound. i 
In contrast to the d(CGCGAATTCGCG)2 dodecamer, for [(CG)6h a cluster was found 
with a maximum centred at 1498 m/z units for [D + 3Cf" with 75% relative intensity. Peaks 
for [D + 2C]5- at 1883 m/z (40%), [D + 2ct· at 2345 mlz (10%) and [D + C]5- at 1675 m/z 
(20%) were also observed. This result may be related to the stronger affinity of cationic 
complexes for the oligonucleotide composed of electron rich nucleobases like cytosine and 
guanine, compared to Adenine and Thymine. 
With the A-[YbL Jat+ and .1-[YbL Jbt+ complexes, evidence for 2 and 3 complexes 
bound to [(CG)6h was also obtained. The observed peaks at 1893 (65%) and 2365 (30%) 
correspond respectively to two complexes bound [D + 2C]5- and [D + 2Ct. Evidence for the 
presence of three complexes bound to [(CG)6h was provided by the observation of peaks at 
2110 (65%) [D + 3C]5- and at 2643 (25%) [D + 3C]4- (Scheme 3.12). 
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i This work involving the use of the Drew and Dickerson oligonucleotide was carried out in collaboration with 
Martin Smith during his Fourth year undergraduate project. 
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The chirality of the complex does influence the binding in various ways; it is 
especially noticeable in the strength of binding of A-[EuL !at+ to AT -rich regions; binding of 
L1-[EuL Ibt+ was found to be 5 times weaker. This suggests that the complementary 
handedness of the complex favours the binding to an AT-rich region. Consequently A-
[EuL Iat+ may present more favourable non-bonding contacts with the B-DNA compared to 
the L1 isomer. For ytterbium complexes, the A isomer was bound more strongly by both 
[(AT)6h and [(CG)6h, exhibiting high binding constants in each case. This suggests that the 
chirality of oligonucleotide binding site must be similar for both [(CG)6h and [(AT)6h and is 
independent of the chirality of the complex. Clearly the binding of each of the complexes to 
the oligonucleotide involves a substantial intercalation of the phenanthridinium moiety 
between the DNA base pairs. 
A last point of importance needs to be highlighted because the binding affinities are 
not only influenced by the nature of the oligonucleotide, and the chirality of the complex but 
also by the nature of the lanthanide ion. The Eu and Yb complexes do not behave in the same 
way, and the choice of the metal influences the strength of the binding. Where the stronger 
Eu complex-[(CG)6h association is with the L1 isomer, in the ytterbium case the binding 
affinities are higher for the A isomer. A possible explanation involving the different size of 
the metal ion inducing a different complex conformation has to be refuted since 1H NMR 
studies showed that both the Eu and Yb complexes adopt a regular square-antiprismatic 
geometry with the same approximate twist angle of 40° for the arms. 12 A tentative suggestion 
for these variations relates to the acidity of the water molecule bound to the lanthanide. This 
will be more acidic in the ytterbium case, and this could affect the binding to the duplex 
through a differential hydrogen-bonding interaction. 13 
3-2.2: Control experiments 
3-2.2.1: Quenching of fluorescence from complexes L1 and A 
Halide ions are known to quench phenanthridinium fluorescence by an electron 
transfer mechanism. In evaluating the strength and the nature of the binding to DNA by such 
complexes, the competition between charge transfer quenching by nucleobase interaction and 
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quenching by electron transfer from x· may give useful comparative information. By taking 
the saturated oligonucleotide-complexes in the presence of a known concentration of added 
iodide or chloride, the change in the fluorescence decay was observed. This competitive 
deactivation of the phenanthridinium singlet state by the halide, notwithstanding the partial 
quenching by charge transfer from the nucleobases, may be quantified in terms of apparent 
Stem-Volmer quenching constants. The reference points for such experiments are the Stem 
Volmer constants established for N-alkyl phenanthridinium fluorescence itself and for 
europium emission in the presence of added iodide or chloride (Table 3.2). 
Halide P henanthridine 
Fluorescence 
er 6.0 
F 1.9 
Europium 
emission 
26 
1.2 
Table 3.2: Stern Volmer quenching constants (Ksv-1, mmol.T1) for the effect of 
halide ions on A-[EuL1/+ (I= 0.1 MNMe4Cl04, 295K/4 
The first quenching experiment involving the A-[EuL1]4+-d(CG)6 binding allowed an 
estimate of the Stem Volmer constants for the effect of chloride and iodide on the 
phenanthridinium fluorescence. The effect of iodide on the free complex resulted in a steeper 
curve ( cr ), that saturated more slowly compared to when the complex is bound to the DNA 
( o ). In the latter case the complex may be shielded from the iodide quenching effect. 
Therefore the observed fluorescence decay is a combination of 'DNA base' quenching and 
halide quenching. 
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Scheme 3.13: Decay ofphenanthridiniumjluorescence in A-[EuL1a/+ (a) and 
A-[EuL1a/+(RRR)I[(CG)6]2 (o) as a function of increasing iodide concentration (295K) 
In the case of added iodide, the observed decay of the fluorescence for the bound 
(CG)6 complex was consistent with an apparent Stem Volmer constant of 15 mM. The 
bound complex is therefore up to 8 times less sensitive to iodide quenching when it is bound 
to the DNA than when free in solution. 
The addition of choride to the solution of {A-[EuL1a]4+-d(CG)6} was also expected to 
quench the fluorescence. However the effect of increasing concentration of added chloride 
led only to an enhancement of the phenanthridinium emission (Ksv-1 = -116 mM). This 
behaviour was at first sight surprising, as chloride was supposed to deactivate the singlet 
excited state of the phenanthridinium. In this experiment, the effect of added sodium chloride 
salt not only increased the presence of chloride but also increased the ionic strength, affecting 
the strength of the binding at the same time. The higher ionic strength seems to lower the 
affinity of A-[EuL 1a]4+ for [(CG)6]2. This aspect will be further studied separately, see part 
3.2-3. 
The comparative quenching studies were extended to include the senes of Yb 
complexes binding to [(CG)6h and [(AT)6]2, particularly examining the strength of their 
interaction in the presence of iodide (Table 3.3). 
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Complex I oligonucleotide Ksv-1 by iodide Kaff # 
(1 o-3 mol.l-1) (1 rf M 1.duplex-1) 
L1-[YbL1b} 4+/[(CG)6]2 23 15 
A-fYbL1al 4+1f(CG)d2 107 57 
Ll-[YbL1b} 4+/[(AT)6]2 16 13 
A-[YbL1a} 4+/[(AT)6]2 22 30 
#The binding affinities taken from Table 2.1 are indicative of the overall apparent binding affinity. 
Table 3.3: Apparent Stern Volmer quenching constants (Ks/. mM) for the effect of iodide 
ions on phenanthridiniumjluorescence (Aexc = 378 nm, Aem = 405 nm) in [YbL1} 4+ 
bound to [(CG)6]2 and [(AT)6}2 (293K, pH 7.4, HEPES JOmM, NaClJOmM) 
The apparent Stem Volmer quenching constants for iodide were at least 10 times 
higher when the complexes are in the presence of added oligonucleotide. This fact suggests 
that the phenanthridinium moiety is shielded by the DNA helix from the quenching effect of 
iodide. The Stem Volmer constant for A-[YbL1at+I[(CG)6h was 6 times higher than any 
other. Such behaviour is consistent with the fact that its binding affinity with [(CG)6h was 
found to be the strongest for this series of complexes. The decay of phenanthridinium 
fluorescence in the case of A-[YbL Iat+; [(CG)6]2 was anomalous: a break in the Stern Volmer 
plot above 30 mM iodide was observed. This suggests that there are two types of binding 
interaction (with differing sensitivities to added iodide or salt) involved in this interaction of 
A-[YbL1at+ with [(CG)6]2. This may explain the apparent size of the Stern-Volmer 
quenching constant. 
The other quenching constants are all of the same order, suggesting the strength of the 
complex-oligonucleotide association was fairly similar in each case. 
lU\ 
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3-2.2.2: Control CD studies of the A and A-tetra-amide L2 complexes 
Any positively charged ligand or complex is likely to bind to a negatively charged 
DNA backbone. To further probe the nature of the interaction of the complex, CD 
experiments were carried out with a parent complex lacking the intercalative moiety, i.e. 
without the phenanthridinium group (Scheme 3.14). Both 11 and A of [EuL2)3+ were titrated 
against oligonucleotide, and changes were monitored by circular dichroism. 
Scheme 3.14: A-[EuL2af+ 
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Scheme 3.15: Difference CD spectra for [(CG)6h following addition of A-[EuL2bf+ 
(295K, pH 7.4, NaCllOmM, HEPES 10 mM) 
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No significant change occurred in the CD spectra of the oligonucleotide following 
addition of increasing concentrations of complex. This behaviour was found for both ~ and A 
complexes. The absence of change in the CD difference spectra of both the ~ and A isomers 
suggests that the changes observed with the corresponding phenanthridinium complexes are 
predominantly due to the binding of the phenanthridinium moiety. A complex lacking the 
intercalative unit cannot bind to the DNA in this manner. The DNA conformation is also not 
affected by the presence in solution of increasing concentrations of the positively charged 
complexes. So the presence of an intercalative moiety is crucial for the interaction with DNA 
and especially for an intercalation binding mode. 
Following these observations, a simple phenanthridinium chromophore was also 
examined by circular dichroism in its interaction with ((CG)6]z, to evaluate its effect on the 
DNA structure. Norden et al. have previously described changes and selectivity in the 
binding of a related chiral phenanthridinium chromophore to DNA 15 
Hepes (10tnM. NaCilOmM), 1cm, ((AT)6) a 3.0s..M 
~.~----------------------· 
I liE 
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Scheme 3.16: Difference CD spectra for [(CG)6]2 in the presence of increasing amounts 
ofN-methyl phenanthridinium iodide (295K, pH 7.4, NaC!JOmM, HEPES JOmM) 
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The slight changes observed (Scheme 3.16) in the CD titration were comparable in 
magnitude to those found following addition of [Eue]H. Only a very weak and negative 
induced CD band was observed at 370 nm, contrasting with the stronger positive induced CD 
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band found for [LnL Iat+. This suggests that while the phenanthridinium moiety alone can 
bind to DNA, it does not promote significant variation in the DNA helical structure. The 
intercalation phenomenon increases the DNA pitch and the extent of unwinding; the helical 
twist is also likely to be slightly modified. However in this case, the combined presence of an 
intercalator and a strongly helical cationic complex which may interact selectively with the 
DNA groove gives rise to the major observed perturbations of DNA structure. 
3-2.3: Dependence of affinity on salt concentration 
The interaction of the positively charged complexes with the negatively charged 
oligonucleotides must also involve a strongly stabilising electrostatic interaction. 16 The CD 
titrations involving the parent tetra-amide complexes have suggested that this component may 
not dominate the binding of these phenanthridinium complexes to DNA. A consequence of 
the cooperativity between ion pairing and intercalation in these complexes is that the 
association binding constant must be strongly dependent on the ionic strength of the solution 
and is expected to decrease with increasing salt concentration. 17 To determine the 
contribution of the electrostatic interaction in the case of the binding of tetra-positive 
complexes to DNA, the salt concentration of the medium has been varied. 18 
The quenching of the fluorescence of A-[EuL1at+ complex upon binding to [(CG)6hii 
was studied under relatively high salt conditions (50 and 100 mM sodium chloride) to 
estimate the relative binding affinities. The titrations were monitored by absorbance and 
fluorescence spectroscopy to evaluate the effect. 
The absorbance spectra showed the same characteristic features of intercalation at a 
sodium chloride concentration of 10 mM, 50 mM and 100 mM. A hypochromism of 30 % 
was noticed in each case, accompanied by a red shift of 7-8 nm. A long wavelength tail was 
observed as well. The fluorescence decay from the phenanthridinium group was analysed and 
the results are listed in Table 3.4. 
;; [(CG)6] 2 was chosen in this study as the complexes exhibit a stronger affinity compared to [(AT)6] 2. 
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Concentration r(ufJ n# % Hypochromism 
ofNa+(mM) (M1.duplex-1) (duplex-1) (320nm) 
20 36 3.9 33 
60 23 1.9 35 
llOa 6.9 2 33 
110b 5.9 2.3 36 
aUsing from 100 mMNaCI. bUsing from 100 mMNaOAc. 
Table 3.4: Intrinsic binding constants (K), site sizes (n), and degree ofhypochromism 
measured for A-[EuL Iaf+ complex with [(CG)6]2 
(295K, pH 7.4, HEPES 10mM) 
Because the presence of a high concentration of chloride in solution leads to 
competitive quenching of the fluorescence signal, a comparative titration was also carried out 
in the presence of 100 mM sodium acetate (110 mM Na+). The resulting binding constant 
was the same as that obtained in 100 mM sodium chloride. This observation suggests that the 
constant presence of chloride does not affect the apparent binding affinity, even though the 
fluorescence signal is partially reduced in intensity. 
7..,-------------------. 
6,5 
~ 6 
..Q 
5,5 
y = -0,9098x + 5,073 
5+-----.----..,.---.,-----,-----! 
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Scheme 3.17: Salt dependence of A-[EuL1a/+-[(CG)6h binding 
(295K, [Na+] = 20, 60 and 110 mM) 
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The linear dependence of the logarithm of the apparent binding constant as a function 
of the logarithm of the salt concentration suggests that the binding of those complexes does 
involve an electrostatic interaction (Scheme 3.17). However the shallowness of the slope of 
this relationship suggests that a major component in the overall free energy of binding must 
involve an intercalative binding mode (i.e. involving a singly charged chromophore), in 
association with a stereochemically sensitive non-covalent interaction with the DNA groove. 
3-3 Control studies examining the unmethylated complexes, L1 and A-[LnL3/+ 
The previous series of complexes involved systems where the intercalating moiety 
itself bore a single positive charge. Aiming to investigate the importance of a positively 
charged chromophore in the intercalation process, complexes were also examined where the 
phenanthridinium nitrogen was not quatemized (Scheme 3.18). The helicity at the lanthanide 
centre remained A or .1 as a function of the chirality of the amide pendent arms. The overall 
charge of the complex is reduced by one, and consequently the binding affinities were 
expected to be lowered. Nevertheless, the lower charge may give rise to modified selectivity 
in the chiral recognition of the DNA by the macrocycle. 
(RRR)-A-[Lnl 3~3+ (SSS)-A-[Lnl 3~3+ 
Scheme 3.18: A and Ll phenanthridinyllanthanide complexes 
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3-3. 1: Bmdmg uffimltes: absorbance, Jluorl!sc.:ence q uenchmg am/ ( '/) 'tudtc., 
The absorbance spectral titration of 1\ and .1 Eu complexes '"lth [(CG )t.h and [(A T),)2 
revealed surprising beha\ Jour With the A isomer, a red sh1ft and hypochrom1sm \\as noticed, 
whereas for the!:!.. isomer the spectra showed first a hyperchrom1sm and then a hypochromism 
upon the addition of oligonucleotide, with both [(CG)~:ob and ((AT)~>h The A isomer 
exhibited two isosbestic points at 310 and 348 nm For the A isomer. no well-defined 
isosbestic point was apparent (Scheme 3.19). 
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For A-[EuL3a] 3+ the characteristic features of an intercalative binding mode were 
compared to those observed previously in the case ofN methylated complexes (Scheme 3.19). 
The red shift was 6 nm and a hypochromism of21% (345 nm) was noted. 
For the ~-[EuL3b] 3+ isomer, a modest hyperchromism was found together with a slight 
shift to the red and the appearance of a long wavelengths tail (Scheme 3.19). The absorbance 
spectra of A-[YbL3a]3+ showed only a hyperchromism and no shift to lower energy was 
observed. Those features, revealed by the absorbance spectra, were also characteristic of the 
binding of ~-[YbL Ibt+ to both oligonucleotides, [(CG)6h and [(AT)6]2. 
The nature of the interaction revealed by the absorbance spectra was further 
investigated by circular dichroism studies. The CD difference spectra were acquired for the 
oligonucleotide [(CG)6h following addition of A and~ complexes (Scheme 3.20). 
The binding of A-[EuL3a] 3+ to [(CG)6h induced the same changes in the 
oligonucleotides as observed with the N-alkylated complex A-[EuL1a]4+. A decrease in the 
intensity of both bands was observed to a similar extent. For the ~ isomer, similar CD 
difference spectra were obtained compared to the N-alkylated analogue. These observations 
suggest that both series of complexes bind to [(CG)6h in a comparable manner in which the 
stereoselectivity of the binding interaction is primarily determined by the handedness of the 
lanthanide complex. 
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Estimates of the apparent binding affinities were obtained by monitoring the 
phenanthridine fluorescence intensity decay (Aexc = 304 nm, Aern = 385 nm). Data sets were 
analysed as before using the McGhee and von Hippel approximation (Table 3.5). The 
europium luminescence changes echoed the decay in intensity found for the phenanthridinium 
fluorescence. 
Complex K# (Jrf) n# % Hypochromism 
(M1.duplex-1) (duplex-1) (345nm) 
L1-[EuL3bf+ I[(CG)6}2 30 5 6 
A-[EuL3af+![ (CG)6] 2 35 5 18 
L1-[EuL3bf+![(AT)6]2 35 3.5 7 
A-[EuL3af+I[(AT)6]2 37 5 21 
A-[YbL3af+![(CG)6]2 10 3 nd 
#Typically [LnL] = 20-30 J.!M; the binding value showed a dependence on the concentration of complex; data 
from fluorescence intensity changes with added oligonucleotide were analysed using the method ofMcGhee and 
vonHippel. 5 
Table 3.5: Intrinsic binding constants (K), site sizes (n), and degree ofhypochromism 
measured for complexes of[(CG)6}2 and [(AT)6]2 with A[LnL3af+ and L1-[LnL3bf+ 
The estimated binding affinities all fall in the same range indicating that the 
complexes bind to the oligonucleotide without any distinctive stereodifferentiation. As a 
consequence of fitting problems associated with relatively small variations of fluorescence 
intensity (overall changes in fluorescence intensity were <80%, compared to 95% for A-
[EuL1atl, these values, especially the number of 'ligand' per duplex n, are subject to a 
significant error. Thus it may be misleading to compare fluorescence intensity changes with 
those of the previous series of N-alkylated complexes. To observe a decrease of 50% of the 
fluorescence intensity, for example, the DNA concentration needed to be 3.7 times higher for 
SW 
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tri-cationic complexes.' 11 So this observation itself suggests that the binding of the tri-cationic 
complexes is approximately 4 times lower than those of the corresponding tetra-cationic 
complexes. 
The absence of a positive charge on the phenanthridine moiety in these tri-catJomc 
complexes has a considerable effect Ev1dently the positive charge on the phenanthridine 
chromophore constitutes a significant driving force for the intercalative interaction, consistent 
with a predominantly charge-transfer binding mode 
In term of the differences observed in the absorbance spectral titrations. a stronger 
association for t\-[EuL Jn)J+ was suggested compared to the 6 isomer. for both !(CG)r.]2 and 
[(AT)6]2. However the data in Table 3.5 indicate that both complexes exhibit comparable 
affinity. Nevertheless, the intensity changes can be compared for equivalent concentrations of 
complex and added oligonucleotide (Scheme 3.2 I). 
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The absorbance data had suggested a more distinctive binding mode for the A isomer. 
Here the normalised intensity decay curve also suggested that a more efficient quenching 
mechanism occurred with the A complex. This observation leads to the conclusion that in the 
binding of the A isomer there may exist a more complementary interaction betw·een the DNA 
groove and the complex allowing more favourable non-bonding interactions than with the .1 
isomer. Given the sense of this interaction this could plausibly involve an interaction from 
the minor groove, as suggested for the binding of certain chiral ruthenium complexes. 19 
3-3.2: Salt concentration effect 
In section 3.2-3, it was shown that the ionic strength modulated the binding affinities 
of these complexes for the oligonucleotide duplex via changes to the electrostatic contribution 
to the binding. The electrostatic attraction energy varies as 1/r and so is very likely to be 
involved in the first step of the binding process. As this contribution has been defined for the 
tetra-cationic complexes, an investigation of the effect of higher ionic strength on the binding 
of these series of triply charged complexes was also undertaken. The estimation of apparent 
binding affinities was not considered possible in the case of complexes bound to DNA under 
high salt concentration conditions, due to the absence of a well defined limiting intensity 
value. 
The absorbance spectra for the titration A-[EuL3a] 3+ with [(CG)6h at 100 mM NaCl 
showed the same behaviour at high salt as in 10 mM sodium chloride. The A-[EuL33]3+ 
exhibited a marked hypochromism and a small red shift, while for the .1 isomer, a small 
hyperchromism was discerned. 
The approximate values found were 0.5 and 0. 8 105 M-1.duplex-1, for the binding of A-
[EuL33]3+ and .1-[EuL3b]3+, respectively bound to [(CG)6]2 in high salt media (100 mM NaCl). 
It is more appropriate to compare the fluorescence decay titration curves to evaluate the 
strength of the binding. 
The fluorescence decay of A-[EuL3a]3+ under normal (10 mM NaCl) and high salt (lOO 
mM NaCl) concentrations were compared (Scheme 3.22). To obtain a quenching effect of 25 
%, the concentration of added DNA needed to be more than 3 times higher under conditions 
of high ionic strength. Furthermore, no evidence for a saturation limit was found, contrary to 
the fluorescence intensity decay changes in 10 mM NaCl solution. 
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A comparison of the bmding of J\-[EuL lnt + and J\-[EuL38]'+ shows that the presence of h1gh 
salt concentration reduced the binding affinity of both complexes to [(CG)6]~ (Scheme 3.23 ). 
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This inhibitory effect is manifested by the near linearity of the decay profiles. As the 
binding of the triply charged complex is already relatively weak, the effect is more evident in 
this case. A decay in the fluorescence intensity of 30% was attained for the triply charged 
complex with a DNA concentration that is 2.5 times higher than for A-[EuL I at+. 
Summary of binding of L1 and A-[EuL3/+: 
This series of complexes exhibits a particular affinity for DNA that is dependent upon 
whether the phenanthridine N is alkylated or not. The binding of the A isomer seems to 
involve at least partially, an intercalative interaction of the phenanthridinyl unit, as shown by 
changes in absorbance spectra. It is estimated that the binding affinity of the tri-cationic 
complexes is at least three times less than those of the corresponding phenanthridinium tetra-
cationic complexes. 
There is some evidence suggesting a slightly favoured binding for A-[EuL3a]3+ 
complex compared to the ,1 isomer. Differences between europium and ytterbium complexes 
in their binding to each oligonucleotide were also evident with the unmethylated series, 
although it is not clear why this should be so. 
3-4 Diaqua A-L 4 Europium complex 
The design of new nucleic acid probe requires systems that possess both a high 
association constant with the biomolecule and also exhibit good recognition of the substrate 
structure. The previous series of tri-cationic complexes presented a neutral intercalative 
chromophore, which inhibits strong binding. Consequently a cationic intercalative moiety 
was regarded as essential in a search for novel DNA probes. 
In the tetra-cationic europium complex ,1-[EuL 4t+ (Scheme 3.24), the linking arm 
between the chiral macrocycle and the intercalating phenanthridinium group has been 
shortened with the aim of improving the stereoselectivity in the binding by bringing the 
element of chirality of the complex closer to the chromophore. The complex possesses two 
bound water molecules at least one of which may be displaced by interaction with a phosphate 
group of a nucleotide residue. Such a change in the local lanthanide coordination 
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environment may be signalled by changes to the europium emission spectrum. Evidence for 
such effects has recently been obtained in the binding of ~-[EuL 4] 4+ with carbonate, and 
monohydrogen phosphate anions, amongst others. 20 
(555)-~·[Eul ~4+ 
Scheme 3.24: Diaqua phenanthridinium europium complexiv 
3. 4-1: Spectroscopic titrations 
The absorbance spectrum of the complex following addition of oligonucleotide 
showed a pronounced hyperchromism of 160% (Aabs = 320 run) for [(CG)6]2 (Scheme 3.25). 
With [(AT)6h the changes in absorption spectra suggested a stepwise interaction with the 
DNA bases. A marked hyperchromism was noticed at the early stage of the titration (very 
high complex concentration). Then, once the ratio complex:DNA had reached [5:1], the 
absorbance decreased. At oligonuleotide saturation, two isosbestic points at 304 and 378 run, 
and a red shift of 7 run were observed. However the behaviour of the absorbance spectra is 
not reliable due to the non-zero baseline. 
iv This complex was synthesised by Dr L. J. Govenlock. 
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With the oligonucleotide [(AT)6h, the intercalative mteraction Wlth the cationic 
complexes was expected to be weaker than for the more electron-rich r<CG)t>h- Unfonunatel) 
solubility problems occurred during these titrations: a white solid precipitated. inhibiting 
further detailed analysis. 
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In the Eu emissiOn spectra similar behaviour \Vas nottced with each oiJgonucleoude 
model. The classical quenching of phenanthridine nuorescence (!"'<:, .. = 409 nm) b) the 
nucleobases was accompanied by a parallel decrease in the Eu emiss10n mtenstt) (Scheme 
3.26). 
The spectra behavwur deptcted in Scheme 3.25 ma} be mterpreted tn tenns of a 
stepwtse btnding process with a markedly different effect on the nature and extent of 
phenanthridine charge transfer. 
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The shape of the emission spectrum is determined by the local coordmat10n em tronment and 
aids definition of the type of interaction involved between the complex and the DNA helix. 
The binding of DNA to the complex was monitored by variations of em1ssion intens1ty and 
the ratio of intensities (t\.1 = 2 I 6.1 = 4, 6 15/697 nm) as a function of the concentration of 
( 'hapter 3 · :!-Phenanthndlf~~·l hawd !Jgund\fVt !J'NA mterat ·flfm 
added oligonucleotide. The Ill= 2 and Ill= 4 transitions of the europium emission spectrum 
are hypersensitive and so are perturbed significantly by variations in the Eu coordination 
environment. 1 ~ 
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in f.tJ-EuL'f' hy /(AT)6}1 (293K, NaCI JOmM, HEPES JOmA1, pH-.~) 
As the concentration of added [(AT)c;h increased, the relative ratio of the transitions 
M= 2 and M= 4 decreased but not in a constant manner. Beyond a relative concentration of 
DNA duplex:complex [1 :5] (concentration of [(AT)6h of 3.5 J.1M; see Scheme 3.27). the 
intensity ratio remained constant. Such a discontinuity is also apparent in the changes to the 
ll.J = 2 I Ill = I ratio. 
By companng the em1sswn spectrum from the complex alone (d1aqua) to that 
saturated with DNA, a change in the fonn and relative intensity of the transitions !!../ = l, !1/ = 
2 and M = 4, was noted suggesting a change in the coordination environment of the 
lanthanide ion (Scheme 3.28). The splitting of the Ill = 1 transition manifold is a complex 
function of the nature of the ligand and axial donor atoms, their polarisability and the local 
site symmetry. The Ill = 4 manifold also exhibits a markedly different fine structure in the 
complex bound form. 
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The Eu emission spectrum of the complex with [(AT)f>h is rather stmilar to the 
spectrum observed following addition of HPO.a ~-to L1-[EuL 4 ]"1~ (scheme 3.29) IYo 
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3-4.2: Binding affinities of iJ-[EuL4/+ to [(CG)6]2 and [(AT)6)2 
Estimations of apparent binding affinities were made from the luminescence decay 
titration curves using the McGhee and von Hippel method. 5 With [(CG)6h, the apparent 
binding constant of the complex has been found to be 20x106 M-1.duplex-1 with a value for n 
of 5. Its binding to [(AT)6h was estimated to be 15 times weaker with an apparent affinity of 
1.3x106 M-1.duplex-1 (n = 2.5). The difference in affinity between the two oligonucleotides 
was partially foreseen by the distinctive behaviour of each absorbance titration. Yet it is 
fairly surprising to observe such a large difference between the two oligonucleotides 
compared to the more modest differences in affinity defined in the tetra-amide series of 
complexes. 
One very important qualification about these values needs to be mentioned: the 
excitation wavelength chosen was 378 nm in each of the luminescence titrations as it 
constituted an isosbestic point. However at high complex/DNA ratios, for both titrations the 
absorbance was not constant at 378 nm throughout. Therefore the extent of quenching of the 
phenanthridinium fluorescence is also a function of the extinction coefficient of the complex. 
The erroneous quenching intensity values leads to binding affinities that may not be reliable. 
3-4.3: Lifetime measurements 
The displacement of water molecules by a coordinating anion, e.g. phosphate, is 
signalled by an increase in the lifetime of the lanthanide excited state and an increase in its 
emission intensity. Such a phenomenon can be demonstrated by measuring the Eu emission 
lifetimes in HzO and DzO for the complex free and bound to the oligonucleotide. These 
values are listed in Table 3.6. 
1.40 
k (c) DzO 
0.28 
0.76 
0.8 
0 (0.2) 
Table 3.6: Rate constants (msl1 for iJ-[EuL4/+ free and bound to [(CG)6]2 (295 K) 
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(a) Hi-exponential decay was observed with both direct and indirect excitation of the Eu centre, 
suggesting that both q=l and q=2 species may be present. 
(b) Hydration states are estimated using methods defined in the reference 21, wherein the quenching 
effect of closely diffusing OH oscillators and static amide NH vibrators is accounted for. 
(c) Complex was allowed to undergo HID exchange for 3h prior to measurement. 
The hydration state of Eu when the complex is in the presence of oligonucleotide was 
determined, using the relation given in Eq 3.9.21 Apparently no water molecule is bound, 
consistent with the displacement by an oligonucleotide phosphate group of the water 
molecules. 
qEu = 1.2 [(kH2o-kD2o)-0.25-0.075x] (Eq 3.9) 
where x is the number of proximate NH oscillators which when equidistant are assumed to quenched in 
a equivalent manner. 
This reorganisation of the coordination sphere around the europium was observed to 
be time dependent. Rate constants for the complex in the presence of excess oligonucleotide 
rose to 1.40 ms-1 after 30 min, and remained unchanged thereafter-equivalent to a 'resting' 
hydration state of 0.2. 
This time dependent problem inhibited the possibility of examining the interaction by 
circular dichroism; the time scale of a typical CD acquisition being superior to 30 minutes. 
Summary of the binding behaviour of L1-[EuL4/+: 
The binding behaviour of the complex to each oligonucleotide presents novel 
features, whose complexity has not allowed the exact nature of the interaction to be defined. 
No unequivocal evidence for an intercalative binding of the phenanthridinium unit nor 
improvement of the stereoselectivity has been found. Nevertheless the interaction of the 
europium with an oligonucleotide phosphate group presents some attractive features as a 
potentially reactive complex. Many articles dealing about DNA cleavage arised from 
hydrolytic properties of the lanthanide (Ill) ions, occurring on the phosphate backbone. 22 
Thus further studies are warranted to examine the possibility of cleavage in a complex where 
the lanthanide possesses displaceable water molecules. 
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Chapter 4: 6-Phenanthridinyl based ligands for DNA interaction 
The previous series of complexes involving the phenanthridine chromophore exhibited 
a particular affinity for nucleic acids, and allowed certain characteristics required for 
intercalative DNA probes to be defined. The charge and the length of the link between the 
chiral macrocycle element and the intercalative moiety appeared to be important features for 
the effective intercalation of the complex into the DNA double strand. In the previous series 
of complexes, the phenanthridinyl chromophore was linked to the chiral macrocycle via its 2 
position. Such a linkage constrained the interaction of the phenanthridine group with the 
nucleobases. 
The possibility to link the intercalative chromophore via another position of the 
aromatic ring may offer alternative geometries to be adopted, depending on whever the 
delocalised surface is able to interact more favourably with the nucleobases. 
In the search for such new DNA probes, the stereoselectivity of the binding represents 
a fundamental aspect in the selective recognition of the helix. It has been shown that the 
chiral amide pendent arms, which determine the helicity of the complex, constitute an 
important issue in this recognition. The design of a new series of complexes was extended in 
scope by the idea that an additional chiral centre on the intercalative unit arm may help to tune 
the selectivity of the complex towards the oligonucleotides, by a more appropriate 'fitting' to 
the DNA backbone. 1 
4-1 A new series of chiral phenanthridinyl complexes 
4-1.1: Aims and objectives 
The salient feature of the chiral complex [EuL't+ was its three chiral pendent arms 
which conferred a A or ~ helicity to the complex. The addition of a fourth arm bearing an 
additional chiral centre, leads to two sets of diastereoisomers which bear the same major 
element of helicity but differ in the local chromophore arm chirality. Accordingly, the series 
of complexes [LnLn]3+, (n = 5,6,7,8), were prepared (Scheme 4.1). 
]()') 
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(R-RRR)-[Ln L ~3+ (S-RRR)-[Lnl ';3+ 
(R-SSS)-[Lnl ~3+ (5-SSS)-[Lrt. 7]3+ 
Scheme 4.1: [LnLni+ complexes (n = 5,6,7,8) 
4-1.2: Synthesis of a series of chiral complexes 
The synthesis of the enantiopure ligands begins with the functionalization of the 
phenanthridine chromophore in a racemic a-haloamide, followed by the coupling with the 
trisubstituted enantiopure cyclen derivative (29 and 30). The ligands which are obtained in 
each case were a mixture of two diastereoisomers, which were separated by column 
chromatography, giving rise to enantiopure ligands. 
Firstly the phenanthridine was C-alkylated following an established procedure.2 
Nucleophilic attack of butyl lithium occurs selectively at the 6-position, i.e. a to the 
phenanthridine nitrogen. The chromophore was re-aromatised using manganese(IV) dioxide. 
The bromination of 1 occurs preferentially at the benzylic position on the butyl chain, and 
gave rise to the two enantiomers of 26 as a racemic mixture. Nucleophilic attack (with 
inversion of configuration) by sodium azide produced 27, which was then reduced to the 
amine 7 by a transfer hydrogenation over Pd(OH)2/C. The resultant mixture of (R)- and (S)-
1 ()1 
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pnmary ammes were coupled to a-chloroacetic acid m the presence of EDCI and 1-
hydroxybenzotriazole, leading to the racemic amide 7. 
X 
1 
26 X : Brj NaN3, DMF 
27 X: N3 aooc 
7 28 
Scheme 4.2: Synthesis of the a-haloamide 7 
The (RRR) or (SSS) chiral trisamides were obtained by reaction of3 equivalents of the 
appropriate (R)- or (S)- a haloamide with cyclen. The reaction was monitored by ESMS and 
showed the formation of trisubstituted and tetrasubstituted compounds, which were separated 
by aqueous washing and column chromatography on silica. 
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Scheme 4.3: Synthesis of the chiral trisamides 29 and 30 
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The coupling reaction of racemic 7 with the macrocycles 29 and 30 led to formation 
of a pair of diastereoisomers, e.g. 31 & 32 and 33 & 34 respectively, which were separated 
chromatographically, thereby using the chiral macrocylic element as a chiral auxiliary. 
H M 
r-\ /'(N')~ e 
C
NH NJ 0 Ph 
Ph 0 
).,N)l_./N\_/~N M~ H 0 
NH 
Ph~ 
"Me 
(RRR) • 29 
Scheme 4.4: Synthesis of the ligands 31 and 32 
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The two diastereoisomers exhibited a different retention factor on neutral alumina. 
Thus repetitive chromatography column allowed the separation of the enantiopure ligands. 
The process was repeated using (SSS)-30 to yield ligands 33 and 34. Scheme 4.5 depicts the 
four diastereoisomeric ligands 31, 32, 33, and 34, that were isolated following this procedure. 
The assignation of the chirality for each of the four ligands was carried out by comparison of 
their NMR spectra. Each enantiomeric pair exhibited the same pattern of couplings. 
The complexation of lanthanide ions was carried out using the approriate lanthanide 
triflate salt in acetonitrile. The europium complexes 35, 37, 39, 41, and ytterbium complexes 
36, 38, 40, 42 were purified by precipitation of the triflate salt in 10% aqueous methanol 
(Scheme 4.6). 
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Scheme 4.5: Four diastereosisomeric ligands L5, L6, L7 and L8 
showing the enantiomeric relationships 
31, 32, 33 or 34 Ln = { Eu: 35, 37, 39, 41 Yb: 36,38,40,42 
Scheme 4. 6: Synthesis of the lanthanide complexes of the stereoisomeric tetra-amides 
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Attemps to quatemise the phenanthridine nitrogen were unsuccessful. Diverse 
alkylating agents like methyl triflate, dimethyl sulfate, or benzyl chloride were used in dipolar 
solvents (MeCN, PhN02) over a range of temperatures but without any success. 
An explanation for the absence of reaction is the lower nucleophilicity of the 
phenanthridinium nitrogen~ hydrogen-bonding between the amide NH and the phenanthridine 
N may inhibit nucleophilic attack. Furthermore the a-substitution sterically hinders the 
approach of any alkylating agent. 
Some pKa titrations were carried out to measure the basicity of the phenanthridine nitrogen, 
for compound 7, and in the complexes 37 and 40. A pKa value of under 3 was measured by 
monitoring changes on the absorption and emission spectra as a function of pH. The low 
basicity of the nitrogen suggests that both steric inhibition of solvation and intramolecular 
hydrogen-bonding may be occurring. 
The 1H NMR spectra of the europium and ytterbium complexes (295K, 400 MHz) 
exhibited a set of 5 singlets ( 1 :3:2: 1: 1) for the four most shifted macrocycle axial ring protons 
between +30 and +26 ppm for europium complexes and+ 111 and+ 103 ppm for ytterbium 
complexes. This behaviour is consistent with the existence of two stereoisomers in solution 
for each complex. The macrocyclic ring may adopt different conformations around the 
lanthanide ion, in each of these isomers. Usually and as revealed by several X-ray analyses, 
for an (S)- stereocentre each of the -NCCN- chelates adopts a A, conformation. In this case 
(A,A,A,A,) and (8A,A,A,) may exist. Such a situation is not unprecedented: Morrow has reported 
such examples in the structural analysis of europium tetra-amide complexes with four simple 
-CH2CONH2 side arms. 3 
4-1.3: Interaction with nucleic acids 
4-1.3.1: Absorbance and fluorescence spectroscopies 
To evaluate the affinity of these complexes for nucleic acids, they were titrated against 
[(CG)6h under the same conditions as described previously. As the phenanthridine nitrogen 
is not alkylated, the absorbance spectra exhibits three bands at 295, 333 and 348 nm to shorter 
wavelength of the phenanthridinium chromophore, and the maximum intensity of absorption 
was noted at 270 nm. 
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Scheme -1. 7: Absorbance speclru of compla I EuL7 / · 39 following wld1twn ~~1 I (( '( i)0 / : 
Finul rufio [(CG)6j / complex f 1 ;2.3} (295K. pH 7.-1. 10 mlv! NaCI, 10 mAl HEPHS) 
Upon addition of [(CG)(';]2 each complex saw its absorbance decrease slightly for the 
two bands at 333 and 348 nm with an isosbestic point at 310 run, as shown Scheme 4.7. The 
hypochromism at 348 nm was calculated to range between 10 and 20% for each comple'\ 
examined. 
A slight shift of the spectrum to the red was observed when the complex was saturated 
with [(CG)6]2 but this is not as pronounced as the effect observed in the cases of previous 
complexes described in Chapter 3. Nevertheless, the same small red shift of 3 nm was 
measured for each complex of the series, i.e. the shift was independent of the chirality and 
was the same for Eu and Yb complexes. 
The affinity towards [(CG)6h was investigated by luminescence spectroscopy, by 
monitoring the phenanthridine fluorescence at 385 nm and the europium emission at 615 nm 
for the tiJ = 2 transition. The quenching of the fluorescence upon addition of oligonucleotide 
results in a quenching of the emissive state of europium as well . Both phenomena undergo 
the same variation, and the same quenching effect was observed in each of the Eu transitions, 
indicating that no perturbation of the Eu coordination environment occured on complexation 
(Scheme 4.8). 
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fhe evaluauon of the apparent bmding aftimt1es usmg the McGhee and von Htppd 
method was rather difficult to interpret. The observed fluorescence decay was such that rather 
weak emission was observed near the end-point which may account for the non-linearity seen 
in the McGhee-von H1ppel analysis. Such behaviour suggests a bmdmg mechan1sm mvolvmg 
more than one step or more than one binding mode. Nevertheless the apparent bmdmg 
affinities found for the mteractton of the four europtum comple:\es with [ ( CG ), b fell m the 
same range of 106 M'1.duplcx 1 (Table 4 1 ). The apparent bmdmg sne stze remams m all 
cases fatrly s1mllar, but JS unsually high considenng that these complexe5 do not bmd very 
strongly. The larger degree of hypochromism of the [EuL "f complex 35 IS <;uggesll\e of a 
stronger binding m this case. Thts was corroborated by the nuorescence quenchmg beha\iour 
( 63 ° o diminution, Acm- 615 nm ). Thts parameter cannot be of course used as a determmant 
for the evaluation of the bmdmg strength. 
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Complex JCI (lrf) n# % Hypochromism 
(M1.duplex-1) (duplex-1) (348nm) 
(R-RRR)-35 [EuL5/+I[(CG)6}2 16 7.7 20 
(S-RRR)-37 [EuL6/+I[(CG)6]2 13 8 12 
(S-SSS)-39 [EuL7/+I[(CG)6]2 9 9.8 13 
(R-SSS)-41 [EuL8]3+/[(CG)6]2 16 6.6 8 
#Typically [LnL] = 20-30 ).lM; the binding value showed a dependence on the concentration of complex; data 
from fluorescence intensity changes with added oligonucleotide were analyzed with the method of McGhee and 
vonHippel. 
Table 4.1: Intrinsic binding constants (K), site sizes (n), and degree of hypochromism 
measured for complexes of[(CG)6]2 with [EuL5/+. [EuL6/+. [EuL)3+, and [EuL8/+ 
Because the values obtained by the analysis of McGhee and von Hippel were not 
considered to be sufficiently accurate to establish the real effect of the additional chiral 
chromophore arm for the four diastereoisomeric europium complexes, their relative 
fluorescence decay curves were analysed (Scheme 4.9). 
The [EuL5] 3+ complex 35 showed the largest reduction in its fluorescence intensity 
being quenched 10% more than the three other complexes. This difference may be tentatively 
associated with a more suitable geometry in the binding to [(CG)6h compared to the other 
complexes. The phenanthridine chromophore in 35 may take up a more favourable binding 
geometry with respect to the oligonucleotide and give rise to a more efficient excited state 
quenching involving the DNA bases. In terms of affinity, the chirallink to the chromophore 
does not appear to influence binding selectivity, although the quenching of the emission 
intensity revealed a different pattern of behaviour for the (S-RRR) and (R-SSS) complexes 37 
and 41. They both exhibited a modest discontinuity, which could be related to a stepwise 
binding process. 
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Comparison of europium and vtterb1um complexes 
Despite the unchanged geometry of the complex the nature of the lanthanide is likely 
to influence the binding with these series of complexes as well. Thus the behaviour of 
ytterbium complexes was investigated and compared to the analogous europium complexes. 
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Firstly the quenching of ytterbium complexes appeared in each case to be less 
significant than was observed for europium. For the L5 isomer the change of lanthanide from 
europium to ytterbium results in a 20% reduction in quenching, and for the S-SSS isomer the 
difference in quenching was 10%. The ytterbium complexes appeared to bind less strongly 
than the europium complexes to the oligonucleotide. 
Secondly the ytterbium complexes were more likely to exhibit a discontinuity in their 
quenching decay profile. This is more marked for [YbL5J3+, 36, than for [Ybe]3+, 40, which 
is consistent with the assumption that a stepwise binding process is more likely to be observed 
for the weakest complex [DNA-ligand]. 
One possible reason for the difference of affinity between europium and ytterbium 
complexes is the acidity of the water molecule bound to the lanthanide. In the case of the 
more charge dense ytterbium complexes, this water is more acidic. 4 It is possible that the 
bound water at Yb is significantly ionised, forming a [YbLOHf+ complex at ambient pH. 
The lower residual charge on the complex offers a simple explanation for the difference in 
affinity. 
This difference is also highlighted with the CD experiments in the following part 4.1-2.2. 
For the simple reason of lack of affinity, the interaction of these complexes with 
[(AT)6lz was studied qualitatively only for the [EuL5]3+ complex, 35. The fluorescence and 
absorbance measurement revealed only slight variations, which precluded a more detailed 
analysis. 
4-1.3.2: CD titrations 
The difference between europium and ytterbium complexes was also investigated by 
circular dichroism studies. The small variations observed by absorption and emission 
_ spectroscopy even in the case of the (R-RRR) and (S-SSS) isomers did not allow firm 
conclusions to be reached concerning the selectivity upon binding of the different complexes. 
Only the (R-RRR) and (S-SSS) enantiomers of europium and ytterbium complexes were 
examined in their binding to [(CG)6h· 
The difference CD spectra were recorded following the addition of each of the 
enantiomeric complexes. Thus the importance of the complex helicity was investigated as 
well as the influence of the lanthanide complexed. 
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Spectra were recorded following addition of the Ll and A europium complexes to 
[(CG)6]2. Different behaviour was observed in each case (Scheme 4.12). The negative band 
at 265 nm decreased in intensity when the complex Ll-[EuC]3+, 39, saturated the 
oligonucleotide. A slight shift to higher wavelength was also observed for the positive band 
at 285 nm. In the case of the A-[EuL5] 3+ complex, 35, the negative band at 265 nm remained 
unchanged while the positive band at 285 nm decreased in intensity and shifted slightly to the 
red. Thus each complex induces different changes in the conformation of the dodecamer 
d(CG)6. The chirality of the europium complex indeed determines the nature of the binding 
interaction, as expected for such diastereoisomeric complexes. 
Secondly, the case of the ytterbium complexes A-36 and Ll-40 was examined (Scheme 
4.13). Upon the addition of either complex, a decrease in intensity was observed for both 
bands at 265 and 290 nm, and thus suggested a similar type of chiral interaction. 
The effect of varying the lanthanide ion was revealed by comparing the CD difference 
spectra for the same ligand complexed by either europium or ytterbium. The changes induced 
in the oligonucleotide duplex upon addition of ligand e are of different nature for europium 
or ytterbium. Decreases in intensity were observed in 285 and 255 bands in the case of the 
ytterbium complex, 40, while for the corresponding europium complex, 39, only the 255 nm 
band was affected. 
With the A-(R-RRR) complexes, the position of the band at 255 nm does not change for the 
europium complex, 35, only the positive band at 285 nm exhibit an intensity decrease which 
was also observed for the ytterbium complex, 36. 
With both enantiomeric ligands, the nature of the complexed metal affected the DNA 
conformation in such a way that the characteristic pair of transitions of aB-form d(CG)6 were 
reduced in intensity or remained unmodified. The chirality of the ligand also promoted a 
variation of intensity for the negative band for the Ll-complexes, while the A-complex 
perturbed (lowering and red shift) the 290 nm positive band. 
With these series of tricationic complexes the possibility of examining induced CD 
bands in the visible region cannot be investigated. This experiment which proved valuable in 
111'; 
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the case of the tetracationic complexes, i.e. those bearing a quatemized nitrogen on the 
phenanthridine chromophore, was not possible with this series as the absorption bands were 
much reduced in intensity in this region. 
4-1.3.3: Ionic strength influence 
The effect of ionic strength on the binding of the [Eu-L5]3+ complex was investigated 
in the same way as for the tri-cationic complex A-[EuL38] 3+, by absorbance and fluorescence 
spectroscopy. An estimation of apparent binding affinities was not considered possible due to 
the small changes observed. Consequently, comparative fluorescence decay curves were 
plotted for qualitative analysis. 
The interaction of the more strongly bound complex [EuL5] 3+ with [(CG)6]2 was 
studied in low salt (10 mM NaCI) and at higher ionic strength (100 mM NaCl) (Scheme 4.14). 
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Scheme 4.14: Fluorescence intensity changes (Aexc = 304 nm, Aem = 385 nm) of[EuL5/+ 
following addition of [(CG)6]2 in 10 mM and 100 mM sodium chloride (295K) 
The intensity of the fluorescence was lowered by up to 75% in 10 mM added salt, 
while in the presence of 100 mM NaCl, the intensity was only quenched by 20%. Such a 
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large change suggests a bindmg mode to f(CG)r, J~ for thiS complex predommantly mvolvmg a 
large electrostatic component. 
To assess the intluence of the high ionic strength on the tn-catton1c complex [EuL5]~+. 
its fluorescence decay curve was also compared to that obtained with [EuL ~a)'- under the 
same conditions (Scheme 4.15 ). 
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Both curves show a similar form suggesting that the behaviour of the two complexes 
[EuL :;a]h and [Eul ~]H in their binding to [(CG)6b under high salt concentration ma~ be 
similar. The quenchmg of the fluorescence from the phenanthridme apparent!) decays almost 
linearly, and does not shov, the marked curvature revealed under lower romc stren!:,rth 
conditions. 
The fluorescence of the complex [EuL 3a)3+ is quenched by 15 % more upon bmdmg to 
[(CG)6h compared to the [EuL 5]H complex. This observation suggests a stronger association 
for [EuL 'al'+-f(CG)I'ih than for [EuLslH-[(CG)6h· The reasons for this difference can only be 
the linking direction or the greater de&rree of steric hindrance around the phenanthridme 
liS! 
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group, which may limit the degree of contact with the DNA bases. The electrostatic 
contribution seems to constitute an important part component in the binding of these 
complexes to oligonucleotides, since no definitive evidence of intercalation of the 
phenanthridine moiety has been found. 
Summary of the binding behaviour of[LnL5-8/+: 
The presence of the additional chiral centre on the linking arm did not improve the 
selectivity upon binding. It also lowered the nucleophilicity of the phenanthridine nitrogen 
which inhibited N-alkylation. Nevertheless a common point emerged: the A-isomers for both 
of the tri-cationic series of complexes A-[EuL3a]3+ and A-[EuL5] 3+ showed the strongest 
affinity possibly suggesting a binding mode involving a more complementary interaction with 
the minor groove. Such a conclusion needs to be substantiated by additional experiments 
however. 
4-2 Mono and bis chiral phenanthridinyl complexes 
In the third chapter, the chiral lanthanide complexes incorporating an N-
phenanthridinium moiety were shown to exhibit some CG base-pair selectivity. The element 
of helicity around the lanthanide ion was also important in this recognition process, so 
consideration was given to bringing it closer to the intercalative moiety aiming to try and 
improve the selectivity of this interaction. The shortening of the linking arm led to a complex 
where the phenanthridine nitrogen itself acts as a coordinating atom for the lanthanide, 
thereby satisfying a coordination number of 8. Thus the potentially intercalative 
chromophore was once again a neutral phenanthridine moiety. The effect of such a 
modification was studied by examining the series of complexes ~- and A-[EuL9-10] 3+ and the 
bis phenanthridine analogue ~-[EuL11 ] 3+ (scheme 4.16). 
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Scheme 4.16: The 6-substituted phenanthridine-bound complexes A-[EuL9f+, iJ-[EuL 10f+ 
and iJ-[EuL 11/+ 
4-2.1: Synthesis of a series of chiral complexes 
The substitution of the phenanthridine in the 6-position was carried out following 
established methods,2 involving nucleophilic attack by methyl lithium in THF at low 
temperature (Scheme 4.17). The re-aromatization of the ring was performed using manganese 
dioxide in dichloromethane. Bromination of 43 using N-bromosuccinimide in a mixture of 
chloroform and dichloromethane occurred exclusively at the benzylic position and led to the 
desired mono-bromo product 44. 
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· Scheme 4.17: Synthesis of the 6-bromomethylphenanthridine 
The coupling of 44 with the cyclen was performed in acetonitrile in the presence of 
caesium carbonate to give the tetra-amide 45. The ligand 46 was obtained by the 
functionalization of the macrocyclic unit with the chiral a-chloroamide (Scheme 4.18). 
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Scheme 4.18: Synthesis of the ligand L9 
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Complexation of a lanthanide occurred easily by reaction of the metal triflate salt in 
dry acetonitrile. The complexes were purified by precipitation of their triflate salt in aqueous 
methanol. The phenanthridine nitrogen may not be alkylated here, due its involvement in the 
coordination of the lanthanide. 
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Scheme 4.19: Synthesis of the complex (RRR)-[EuL9/+ 
Following the same procedure,5 the ligand enantiomer L10 bearing three (S)-amide 
pendent arms was obtained.i For purposes of comparison, the synthesis of a bis analogue6 
was also carried out to investigate the possibility of such a complex spanning two 
oligonucleotides. The distance between the phenanthridine group in [EuL11 ] 3+ is about 5.5 A 
(N-Eu-N), compared to an 11 A width in the major groove ofB-DNA. 
4-2.2: Characterisation of the complexes [EuL9/+ [EuL10/+ and [EuL11/+ 
4-2.2.1: Circularly Polarized Luminescence 
For each of these complexes, the circularly polarized luminescence emission spectrum 
was measured. The two enantiomeric complexes [EuL9] 3+ and [EuL 10] 3+ gave rise to equal 
and opposite CPL spectra (Scheme 4.20). 
i The synthesis of [EuL 10] 3+ was carried out by Dr Linda J. Govenlock, and for [EuL 11 ] 3+ by Alessandra Badari. 
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The comparison of these spectra with those reported for analogous chiral comple"e~. 
e.g. 6-[EuL 2f +,7 reveals a similar spectral form and the observed dissymmetry factors (g~'1T1 ) 
value for [EuLur+ of +0.14 (586 nm), -0.07 (591 nm) (6./ - l transition), +0.0-l (648 nm. D.-I 
= 3) and - 0 07 (685 nm, tiJ = 4) were also similar in both magnitude and sign. This suggests 
that (SSS)-[EuL 10]""+ adopts a right-handed helicity in the layout of the ring nitrogen 
· r 'J H Ill , .. 
subst1tuents. There1ore the complexes are denoted A-[EuL ] and 6-[EuL J . 
The CPL spectra of the complex [EuL 11]'"" showed the same overall ~pectral form 
However the mtenslty of the em1ssion was at least 10 times weaker. suggestmg that the metal 
centred 6 helicity 1s much less pronounced in the C2-symmetnc h1.\ {EuL 11 ]'- comple'< 
compared to the mono substituted one. 6-[EuL 11']H. Evidently the presence of two trans-
related substituents bearing the stereogenic centres at C induces a less marked helicity around 
the lanthanide ion. 
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-1-2.2.2. Ha!JJe effect quenching 
The distinguishing feature of these complexes is the coordination of the 
phenanthridine nitrogen to the lanthanide ion. Consequently the resulting complex is likely to 
become more rigid, and so could possess a somewhat electron-deficient and potentially 
intercalative chromophore. A cationic aromatic chromophore is considered as an important 
factor for efficient intercalation. but IS not essential for a charge-transfer mteraction between 
the DNA bases and the chromophore. In the comple~ J\-[EuL ;at· for example. tt has been 
shown that the neutral phenanthridine group shows evtdence for mtercalat10n between the 
DNA bases. 
The electronic structure of these complexes A-[EuL 9f ·. t.\-[EuL 10t··. ~-[EuL 11 f "' 
therefore presents a compromise between a neutral and a cationic phenathndyl moiety. and so 
the quenchmg effect of halide on the luminescence is expected to be less pronounced than for 
[EuLI)l+.R 
I"J 
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To quantify the effect of added halide on the emission characteristics of such 
complexes, the phenanthridine fluorescence and the europium emission were monitored in 
presence of increasing concentration of iodide and chloride. The resulting Stem-Volmer 
quenching constants are listed Table 4.2, and reveal similar behaviour for the mono and bis-
phenanthridine complexes. 
Iodide 
Chloride 
P henanthridine 
Fluorescence 
23 
124 
Europium 
emission 
40 
144 
Phenanthridine 
Fluorescence 
16 
80 
Europium 
emission 
34 
>250 
Table 4.2: Stern-Volmer quenching constants (Ks/. mmolJ1, ±10 %) for the effect ofhalide 
ions on phenanthridinium fluorescence (A.em = 405 nm) and europium emission 
(Aem = 615 nm) in LJ.-[EuL10/+ and L1-[EuL11/+ (295 K, Aexc = 365 nm) 
The comparison of the values found for the complexes .1-[EuL 10]3+ and .1-[EuL 11 ]3+ 
and those of [EuL1t+ (Table 4.2) showed that the quenching was less effective for the 
phenanthridinyl bound complexes. A simple explanation is provided by the ease of charge 
transfer from an halide to the more readily reduced cationic phenanthridinium compared to a 
transfer to the electron-deficient phenanthridine moiety in .1-[EuL 10]3+ and i\-[EuL 11 ] 3+. The 
stronger quenching occured each time with the iodide halide, which is easier to oxidise than 
chloride. 
4-2.2.3: Variable temperature NMR 
The paramagnetic shifted 1H NMR spectra of [EuL9] 3+ and [EuL 11] 3+ were recorded in 
methanol at various temperatures from 240 to 330 K. 
1'?'\ 
The analys1s of the chemical shift of the most shifted ring axial protons re,ealed one 
set of four singlets (39.0, 35 6, 25.1 and 22.3 ppm, 295 K), wh1ch is consistent with the 
presence in solution of one major stereoisomeric species ( >95°1o ). Such beha\ Jour was also 
f , 1+ ' H· 7u observed 1n the case o L\-[EuL ~l and A-[EuL-l tetra-amtde complexes. 
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,,12-11. 251, 2(i(J, 272, 293, 29R, 308,3/8, 328 K (CD 3(}])) 
The approx11nately linear variatton of the chemical shdt ~8 of nng axtal protons and 
the mverse of the temperature squared suggests the existence of a predominant d1polar or 
pseudocontact shift. The rrng axial proton is quite remote from the Eu centre. so that any 
contact shift, operatmg through the bonds, is likely to be small The r~ dependence of the 
chemical shift of the bound water represents a good approximation for the d1polar term ' The 
near-linearity of the relation between ~8 and 1/T2 was observed for both the mono and b1s 
complexes. 
The implication of the observed temperature variation and the absence of an) other 
significant line broadening phenomena is that there are no significant chemical dynam1c 
exchange processes occurring below 300K. This suggests that each of the complexes ts 
relatively rigid on the NMR time scale and to a similar extent 
,,,, 
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-1-2.3. I: Ahsorbance spectroscopJ 
The interaction of the bound phenanthridinyl complexes was mvesttgated b~ 
absorbance spectroscopy. The absorbance spectra of each complex exhibited long 
wavelength maxima at 310, 345 and 365 nm, figures which are intermediate tn value betvveen 
the absorption spectrum of an alkylated (or protonated) phenanthridinium group and a neutral 
phenanthridine. 
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The absorbance spectra of the complex A-[EuL"l., .. and ~-(EuL 111t foliO\\ mg addition 
of CT-DNA or [(CG)toh exhibit one isosbestic pomt at 304 nm. The hypochromtsm at 358 
nm was 20°·o and 41°o respective!} for i\-[EuL9]"' .. and ~-[EuL wf. and no red shift was 
observed for either enantiomer. The titration curves seemed to mdtcate the extstence of an 
interaction, but an mtercalative binding mode was not suggested by this beha\tour Howe\er 
a more well-defined mteraction seems to occur with the ~ comple'\ [EuL 1(1]., . 
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In the case of the bis complex ~-[EuL 11t·, the absorbance spectra changed even less. 
any variation presumably may even be due to the tail absorption of the added DNA Itself No 
sign of an tntercalative binding mode was found with this complex fhe beha' tour obsen ed 
for the mono comple'<es was clearly different for the ht' complex fEul ''f-. 
-1-2.3.2: ! .wmJU! \Cence .\pectrmcopy 
Lurmnescence titration with monu and bts complexes A-[EuL<J]'+, ~-[Eul 10 1 ;- and j-
[EuL 11 ]"+ revealed some surprising behaviour. While the absorbance spectral stud) had 
suggested the presence of a binding interaction for t\.-[EuL9t and ~-[EuL 101 H, there was 
only a small change in the europium emission intensity ( Aem = 615 nm ). The phenanthndine 
Chupli!l -1 fi-Piuma111hnd/l~l'l hosed ltJ.rulld\ for I 1,\ A mlaac'f/011 
fluorescence tntensity (l..c,c- 304 nm, /,em = 385 nm) from both complexes A-[EuL qf and~­
[EuL 10]"" decreased b) 36°/o, which constitutes a small variatiOn compared to any of the other 
complexes studied. The europium emission intensity exhibited a slightly greater \anatlon of 
44% (A~:m = 615 nm) for both complexes. 
Moreover the phenanthridine fluorescence (A..:,c = 304 nm, Ao:m 385 nm ) from the 
complex .!l-[EuL11] H remained almost unchanged following add1tion of CT-DNA Thus no 
evidence for quenching of the phenanthridine fluorescence by charge transfer from the 
electron rich CG-base pairs was found. 
In the case of the complexes A-[EuL9] 3+ and .!l-(EuL 111f+, the emission spectra showed 
slight variation in the fonn of the IJ.! = 2 transition. The shoulder of the IJ.J = 4 band also 
seems to disappear at saturation of the oligonucleotide. These two transitions are sensitive to 
the environment of the europium ion, slight changes in coordinatton geometnes around the 
europium ion may occur follov .. ing addition of the oligonucleotide. 
For 6-[EuL 11] l• however, the transitions in the europiUm emission spectra retamed the 
same fonn, consistent w1th the existence of the same coordinat1on em 1ronment around the 
lanthanide ion with and Without added DNA 
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Chapter 4: 6-Phenanthridiny/ based ligandsfor DNA interaction 
This senes of complexes apparently does not possess suitable properties for an 
efficient binding interaction. The lack of flexibility in their structure appeared to inhibit their 
interaction with nucleic acids. It may be that the complex is too bulky to bring its positively 
charge closer to the DNA polyanionic phosphate backbone. Thus the first step of the binding 
interaction, e.g. the electrostatic interaction, may not be occurring efficiently. Furthermore, no 
evidence for any stereoselectivity in the binding interaction was observed. The 
phenanthridine unit itself may also not be sufficiently electron-deficient to interact strongly 
with the nucleobases by an intercalative process. 
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Solvents were dried from an appropriate drying agent when required and water was 
purified by the « PuriteSTILL plus » system. Thin layer chromatography was carried out using 
neutral aluminium oxide plates (Merck Art 5550) or silica plates (Merck Art 5554), both 
being fluorescent on irradiation at 254 nm. Preparative colomn chromatography was carried 
out using silica (Merck silica gel 60, 230-400 mesh) or alumina (Merck neutral alumina ). IR 
spectra were recorded with a Perkin Elmer 1600 FT-IR spectrometer operating with a 
GRAMS Analyst software using a "Golden Gate" accessory. 
Mass spectra (Cl) were recorded using a VG 7070E spectrometer using ammonia as 
the impingent gas. Electrospray mass were recorded using a VG II Platform spectrometer 
(Fisons Instruments) with methanol or H20 as the carrier solvent. Accurate masses were 
measured by EPSRC Mass Spectroscopy Service at the University of Wales at Swansea. 
Mass Spectrometry of oligonucleotides : The oligonucleotides were prepared by stirring at 
60°C in ammonium acetate (0.1 M) for 10 min and then left cooling down at room 
temperature overnight. The concentration of oligonucleotide was adjusted to 18 J..LM (duplex) 
by addition of Purite water. Measurements of oligonucleotide mass spectra were carried out 
in negative mode, (ES-), over a mass range from 200 to 2800 with a cone voltage of 79 V (295 
K). The complex solutions established in purite water were added directly to the 
oligonucletide solution, and the mixture injected without any further preparation. 
Proton NMR spectra were recorded on a Varian VXR 400 (65.26 MHz), Varian VXR 
200 (199.99 MHz), Varian Gemini 200 (199.99 MHz), Varian Mercury 200 (199.99 MHz) or 
Varian Unity 300 (299.91 MHz). Carbon NMR spectra using the Varian Merury 200 (50.29 
MHz), Varian Unity 300 (75.4 MHz), Varian VXR 400 (100.58 MHz) or Broker AMX 500 
spectrometer (125.77 MHz). Spectra were referenced to solvent residual proton resonances. 
All chemical shifts (3) are reported in ppm and coupling constants reported in Hz. 
Melting points were measured using a Reichart-Kofler block and are uncorrected. 
Ultraviolet absorbance spectra were recorded on a Unicam UV2 spectrometer 
operating with a Unicam Vision software, with extinction coefficients reported in parentheses, 
in units of M-1cm-1. Luminescence spectra were recorded either using a Perkin Elmer LS 
50B or an Instruments SA Fluorolog 3-11 equipped with a SPX 1934D3 phosphorimeter. 
Corrected spectra were obtained taking into account the wavelength-dependent response of 
the instrument. 
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Non-zero baseline effects were allowed for by running a blank sample and subtracting this 
from the obtained spectra. Second order diffraction effects were obviated by using a cut-off 
filter to remove the scattered light before it enters the emission monochromator, e.g. by use of 
a 380 nm cut-off filter when acquiring Eu emission spectra. 
Excited state lifetime measurements for europium and terbium were made on either 
the Perkin Elmer LS 50B (using Phlemming data acquisition written by Dr. A Beeby, 
University of Durham) or the Instruments SA Fluorolog (using DataMax for Windows v2.1). 
Lifetimes were measured by excitation of a sample by short pulse of light (397 nm for 
europium) followed by monitoring the integrated intensity of light (594 or 616 nm for 
europium) emitted during a fixed gate time, tg, a delay time, td, later. At least 20 delay times 
were used covering 3 or more lifetimes. Typically gate times of between 100 and 250 JlS 
were used , and the excitation and emission slits were set to 5-15 nm bandpass. The obtained 
decay curves were fitted to a simple mono-experimental decay curve using either Grafit 3.0 
(Erithacus software) or Microsoft Excel. 
Quantum yield measurements were made relative to two known standards. For 
europium complexes these were Rhodamine 101 in ethanol ($ = 1) and Cresyl violet in 
methanol($= 0.54). These standards were chosen as they emit in a similar spectral window 
to europium and possess a similar absorbance to the aromatic antenna, at the excitation 
wavelength used in the studied complexes. For each of the standards and the unknown, five 
solutions with absorbances between 0.02 and 0.1 were used. For each of these solutions the 
absorbance at the excitation wavelength and the total integrated emission was determined. 
Errors in quantum yield determinations can arise due to the inner filter effect or errors in the 
amount of absorbed light. The first of these can be very important when using references 
such as Rhodamine 101 and Cresyl violet as these are both strongly absorbing in the emission 
region. This effect was minimised by only using samples with absorbances below 0.2. Errors 
in the amount of light absorbed by each sample were minimised by choosing the excitation 
wavelength to be on a relatively flat area of the absorption curve (i.e. ea. 270 nm) and by a 
small band pass for excitation. 
pH measurements were made using a Jenway 3320 pH meter (fitted with a BDH Glass 
+combination electrode- microsample) calibrated with pH 4, 7 and 10 buffer solutions. 
pH Titrations: Luminescence pH titrations were carried out in a background of 
constant ionic strength (I= 0.1 M NMe4Cl04, 295 K) on solutions with absorbances of< 0.3 
111 
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at wavelengths ;::: Aex in order to avoid any errors due to the inner filter effect. Solutions were 
made basic by addition of 1M KOH and titrated to acidic pH using small aliquots (typically 
0.5 J.LL) of 1M or 0.1 M TFA. The luminescence spectra were recorded at each point (30- 40 
points per titration). Excitation wavelengths of 304 or 378 nm (sensitisation via 
phenanthridine chromophore) were used to obtain the luminescence spectra. Excitation and 
emission slits were 1 nm and 1.5 nm bandpass respectively. Points were recorded at 1 nm 
intervals with a 0.5s integration time. Standard least squares fitting techniques were used to 
determine protonation constants from the luminescence intensity data. 
Oligonucleotide titrations : Luminescence DNA titrations were carried out in a background 
of buffered medium (pH 7.4, NaCl 10, 50 or 100 mM, HEPES lOmM, 295 K) on complexes 
solutions with absorbances of 0.2 at wavelengths 304 or 320 nm (typically a complex 
concentration between 20 and 30 J.LM). The oligonucleotide solutions were incremented by 
addition of aliquots of 10 J.tl of commercial solution (concentration of single strand typically 
0.3 mM) purchased from Oswel company, Southampton. The luminescence spectra were 
recorded at each point. Excitation wavelengths of 304 or 378 nm (sensitisation via 
phenanthridine chromophore) were used to obtain the luminescence spectra. Excitation and 
emission slits were 1.5 nm bandpass. Points were recorded at 1 nm intervals with a 0.5 s 
integration time. Second order diffraction effects were obviated by using a 375 nm cut-off 
filter in the case of the luminescence spectra recorded after excitation at 304 nm (neutral 
phenanthridine chromophore ). 
Circular Dichroism spectra were recorded using a Jasco J-810 Spectropolarimeter. 
Circular dichroism titrations : Difference CD titrations were carried out in a 
background ofbuffered medium (pH 7.4 NaCllO mM HEPES lOmM, 295 K) in a 1 cm path 
quartz cell. The concentration of oligonucleotide solutions was 3.06 ~and the complex 
solution was incremented to the oligonucleotide solution by addition of aliquots of 20 J.!l of a 
0.16 mM solution concentration. The spectra were recorded with a sensitivity of 5 mDeg, in 4 
successive scans. A spectra of the buffered background was deduced from each row spectra. 
A spectrum of the complex at its highest concentration was recorded, normalized and 
proportionally deducted from each normalized spectra of DNA-complex after each addition, 
to show the CD difference spectra. Dilution factors were considered at the time of the 
normalisation step included in the calculation of coefficients. 
11LI. 
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6-Butylphenanthridine1 
9 
Phenanthridine (1 g, 5.6 mmol) was dissolved in dry diethyl ether under argon. The solution 
was cooled down to -78°C and n-butyllithium (4.1 ml, 6.1 mmol) was added dropwise. The 
yellow solution was stirred at -78°C for one hour, then quenched using an aqueous solution of 
potassium hydroxide (0.1 M, 5 ml). The product was extracted using dichloromethane ( 4 x 
20 ml), the organic layers washed using brine (3 x 20 ml), dried over potassium carbonate, 
filtered and the solution was concentrated to one third of the volume. Manganese (IV) 
dioxide (2 g) was added, and stirred at room temperature overnight. The manganese residue 
was filtered and the solvent removed. The residue was purified by column chromatography 
on silica using dichloromethane as the eluent (Rr= 0.3), to give a colourless oil (1.1 g; 85%). 
1H NMR (CDCI), 300 MHz): 3 8.59 (IH, d, J 8, H4); 8.50 (IH, d, J 8, HI); 8.23 (IH, d, J 
8, H7); 8.15 (IH, d, J 8, HlO); 7.78 (1H, t, J 7.1, H2); 7.65 (3H, m, H8H9H3); 3.37 (2H, t, 
J7.9, H11); 1.91 (2H, m, H12); 1.57 (2H, m, H13); 1.00 (3H, t, J7.5, H14). 
13C NMR (CDCI), 75.4 MHz): 3 160.3 (C6); 158.5 (C-Ar); 130.5, 129.7, 129.0, 128.8, 
127.5, 127.1, 127.1, 126.5, 123.4, 122.7, 122.1, 118.9, 115.6 (C-Ar); 36.6 (C11); 28.2 
(C12); 22.1 (C13); 12.9 (C14). 
M/z (ES+) : 235 [M+Ht 
Elemental analysis: Found C 84.7, H 7.53, N 5.80%; Cl7HJ7N.0.25Hz0 requires: C 85.2, H 
7.31, N 5.84. 
6-Phenylphenanthridine1 2 
1 H.Gilman, J. Eisch, J. Am. Chem. Soc., 1957, 79, 5479. 
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Phenanthridine (0.15 g, 0.86 mmol) was dissolved in dry diethyl ether under argon. The 
solution was cooled down to -78°C. Phenyllithium (1.2 ml ; 1M, 1 mrnol) was added 
dropwise. The yellow solution was maintained at -78°C for one hour. Then the solution was 
quenched using aqueous solution of potassium hydroxide (0.1 M, 5 ml). The product was 
extracted using dichloromethane (4 x 20 ml), the organic layers washed using brine (3 x 20 
ml), dried over potassium carbonate, and filtered off. The solution was concentrated and 
manganese (IV) dioxide was added, and stirred at room temperature overnight. The 
manganese residue was filtered and the solvent removed. The residue was purified on silica 
chromatography column using dichloromethane as eluent (Rr = 0.25), to yield a white solid 
(0.26 g; 78%), m.p. 95-96 °C (litt. 103-106°C). 
1H NMR (CDCh, 200 MHz): 15 8.74 (IH, d, J 8.3, HI); 8.66 (IH, d, J7.8, H4); 8.27 (IH, d, J 
7.8, H7); 8.13 (lH, d, J 8.3, H10); 7.88 (lH, t, J7.3, H2); 7.77-7.53 (8H, m, H3H8H9, PhH). 
13C NMR (CDCh, 50 MHz): 15 161.5 (C6); 159.5 (C-Ar); 140.2, 135.6, 133.5, 132.1, 131.3, 
130.2, 129.7 (C-Ar); 125.1, 124.8 (CH-Ph), 124.6, 124.2, 124.1, 123.8, 122.9 (C-Ar). 
M/z (ES+): 256 [M+Ht. 
6-Benzylamine phenanthridine2 3 
6-Chlorophenanthridine 11 (0.1 g, 0.46 mmol) was solubilized in dimethylformamide (5 ml), 
benzylamine (2 ml) was added and the mixture was heated at 150°C for 2d. After cooling 
down the solution was poured into ice. The product was extracted using CH2Ch ( 4 x 30 ml), 
washed with sodium carbonate solution (0.1 M, 30 ml), dried over potassium carbonate, 
filtered off. The solvent was removed to yield a yellow oil (82 mg; 63%). 
1H NMR (CDCh, 200 MHz): 15 8.55 (1H, d, H1); 8.46 (IH, d, H4); 8.15 (1H, d, H7); 8.07 
(IH, d, HlO); 7.78 (1H, t, H2); 7.65 (3H, m, H3H8H9); 7.20 (5H, m, PhH); 2.99 (2H, s, 
NCH2-), 1.52 (IH, br s, NH). 
2 a) C. B. Reese, J. Chem. Soc., 1958, 173, 895-899. 
b) C. B. Reese, J. Chem. Soc., 1958, 174, 899-901. 
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13C NMR (CDCh, 75.4 MHz): 8 154.3 (C6); 150.8, 135.6, 129.5, 128.5, 127.5, 127.1 (C-Ar); 
128.8, 125.3 (CH-Ph); 124.9, 124.8, 124.4, 122.9, 118.2, 116.7, 115.8 (C-Ar); 47.5 (~H2NH). 
M/z (ES+) : 285 [M+Ht. 
6-Dibenzylamine phenanthridine2 4 
6-Chlorophenanthridine 11 (0.2 g, 0.93 mmol) was heated in dibenzylamine (5 ml) at 150°C 
overnight. The solution was poured into water. The product was extracted using CH2Ch ( 4 x 
20 ml), washed using potassium carbonate solution (0.1 M, 20 ml), dried over potassium 
carbonate, and filtered off The oily residue was used without any further purification. 
1H NMR (CDCh, 200 MHz): 8 8.59 (lH, d, HI); 8.50 (1H, d, H4); 8.48 (IH, d, H7); 7.97 
(1H, d, H10); 7.79 (lH, t, H2); 7.65 (2H, q, H3H8); 7.49 (5H, m, H9, Ph Hortho); 7.33 (6H, 
m, Ph Hmeta,para ); 4. 77 ( 4H, s, NCH2-). 
13C NMR (CDCh, 50 MHz): 8 155.2 (C6); 150.4, 134.8, 130.8, 130.1, 129.4, 1296, 129.3 
(C-Ar); 127.9, 127.2, 126.1 (C-Ph); 125.9, 117.1, 114.2, 112.7 (C-Ar), 55.1 (CH2N). 
M/z (ES+): 375 [M+Ht, 397 [M+Na( 
6-Thiophenanthridine 8 
CC6H 
6-Chlorophenanthridine 11 (1 g, 4.6 mmol) was heated in ethanol for 2 h, then thiourea (0.38 
g, 5 mmol) was added and the mixture was stirred at 60°C for 2hrs. The solvent was removed 
and the product was recrystallized from ethanol to yield a yellow solid (0.91 g; 94%). 
1H NMR (CDCh, 300 MHz): 811.07 (lH, br s, SH); 9.10 (lH, d, H1); 8.32 (2H, t, H4 H7); 
7.85 (1H, d, HlO); 7.65 (1H, d, H2); 7.54 (IH, t, H3); 7.40 (2H, m, H8H9). 
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13C NMR (CDCh, 75.4 MHz): ~ 165.4 (C6), 147.1, 133.7, 133.1, 130.0, 128.8, 127.9, 127.4, 
125.1, 123.3, 116.5 (C-Ar). 
Mlz (ES+): 210 [M+H( 
6-Cyanophenanthridine 9 
6-Chlorophenanthridine 11 (1 g, 4.6 mmol) was solubilized in DMF (10 ml), with potassium 
cyanide (1 g, 12 mmol) and the mixture was heated at 100°C overnight. The mixture was 
cooled down to room temperature, and poured into ice. The product was extracted using 
CH2Ch ( 4 x 30 ml), washed using water (3 x 30 ml) and potassium carbonate solution (0.1 M, 
20 ml), dried over potassium carbonate and filtered off. The solvent was removed and the 
residue recrystallized twice from aqueous ethanol, to give a pale yellow solid (0.6g; 64%), 
m.p. 104-106°C. 
1H NMR (CDCh, 300 MHz): ~ 8.70 (IH, d, HI); 8.64 (IH, d, H4); 8.48 (IH, d, H7); 8.27 
(IH, d, HIO); 8.00 (IH, t, H2); 7.86 (3H, m, H3H8H9). 
13C NMR (CDCh, 75.4 MHz): ~ 152.5 (C6), 132.5; 131.3; 130.2; 129.1; 127.0; 122.6; 
122.5; 112.7 (C aromatic); 106.7 (CN). 
Mlz (ES+): 205 [M+H( 
Elemental analysis: Found C 80.97, H 3.82, N 13.00%; C1JlsN2.0.25H20 requires C 80.6, H 
4.08, N 13.4% 
IR (thin film) : Umax 2015 (CN). 
6-Aminomethylphenanthridine 10 
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6-Cyanophenanthridine 9 (0.6 g; 2.9 mmol), hydrazine hydrate (3 ml, excess), palladium 
hydroxide (Pearlman's catalyst) (0.5 g) were stirred in methanol (30 ml) at room temperature 
overnight. The solid was filtered off and the solvent was removed under reduced pressure to 
yield a pale yellow oil (0.59 g; 98 %). 
1H NMR (CDCh, 300 MHz): () 8.59 (lH, d, HI), 8.50 (lH, d, H7), 8.20 (IH, d, HlO), 8.15 
(lH, d, H4), 7.84 (lH, t, H2), 7.72-7.67 (3H, m, H3H9H8), 3.06 (2H, s, CH2), 1.65 (2H, br.s, 
NHz). 
13C NMR (CDCh, 75.4 MHz): () I58.9 (C6); I44.5, 129.6, 127.9, 127.2, 126.4, I26.0, I25.I, 
123.0, 121.3 (C-Ar); 45.7 (CHzN). 
M/z (ES+): 209 [M+ Ht. 
6-Chlorophenanthridine3 11 
o=t;l 
Phenanthridinone (5 g, 25 mmol) was solubilized in phosphorus oxychloride (60 ml) in the 
presence of N,N-dimethyianiline (2 ml) and the mixture was heated at reflux for 3hrs. The 
solvent was removed under reduced pressure and the residue poured into ice and the product 
was extracted using CH2Cl2 ( 4 x 20ml). The organic layers were washed using an aqueous 
solution of KzC03 (O.I M, 2 x 20ml), dried over KzC03, filtered and the solvent was 
removed. The product was recrystallised twice from ethanol-water, to yield beige crystals 
(3.8 g; 72%) mp: 90-92°C (lit. I13-II4°C). 
1H NMR (CDCh, 300 MHz): 3 8.65 (lH, d, J 8.4, HI); 8.57 (lH, d, J 8.I, H7); 8.52 (IH, d, 
J 8.I, H4); 8.I2 (lH, d, J7.6, HlO); 7.94 (IH, t, J7.2, H2), 7.82-7.71 (3H, m, H3H9H8). 
13C NMR (CDCh, 75.4 MHz): 3 149.7 (C6); 131.8, 130.8, 130.3, 130.0, 128.9, 127.8, I26.9, 
125.4, 123.9, 122.8, 118.9 (C-Ar). 
Elemental analysis: Found C 70.01, H 3.57, N 5.84%; C1JfgN2 requires C 73.07, H 3.77, N 
6.55%. 
· 
3 G. M. Badger, J. H. Seidler, B. Thomson, J. Chem. Soc., 1951,3207-3211. 
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2-Bromophenanthridine 12 
9 
Title compound was prepared according to the literature method.4 Phenanthridine (5 g, 28 
mmol) and N-bromosuccinimide (5 g, 29 mmol) were taken into carbon tetrachloride (50 ml) 
and the suspension was heated at reflux for 2 days, to give a bright yellow red solution. A 
small amount of solid adhered to the sides of the reaction flask. The solution was decanted and 
benzene (20 ml) was added. The solvent was reduced to about one third of the initial volume 
and left to crystallise from ethanol. The solid was purified using column chromatography 
(silica, dichloromethane, Rf = 0.25, W% EtOH-CH2Ch) to yield a yellow solid, 4.8 g (54%), 
m.p.:156-158°C (lit.4 160-162°C). 
lu NMR (CDCI3, 200 MHz): 8 9.29 (IH, s, H6), 8.72 (lH, d, HI), 8.57 (lH, d, J 7.5, H4), 
8.09 (lH, d, J 8, H3), 8.06 (lH, d, J 8, H7), 7.91 (lH, d, J 7, HIO), 7.85 (lH, dd, J 7.5, J 7.5, 
H8), 7.79 (IH, dd,J7,J7, H9) 
Mlz (ES+): 258/260 [M+Ht 
2-Bromo 6-butylphenanthridine 13 
Br 
9 
2-Bromophenanthridine 12 (0.98 g, 3.8 mmol) was dissolved in dry diethyl (20 ml) ether under 
argon. The suspension was cooled down to -W°C. Butylmagnesium chloride (2.2 ml, 4.0 
mmol) was added dropwise and the mixture stirred for 2hrs at -W0 C. The solution was 
allowed to warm up to room temperature overnight. The orange solution was treated with 
hydrochloric acid (5 ml, 0.1 M solution) and the solution extracted with ether (3 x 20 ml) and 
with dichloromethane ( 4 x 20 ml). The organic layers were combined, washed using brine (2 x 
4 H. Gilman, J. Eisch, J. Am. Chem. Soc., 1955, 77, 6379. 
ld() 
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20 ml), and dried over potassium carbonate. Solvent was removed under reduce pressure, the 
residue dissolved in dichloromethane (50 ml) and manganese (IV) dioxide (1 g) was added. 
After stirring the suspension overnight at room temperature, the solid was filtered off and the 
residue was purified by chromatography on silica gel (Rf= 0.3, CH2Ch) to give a pale yellow 
solid (m= 0.93 g, 78%), mp. 118-ll9°C. 
1H NMR (CDCh, 300 MHz): 8 8.66 (IH, d, J 2, HI), 8.56 (lH, d, J 8, H4), 8.26 (IH, d, J 8, 
H7), 7.80 (IH, d, J 8.6, HIO), 7.85-7.73 (3H, m, H3H9H8), 3.35 (2H, t, J 8, H11), 1.90 (2H, m, 
H12), 1.55 (2H, tq, H13), 1.01 (3H, t, Hl4). 
M/z (ES+): 314/316 [M+Ht 
HR-ESMS (m/z): Found 314.0545. C17H1J3rN requires 314.0546. 
2-Cyano 6-butyl phenanthridine 14 
NC 
2-Bromo-6-butyl-phenanthridine 13 (0.9 g, 2.8 mmol) was dissolved in anhydrous 
dimethylformamide (20 ml). The solution was heated at 100°C for lh and copper(!) cyanide 
(0.55 g, 5.7 mmol) was added. The reduced solution was stirred at 140°C under argon for 2 
days. Solvent was removed under reduced pressure and the residue was taken in concentrated 
hydrochloric acid (30 ml, 6 M) to give a yellow solution. The pH of the solution was increased 
up to 12 by addition of potassium hydroxide pellets. The product was extracted using 
dichloromethane (4 x 20 ml). The combined organic layers were washed with aqueous 
potassium carbonate solution (0.1 M, 2 x 20 ml), dried over potassium carbonate and the 
residue was recrystallised twice from ethanol to give a pale yellow solid (0.57 g, 77%), m.p. 
110-lll°C. 
1H NMR (CDCh, 300 MHz): 8 8.83 (1H, d, J I, H1), 8.56 (IH, d, J 5.4, H4), 8.28 (IH, d, J 
5.6, H7), 8.15 (IH, d, J 6, HIO), 7.90-7.78 (3H, m, H3H9H8), 3.37 (2H, t, J 5.2, Hll), 1.90 
(2H, m, Hl2), 1.55 (2H, tq, H13), 1.01 (3H, t, Hl4). 
1Ll1 
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13C NMR (CDCh, 75.4 MHz): 8 164.8 (C6), 144.3 cc-cN), 130.5, 130.2, 129.6, 129.0, 127.5, 
126.6, 125.5, 124.4, 122.6, 121.3, 118.1 (Ar-C), 108.4 (CN), 35.1 (Cll), 30.3 (C12), 22.0 
(C13), 12.9 (C14). 
Mlz (ES+): 260.9 [M+Ht 
Elemental analysis: Found: C, 81.79; H, 6.08; N, 10.48. C1sH16N2 (+ 1/4H20) requires C, 
80.7; H, 6.25; N, 10.60. 
IR, cm-1 (thin film): Ymax 2940 (CH), 2215 (CN). 
2-Aminomethyl 6-butyl phenanthridine 15 
2-Cyano 6-butyl-phenanthridine 14 (0.1 g, 0.38 mmol) was dissolved in borane-
tetrahydrofuran solution (15 ml, 1 M) under argon and the mixture heated at 70°C for 4 days. 
The reaction was monitored by analysis of a quenched sample by IR spectroscopy. The 
solution was cooled to room temperature and methanol (20 ml) was added carefully, dropwise. 
The solvent was removed and the residue was taken up in methanol (20 ml). This procedure 
was repeated three times and finally the residue was dissolved in hydrochloric acid (20 ml, 1 
M) and heated at 80°C for 1 h. The temperature was maintained at 60°C overnight. The acid 
solution was washed using ether (30 ml). The pH was raised up to 13 and the product extracted 
using dichloromethane (5 x 20 ml). The combined extracts were washed using brine (2 x 20 
ml), dried over potassium carbonate and the solvent removed under pressure to yield a brown 
solid, 91 mg (90% ), which was used directly without further purification. 
1H NMR (CDCh, 200 MHz): 8 8.53 (lH, d, J 8, H4), 8.36 (IH, s, H1), 8.13 (1H, d, J 8.2, 
H7), 7.98 (lH, d, J 6, HlO), 7.70 (1H, t, H3), 7.90-7.78 (2H, m, H9H8), 4.0 (2H, br.s, NH2), 
3.37 (2H, s, CH2N), 3.23 (2H, t, J 5.2, H11), 1.80 (2H, m, H12), 1.45 (2H, tq, J 3.2, H13), 0.91 
(3H, t, H14). 
13C NMR (CDCh, 75.4 MHz): 8 162.2 (C6), 142.9, 132.9, 130.3, 129.7, 128.2, 127.3, 126.4, 
125.3, 123.7, 122.6, 120.0 (Ar-C), 50.5 (C11), 36.2 (C2'), 31.9 (C12), 23.3 (C13), 14.3 (C14). 
M/z (ES+): 264.9 [M+Ht 
14? 
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N-Chloroacetyl-2-aminomethyl-6-butyl phenanthridine 16 
2-Aminomethyl-6-butyl-phenanthridine 15 (0.32 g, 1.24 mmol) was dissolved in 
tetrahydrofuran (30 ml) under argon. Chloroacetic acid (0.068 ml, 1.26 mmol) and 1-
hydroxybenzotriazole (0.116 g, 1.26 mmol) were added and the solution was cooled at 0°C. 
EDC [1-(3-Dimethylaminopropyl)-3-ethyl-carbodiimide hypochloride] (0.245 g, 1.29 mmol) 
was added then and the solution stirred at 0°C for 1 h and at room temperature for 3 hrs. The 
solvent was removed and the residue washed with cold tetrahydrofuran (20 ml). The product 
was extracted using dichloromethane (3 x 25 ml), washed using a saturated solution of sodium 
carbonate (2 x 20 rnl) and finally dried over potassium carbonate. Solvent was removed to 
yield a white solid, 0.33 g (78%), m.p.>250°C. 
1H NMR (CDCh, 300 MHz): 8 8.63 (lH, d, J 8, H4), 8.39 (lH, s, H1), 8.20 (lH, d, J 8.2, 
H7), 8.03 (1H, d, J 6, H10), 7.80 (2H, t, H3), 7.65-7.50 (2H, m, H9H8), 6.95 (lH, br. s, NH), 
4.67 (2H, d, J 6, CH2NH), 4.10 (2H, s, CH2Cl), 3.30 (2H, t, J 5.2, H11), 1.83 (2H, m, H12), 
1.45 (2H, m, H13), 0.93 (3H, t, H14). 
13C NMR (CDCh, 75.4 MHz): 8 165.9 (C6), 162.6, 143.1, 135.1, 132.4, 130.2, 130.0, 128.1, 
127.4, 126.3, 125.2, 123.5, 122.3, 121.1 (Ar-C); 44.0 (CH2Cl), 42.6 (CH2N), 36.1 (Cll), 31.6 
(C12), 23.0 (C13), 14.0 (C14). 
Mlz (ES+): 340.9, 342.9 [M+Ht 
HR-ESMS (m/z): Found 341.1421; C20H22ClN20 requires 341.1421 [M+H( 
JR, cm-1 (thin film): Vmax 3103, 1637, 1539, 1226, 1051. 
1,4, 7-Tris-(t-butoxycarboxymethyl)-1,4, 7,1 0-tetraazacyclododecane 17a 
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Sodium hydrogen carbonate (0.81 g, 9.6 mmol) and cyclen (0.55 g, 3.2 mmol) were placed into 
a flask containing 4A molecular sieves under argon. A solution of tert-butyl bromoacetate 
(1.88 g, 9.6 mmol) in acetonitrile (15 ml) was added at room temperature under argon. The 
reaction was left to stir for 18hrs at room temperature. The inorganic material and the 
molecular sieves were removed by filtration. The solvents were removed under vacuum and 
the residue purified by chromatography on silica gel. The column was first washed with 
dichloromethane, then 30% THF in CH2Ch before the title compound was eluted using 5% 
ammonia, 5% methanol, 30% CH2Ch, 60% THF (Rr = 0.5, Si02). The pale oil obtained was 
crystallised from acetonitrile and diethylether to give small colourless crystals (0.41 g, 25%), 
mp. 166-168°C. 
1H NMR (CDCh, 300 MHz): 8 3.34 (s, 4H, 2x acetate CH2'), 3.26 (s, 2H, acetate CH2), 2.95 
(br m, 16H, cyclen ring), 1.42 (s, 27H, t-Bu). 
13C NMR (CDCh, 75.4 MHz): 8172.2 (2 C=O), 171.4 (C=O), 83.8 (C(CH3)3), 83.6 (2 
C(CH3)3), 60.4 (CH2 ring), 53.6 (CH2 ring), 51.2 (CH2 acetate), 50.4 (CH2 acetate), 49.5 (CH2 
ring), 30.2 (9 CH3). 
M/z (ES+): 515 [M+Ht, 537 [M+Na( 
IR, cm"1 (thin film): Ymax 1715 (C=O). 
1- { [2-aminomethyl-( 6-butyl-phenanthridine)]-carbamoylmethyl} -4,7, 1 0-tris-(t-
butoxycarboxymethyl)-1 ,4, 7,1 0-tetraazacyclododecane 17b 
1,4,7-Tris-(t-butoxycarboxymethyl)-1,4,7,10-tetraazacyclododecane 17 (0.15 g, 0.29 mmol) 
and N-chloroacetyl-2-aminomethyl-6-butyl phenanthridine (0.1 g, 0.2 mmol) were dissolved in 
dry acetonitrile (20 ml). Potassium carbonate (0.02 g, 0.15 mmol) was added and the mixture 
was heated at 70°C for 4 hrs. Solvent was removed under reduced pressure and the residue 
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taken in dichloromethane (20 ml), washed with water (2 x 20 ml), dried over potassium 
carbonate, filtered and the solvent removed. The product was purified by chromatography 
column on alumina (Rr = 0.2, 5% EtOH-CH2Ch), to give a colourless solid (0.1 g, 62% ). 
1H NMR (CDCh, 300 MBz): 8 10.2 (1H, t), 8.70 (lH, d,J8.4, H4), 8.57 (lH, s, HI), 8.18 
(1H, d, J 8.2, H7), 7.93 (IH, d, J 8.4, HlO), 7.80-7.58 (3H, m, H3H9H8), 4.64 (2H, d, J 5.7, 
CH2NH), 3.31 (2H, t, J 8.1, Hll), 2.60-2.2 (16H, br m, CH2ring ), 1.80 (2H, m, H12), 1.50 
(2H, m, H13), 1.29 (27H, m, tert-Bu), 0.97 (3H, t, H14). 
13C NMR (CDCh, 75.4 MHz): 8 172.4 (C=O), 161.8 (C6), 142.8, 138.7, 133.3, 130.4, 129.3, 
129.1, 127.2, 126.2, 125.2, 123.6, 123.3, 121.3 (Ar-C); 82.0, 81.9 (~(CH3)3), 58.2 (CH2NH), 
56.3-55.8 (8C, Cring), 43.3 (C2'), 36.4 (Cll), 31.5 (C12), 28.3, 28.1, 28.0 (C(~H3 )3), 23.3 
(Cl3), 14.2 (C14). 
Mlz (ES+): 842 [M+Na( 
1-{Methylcarbonyl-[2-aminomethyl-(6-Butyl-Phenanthridine)]}-4, 7,1 0-tris-
( carboxymethyl)-! ,4, 7,1 0-tetraazacyclododecane 18 
Tert-butyl ester 17b (0.1 g, 0.12 mmol) was dissolved in a solution of 80% trifluoroacetic acid 
in dichloromethane (10 ml). The mixture was stirred at room temperature for 3hrs. The 
solvents were removed under reduced pressure and the residue taken in water. Solvent was 
removed on the freeze-drier to yield a colourless solid (0.073 g; 95%). 
1H NMR (D20, 200 MBz): 8 8.40 (IH, d, J 8.4, H4), 8.16 (2H, m, HIH7), 7.90 (1H, d, HlO), 
7.75-7.55 (3H, m, H3H9H8), 4.39 2H, (br d, CH2NH), 3.85 (lH, br s, NH), 3.2-2.8 (16H, br m, 
CH2ring ), 1.45 (2H, m, H12), 1.15 (2H, m, H13), 0.64 (3H, m, H14). 
M/z (ES+): 647 [M+Ht 
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Europium complex of 18 : 19 
Europium acetate (15 mg, 45 ~-tmol) and compound 18 (25 mg, 38 ~-tmol) were dissolved in 
water (3 ml). The pH was adjusted to 5.5 and the solution heated at 80°C for 2 hrs. The 
product was purified on a short alumina chromatography column (eluent 10% methanol in 
CH2Ch), to give a white solid (27 mg, 90% ). 
1H NMR (D20, pD = 5.5): 8 33.8 (1H), 32.1 (2H), 31.6 (1H) (ring Hax); 8.1-7.0 (m, 7H, Phen-
H), 4.0-1.0 (m, 11H, CHzN +Butyl chain), 0.1 (br s, 2H, lfeq'), -2.4 (1H, lfeq'), -3.1 (2H, lfeq'), 
-4.8 (lH, Heq), -6.0 (1H, lfeq), -7.2 (2H, Hax', Heq), -7.6 (1H, Hax'), -11.5 (2H, Bax'); -11.9 (lH, 
CHCO), -12.4 (lH, CHCO), -14.8 (2H, CHCO), -15.6 (1H, CH'CO), -16.0 (lH, CHCO), -17.0 
(lH, CH'CO), -17.5 (1H, CHCO). 
M/z (ES+): 801 [M+Ht, 839 [M+K( 
HR-ESMS (m/z): Found 800.2270; C34~4N601Eu requires 800.2272 [M+Ht 
1-{Methylcarbonyl-[2-aminomethyl-( 6-butyl-phenanthridine )] } -4,7, I 0-
tetraazacyclododecane 21 
Freshly prepared 12N4-molybdenum tricarbonyl complex (0.22 g, 0.61 mmol) was solubilized 
in degassed DMF under argon. Potassium carbonate (0.13 g, 0.61 mmol) was added and the 
suspension was heated up to 80°C. N-Chloroacetyl-2-aminomethyl-6-butyl phenanthridine 16 
(0.20 g, 0.61 mmol) was solubilized in degassed DMF (10 ml) under argon and added to the 
suspension. Heating was continued for 2 hrs at 80°C. The solvent was removed under vacuum. 
The residue was taken in hydrochloric acid (20 ml, 1 M), stirred overnight and the pH was 
raised up to 14 using potassium hydroxide pellets. The product was extracted using 
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dichloromethane (4 x 30 ml), washed with brine (2 x 30 ml) and dried over potassium 
carbonate to yield a yellow oil, 0.26 g (89%), which was used without any further purification. 
1H NMR (CDCh, 200 MHz): o 8.59 (IH, d, J8.4, H4), 8.39 (lH, d, J 1.5, H1), 8.16 (lH, d, J 
8.2, H7), 7.98 (1H, d, J 8.4, HlO), 7.74 (2H, t, H3), 7.63-7.57 (2H, m, H9H8), 6.95 (1H, br.s, 
NH), 4.64 (2H, d, CH2NH, J 5.7), 3.27 (2H, t, J 8.1, H11), 2.86 (s), 2.79 (2H, s), 2.58 (2H, s), 
2.53 (s), 2.43 (m,), 2.35(m, ), 1.60 (2H, m, H12), 1.45 (2H, m, H13), 0.93 (3H, t, H14). 
13C NMR (CDCh, 75.4 MHz): o 171.8 (C=O), 162.6 (C6), 162.6, 143.1, 136.9, 132.7, 130.5, 
130.4, 129.8, 128.7, 127.5, 126.4, 125.4, 123.7, 122.7, 121.3, 59.3 (CH2NH), 47.2-45.8 (8C, 
Cring), 43.6 (2-CH2Phen), 36.6 (C11), 31.5 (C12), 23.2 (C13), 14.2 (C14). 
M/z (ES+): 477.3 [M+Ht 
1-{Methylcarbonyl-[2-aminomethyl-(6-butyl-phenanthridine)]}-4,7,10-tris-
{ ( ethoxymethylphosphinyl)methyl} -1,4, 7, 1 0-tetraazacyclododecane 22a 
1-{Methylcarbonyl-[2-aminomethyl-(6-butyl-phenanthridine)]}-4,7,10-tetraazacyclododecane 
21 (0.23 g, 0.55 mmol) and paraformaldehyde (0.08 g, 2.67 mmol) were taken into anhydrous 
tetrahydrofuran (20 ml) and the reaction mixture heated up to 60°C. Methyldiethoxyphosphine 
(0.26 g, 1.92 mmol) was added and the solution was refluxed over 4A molecular sieves 
according to the general procedure described previously. 5 The product was purified by column 
chromatography on alumina (gradient elution from dichloromethane to 2% ethanol-
dichloromethane, Rr= 0.3 by TLC using 5% ethanol-dichloromethane) to give a pale yellow 
oil, 0.25g, 55%. 
5 a) T. J. Norman, D. Parker, K. Pulukkody, L. Royle, C. J. Broan, J. Chem. Soc., Perkin Trans. 2, 1993, 605. 
b) S. Aime, M. Botta, D. Parker, J. A. G. Williams, J. Chem. Soc., Dalton Trans., 1995, 2259. 
1;17 
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1H NMR (CDCh, 200 MHz): 8 8.57 (lH, d, J 8.4, H4), 8.45 (lH, d, J 1.5, HI), 8.20 (lH, d, J 
8.2, H7), 7.98 (lH, d, J 8.4, HlO), 7.80 (lH, t, H3), 7.62 (2H, m, H9H8), 7.14 (15H, m, Ph), 
4.64 (2H, m, CH2-Phen), 4.06 (6H, m, P-OCH2), 2.60-2.20 (22H, br m, CH2 ring, N-CH2-P), 
3.25 (2H, t, Hll), 1.78 (2H, m, H12), 1.42 (2H, m, H13), 1.16 (9H, t, CH2 CH3), 0.97 (3H, t, 
H14). 
31P NMR (CDCh): 8 53.1-51.7 (m, P-OEt) 
Mlz (ES+): 859.1 [M-Nat, 837.1 [M-H( 
1-{Methylcarbonyl-[2-aminomethyl-(6-butyl-phenanthridine)J}-4,7,10-tris-
{(ethoxymethylphosphinyl)benzyl}-1,4,7,10-tetraazacyclododecane 22b 
1-{Methylcarbonyl-[2-aminomethyl-( 6-butyl-phenanthridine)]} -4,7, 1 0-tetraazacyclododecane 
21 (0.23 g, 0.55 mmol) and paraformaldehyde (0.08 g, 2.67 mmol) were taken into anhydrous 
tetrahydrofuran and the reaction mixture heated upto 60°C. Benzyldiethoxyphosphine (0.4 g, 
1.92 mmol) was added and the solution was refluxed over 4A molecular sieves according to 
the general procedure described previously. 5 The product was purified by column 
chromatography on alumina (gradient elution form dichloromethane to 2% EtOH-
dichloromethane, Rr = 0.33 by TLC using 10% EtOH-dichloromethane) to give a pale yellow 
oil (0.35 g, 60%). 
1H NMR (CDCh, 300 MHz): 8 8.59 (lH, d, J 8.4, H4), 8.45 (lH, d, J 1.5, HI), 8.20 (lH, d, J 
8.2, H7), 7.98 (lH, d, J 8.4, HIO), 7.80 (lH, t, H3), 7.62 (2H, m, H9H8), 7.14 (15H, m, Ph), 
4.64 (2H, m, CH2-Phen), 3.90 (6H, m, P-OCH2), 2.55-2.70 (22H, br m, CH2 ring, N-CH2-P), 
3.25 (2H, t, H11), 1.78 (2H, m, H12), 1.42 (2H, m, H13), 1.19 (9H, t, CH2 CH3), 1.01 (3H, t, 
H14). 
31p NMR (CDCh): 8 49.8, 49.0. 
M/z (ES+): 1088 [M+Na( 
lLISI 
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1-{Methylcarbonyl-[2-aminomethyl-(6-butyl-phenanthridine)]}-4,7,10-tris-
{(methylphosphinyl)methyl}-1,4, 7,1 0-tetraazacyclododecane 23a 
A solution of potassium deuteroxide in D20 (15 ml) was added to the phosphinate ester 22a 
(0.13 g, 0.16 mmol) and the mixture stirred at room temperature for 16 h to give clear solution. 
The reaction was monitored by 31P NMR. The solution was neutralized by addition of dilute 
hydrochloric acid and the solvent removed under low pressure to give a hygroscopic glassy 
solid (O.lOg, 87% ). 
8 31P NMR (CDCh): 40.4, 37.1-36.5 (m, P-OH) 
1-{Methylcarbonyl-[2-aminomethyl-( 6-butyl-phenanthridine )] } -4,7, 1 0-tris-
{(methylphosphinyl)benzyl} -1 ,4, 7,1 0-tetraazacyclododecane 23b 
Ligand 23b was prepared similarly to ligand 23a. 
31P NMR (D20): 8 32.1. 
1.10 
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Europium complex of 23a : 24 
Europium nitrate was added to a solution of compound 23a (0.10 g, 0.14 mmol) in water and 
the mixture heated at 70°C for 16hrs to give a clear solution. The progress of the reaction was 
monitored using 31P NMR. The solvent was removed and the product was purified by 
chromatography on a short alumina column (eluent 10% MeOH-CH2Ch, Rr = 0.3) to give a 
colourless solid. 
Mlz (ES+): 903 [M-Ht, 452 [M-H]2+. 
Europium complex of23b: 25 
Same procedure as described before . 
1H NMR (CD30D): o 31.6, 31.6, 29.2, 19.2, 15.9, 14.6, 12.8, 12.2 (ringHax); -0.60, -1.3 
(ringHeq); -3.4 (ringHax); -6.8(PCH3); -11.1,-11.8,-12.3,-13.1,-15.8 (ring H and 
NCH2CO). 
31P NMR (D20): o 91.1, 87.2, 74.0. 
M/z (ES"): 1130 [M+ Ht 
(+)(1 '-Bromo) 6-butyl phenanthridine 26 
9 
Br 
6-Butyl phenanthridine 1 (1.1 g, 4.7 mmol) and N-bromosuccinimide (1.1 g, 6.2mmol) were 
dissolved in carbon tetrachloride and heated at reflux (80°C) for 4 hrs. The warm suspension 
was filtered over Celite, washed with a mixture of carbon tetrachloride/benzene and the 
solvents were removed. The product was recrystallized twice from ethanol to give white 
needle-shaped crystals ( 1.26 g, 83%), m.p. 158-159°C. 
1<;() 
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1H NMR (CDCh, 300 MHz): 8 8.62 (IH, d, J 8.4, H4); 8.50 (IH, d, J 8, HI); 8.36 (IH, d, 
J 8, H7); 8.13 (IH, d, J 8, HIO); 7.79 (IH, t, J 7.1, H2); 7.65 (3H, m, H8H9H3); 5.77 (IH, 
t, J 8, Hll); 2.61 (2H, m, H12); 1.62 (2H, m, Hl3); 0.97 (3H, t, J7.5, Hl4). 
· 
13C NMR (CDCh, 75.4 MHz): 8 157.8 (C6); 130.4 (Ar-C); 128.7 (Ar-C); 127.4 (Ar-CH); 
127.2 (Ar-CH); 125.5 (Ar-CH); 124.7 (Ar-C); 124 (Ar-CH); 122.6 (Ar-CH); 121.9 (Ar-
CH); 77.2 (Cll); 37.5 (C12); 21.5 (C13); 13.7 (C14). 
M/z (ES+): 313 [M+Ht, 233 [M-(Br)t 
HR-ESMS (m/z): Found 314.0540; C11H1J3rN requires 314.0544 
(±) 6-(1 '-Azido) butyl phenatithridine 27 
9 
(±)(1 '-Bromo) 6-butyl phenanthridine 26 (1 g, 3.2 mmol) and sodium azide (0.57 g, 9 mmol) 
were dissolved in dimethylformamide. The solution was heated at 70°C overnight. The 
solution was poured into ice and extracted using dichloromethane (3 x 20 ml), the organic 
layers washed using distilled water ( 4 x 20 ml) and sodium carbonate solution (3 x 20 ml), 
dried over potassium carbonate, and filtered off. The solvent was removed and the residue 
purified on silica column (Rr = 0.3, eluent dichloromethane/hexane 60:40), to give a white 
solid (0.84 g, 96%). 
1H NMR (CDCh, 300 MHz): 8 8.69 (IH, d, J 6.2, H4); 8.58 (1H, d, J 6, Hl); 8.31 (IH, d, J 
6, H7), 8.22 (IH, d, J 8, H10); 7.86 (IH, t, J 7.1, H2); 7.72 (m, 3H, H8H9H3); 5.16 (t, 1H, J 
7, Hll); 2.22 (m, 2H, H12); 1.66-1.55 (m, 2H, H13); 1.03 (3H, t, J7.5, H14). 
13C NMR (CDCh, 75.4 MHz): 8 162.7 (C6); 130.8 (2C, Ar-C); 128.9 (IC, Ar-C); 127.4 
(IC, Ar-CH); 125.6 (2C, Ar-CH); 122.9 (2C, Ar-C); 122.1 (2C, Ar-CH); 36.7 (Cll); 31.6 
(C12); 20.2 (C13); 14.1 (C14). 
Elemental analysis: Found (C 74.0, H 5.82); C17H16N4.0.5H20 requires (C 73.9, H 5.83). 
Mlz (ES+) : 249 [M-HN2t. 
IR Umax(Cm-1): Vmax 2098 ( -N3). 
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(+)6-(1 '-Amino) butyl phenanthridine 28 
9 
(±)(1'-Azido)6-butyl phenanthridine 27 (0.84 g, 3 rnmol), hydrazine hydrate (3 ml, exces), 
palladium hydroxide (Pearlman's catalyst) (0.5 g) were heated in methanol (20 ml) at 60°C 
overnight. The suspension was filtered and the solvent removed. The residue was dissolved 
in dichloromethane, washed using sodium carbonate solution, dried over potassium carbonate, 
filtered and the solvent was removed to give a colorless oil (0.54 g, 73%). 
1H NMR (CDCh, 300 MHz): 8 8.69 (lH, d, J 6.2, H4); 8.58 (lH, d, J 6, HI); 8.31 (lH, d, J 
6, H7); 8.22 (lH, d, J 8, H10); 7.86 (2H, t, J 7.1, H2); 7.72 (3H, m, H8H9H3); 4.87 (t, 1H, 
J 8, Hll); 2.22 (2H, m, Hl2); 1.76 (2H, broads, -NH2); 1.55 (m, 2H, H13); 0.96 (3H, t, J 
7.5, Hl4). 
13C NMR (CDCh, 75.4 MHz): 8 157.8 (C6); 131.3 (2C, Ar-C); 130.3 (1C, Ar-C); 129.0 
(1C, Ar-CH); 128.3 (lC, Ar-CH); 127.7 (1C, Ar-CH); 127.3 (lC, Ar-C); 123.3 (1C, Ar-
CH) ; 122.3 (2C, Ar-CH) ; 122.1 (2C, Ar-CH) ; 42.6 (Cll); 31.2 (Cl2); 17.8 (C13); 14.1 
(C14). 
Elemental analysis: Found (C 77.48, H 6.50, N 9.86); C17H1sN2.0.75H20 requires (C 77.4, 
H 7.40, N 10.60) 
M/z (ES+): 251 [M+Ht 
(+)6-(N-Chloroacetyl-1 '-amino)-butyl phenanthridine 7 
14 
9 
Chloroacetic acid (0.151 g, 1.6 mmol), and 1-hydroxybenzotriazole (0.22 g, 1.6 mmol) were 
disssolved in anhydrous THF, and the solution cooled down to 0°C. EDCI (0.36 g, 1.9 rnmol) 
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was added. ( 1 '-Amino) 6-butyl phenanthridine 28 (0.4 g, 1.6 mmol) was dissolved in THF (2 
ml) and added dropwise. The solution was stirred at 0°C for one hour and warmed up to 
room temperature for 2 hrs. After filtration, the solvent was removed and the residue taken up 
in dichloromethane (20 ml), washed using sodium carbonate solution (3 x 20ml), dried over 
potassium carbonate, and filtered off. The solvent was removed and the residue purified on 
silica column (Rf = 0.3, eluent dichloromethane/ethyl acetate 60/20), to give a beige solid 
(0.33 g, 63%), m.p. : 140-141 °C. 
1H NMR (CDCh, 300 MHz) : o 8.69 (1H, d, J 6.2, H4); 8.58 (lH, d, J 6, H1); 8.31 (1H, d, J 
6, H7); 8.22 (lH, d, J 8, HlO); 7.86 (lH, t, J 7.1, H2); 7.72 (3H, m, H8H9H3); 4.87 (lH, q, 
J 3 , H11); 2.22 (2H, m, H12); 1.76 (2H, broads, -NH2); 1.55 (2H, m, Hl3); 0.96 (3H, t, J 
7.5, H14). 
13C NMR (CDCh, 75.4 MHz): o 169.2 (CO); 162.4 (C6); 137.0 (C, Ar-CH); 134.6 (C, Ar-
CH); 133.66 (C, Ar-CH); 132.6 (C, Ar-CH); 131.4 (C, Ar-C); 130.8 (C, Ar-C); 129.0 (2C, Ar-
CH); 127.6 (C, Ar-CH); 126.5 (C, Ar-CH); 125.8 (2C, Ar-CH); 53.9 (C11); 46.8 (CH2Cl); 
42.4 (C12); 22.4 (Cl3); 17.8 (C14). 
M/z (ES+): 348 (M+Nat 
Elemental analysis: Found C 69.8, H 5.86, N 8.57%; C19H1 9ClN20 requires C 69.9, H 5.84, 
N 8.60% 
IR Umax(cm-1): Vmax 1664 (CO) 
1,4, 7-Tris[(R)-1-(1-phenyl)methy1-carbamoylmethyl]-1,4, 7,10-
tetraazacyclododecane 29 
Me y~Ph 
HN 
(h 
(
N HN) 
Ph 0 ,-~NJl-;N N~ Me' \__} 
H 0 
NH 
Ph~* /Me 
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(R)-N-(2-Chloroethanoyl)-2-phenylethylamine (1.13 g, 5.67 mmol) in dry ethanol (10 ml) was 
added dropwise over 8 hrs to a stirred solution of 1,4,7,10-tetraazacyclododecane (0.30 g, 
1.77 mmol) and triethylamine (0.80 ml. 5.7 mmol) in dry ethanol (30 ml) at 600C. The 
mixture was boiled under reflux for 18 hrs, concentrated to small volume, poured into 
aqueous hydrochloric acid (0.1M, 40 ml) and washed with diethyl ether (3 x 30 ml). The 
aqueous phase was neutralised by careful addition of sodium hydroxide (1M) the pH adjusted 
to 13 and the solution extracted with dichloromethane (3 x 30 ml). Extracts were dried 
(K2C03) and solvent removed to yield an oily residue which was purified by chromatography 
on neutral alumina (100% CH2Cl2 to 2% MeOH/CH2Cl2), Rr (Al20 3; 10% MeOH/CH2Cl2) = 
0.5 to yield a pale yellow solid (430 mg, 37%), m.p. 60-610C. 
1H NMR (CDCh, 400 MHz): 8 7.32 (3H, s, NHCO), 7.29-7.20 (ISH, m., 3Ph), 3.8 (3H, 
dq+dq, C*H), 2.96 (4H, s, CH2CO), 2.91 (2H, s, CH2C'O), 2.70 (16H, br m., CH2Nring), 2.05 
(1H, br s, NH), 1.50 (9H, d, J 7.2, 3CH3). 
13 
C NMR (CDCI3, 75.4 MHz): 8170.8, 170.6, 143.7 (C quater.), 129.1 (meta Ph-C), 127.8 
(para Ph-C), 127.0, 59.9 (CH2CO), 58.0 (CH2CO), 54.5 (CH2N), 53.6 (CH2N), 48.9 (CHN), 
48.6 (CHN), 22.1, 21.9 (CH3). 
Mfz (ES+): 348[M+H]2+, 656 [M+Ht 
HR-ESMS (m/z): Found 656.4284. C38H54N70 3 requires [M+Ht, 656.4288. 
Elemental analysis: Found C 68.2; H 8.18; N 14.6; C38H53N70 3·0.5H20 requires C 68.66; H 
8.13; N 14.76. 
1,4, 7-Tris[(S)-1-(1-phenyl)methyl-carbamoylmethyl]-1,4, 7,10-
tetraazacyclododecane 30 
Ph Y"~Me 
HN 
(~ 
e
N HN) 
Me 0 
},NJl.....:N N~ Ph' \__/ 
H 0 
NH 
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(S)-N-(2-Chloroethanoyl)-2-phenylethylamine (1.17 g, 5.9 mmol) in dry ethanol (10 ml) was 
added dropwise over 8 hrs to a stirred solution of 1,4,7,10-tetraazacyclododecane (0.34 g, 2.0 
mmol) and triethylamine (0.83 ml. 5.9 mmol) in dry ethanol (30 ml) at 600C. The mixture 
was boiled under reflux for 18 hrs, concentrated to small volume, poured into aqueous 
hydrochloric acid (0.1M, 40 ml) and washed with diethyl ether (3 x 30 ml). The aqueous 
phase was neutralised by careful addition of sodium hydroxide (1M) the pH adjusted to 13 
and the solution extracted with dichloromethane (3 x 30 ml). Extracts were dried (K2C03) 
and solvent removed to yield an oily residue which was purified by chromatography on 
neutral alumina (100% CH2Cl2 to 2% MeOHICHzCl2), ~ (Al20 3; 10% Me0H/CH2Cl2) = 0.5 
to yield a pale yellow solid (380 mg, 29%), m.p. 63-65°C. 
1H NMR (CDCh, 400 MHz): 8 7.30 (3H, s, NHCO), 7.29-7.21 (15H, m., PhH), 5.12 (3H, 
dq+dq, C*H), 2.97 (4H, s, CH2CO), 2.93 (2H, s, CH2C'O), 2.58 (16H, br m., CH2Nrmg), 1.80 
(1H, br s, NH), 1.48 (6H, d,J7.2, CH3), 1.45 (3H, d, CH3). 
13 
C NMR (CDC13, 75.4 MHz): 8 170.8, 168.1 (CO), 143.4 (Ar-C), 128.8 (ortho Ar-C), 127.9 
(meta ArC), 126.5 (para ArC), 58.4 (CH2CO), 53.1 (CH2Nrmg), 50.6 (CH2Nrmg), 49.2 (C*H), 
47.6 (C*H), 22.0, 21.7 (CH3). 
HR-ESMS (m/z): Found 656.4287. C38H54N70 3 requires [M+Ht, 656.4288. 
Elemental analysis: Found (C 65.7; H 8.54; N 14.0); C38H53N703'2H20 requires C 66.0; H 
8.30; N 14.2. 
Ligands R-RRR 0/), S-RRR (I}), S-SSS (L7), R-SSS (L 8) : 
6-(N-Chloroacetyl-1'-amino)-butyl phenanthridine (0.2 g, 0.61 mmol), the (RRR) 29 or (SSS) 
30 tris-amide (0.4 g, 0.61 mmol), caesium carbonate (0.2 g, 0.6 mmol), potassium iodide 
(0.02 g, 0.12 mmol) were heated at 70°C in acetonitrile for 2d. The formation of product was 
followed by ESMS. The reaction was quenched using water, the product was extracted using 
CH2Clz ( 4 x 20 ml), washed using potassium carbonate aqueous solution, dried over KzC03, 
filtered off and the solvent was removed. The two diastereoisomers were purified and 
separated on an alumina chromatography column (gradient eluent from 1% to 4% MeOH in 
CH2Clz), Rt(Al20 3, 10% MeOHICHzClz) (A)= 0.58, (B)= 0.27, to yield pale yellow solids: 
A (S-RRR or R-SSS)(95 mg, 17%) and B (R-RRR or S-SSS)(90 mg, 15%). 
• (S-RRR)-(L6): 31 
Me~ )-Ph 
HN 
)=o H 
(_/\ ~N ,..Me 
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( O c ) 0 Ph 
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1H NMR (CDCh, 300 MHz): 8 8.60 (lH, t, J 6.2, H1); 8.54 (lH, t, J 6, H7); 8.15 (1H, d, J 
6, H10); 8.06 (lH, m, H4); 7.82 (lH, m, J 6, H2); 7.77-7.60 (3H, m, H8H9H3); 7.30-7.10 
(16H, m, Ph, NH); 6.78 (2H, m, NH); 5.98 5.90 (1H, 2br m, C*H); 5.06-4.80 (3H, m, 
C*HMePh); 2.90-2.40 (14H, m, ring H, CH2 arms); 2.10-1.84 (4H, m, H12H13); 1.45 (9H, 
m, Me arms); 0.84 (3H, t, J7.5, H14). 
13C NMR (CDCh, 75.4 MHz): 8 170.6 170.4, 170.0 (CO); 159.5 (C6); 144.4, 142.9, 143.6, 
133.4 (C, Ar-CH); 131.2 (C, Ar-CH); 129.7 (C, Ar-CH); 129.1 (C, Ar-CH); 128.8 (C, Ph); 
128.3 (C, Ar-C); 127.4 (C, Ph); 126.6 (C, Ph); 125.5 (C, Ar-C); 124.1 (2C, Ar-CH); 
123.8 (C, Ar-CH); 122.9 (C, Ar-CH); 122.4 (2C, Ar-CH); 59.5, 59.21, 57.6, 57.32 
(4CH2CO); 51.2-49.8 (Cring); 47.06 (C*HNH); 38.8 (Cll); 25.6 (C12); 22.2-21.7 (CH3); 
19.2 (C13); 14.2 (C14). 
Mlz (ES+): 493 [M+Ca]2+, 968 [M+Nat 
Elemental analysis: Found C 70.75, H 7.6, N 13.0; Cs7H73N904.0.5H20 requires C 71.5, H 
7.8, N 13.2. 
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1H NMR (CDCh, 300 MHz): 8 8.66 (IH, d, J 6.2, HI); 8.55 (IH, d, J 6, H7); 8.28 (IH, d, J 
6, HIO); 8.08 (IH, t, J 3, H4); 7.85 (IH, t, J 6, H2); 7.73-7.64 (3H, m, H8H9H3); 7.28-7.I4 
(17H, m, Ph, NH); 6.94 (2H, br.m, NH); 6.12 (1H, br., C*H); 5.I5 (3H, m, CHMePh); 2.87 
(8H, m, CH2 pendent arms); 2.60 (I6H, br. m, ring H); 2.08 (2H, m, HI2); 1.70 (2H, m, 
H13); 1.43 (9H, dd, Me arms); 0.87 (3H, t, J7.5, HI4). 
13C NMR (CDCh, 75.4 MHz): 8 I69.9 (CO); I62.4 (C6); I43.3, I43.0, 133.4 (C, Ar-CH); 
131.2 (C, Ar-CH); 129.7 (C, Ar-CH); 129.I (C, Ar-CH); I28.8 (C, Ph); I28.0 (C, Ar-C); 
I27.7 (C, Ph); I26.6 (C, Ph); I26.5 (C, Ar-C); I25.6 (C, Ar-CH); I24.I (2C, Ar-CH); 
122.8 (C, Ar-CH); I22.4 (2C, Ar-CH); 59.6, 59.45, 59.1, 58.8 (4~H2CO); 53.6-53.1 (Cring); 
49.5, 48.5, 48.4 (C*HNH); 38.7 (C11); 25.6 (C12); 21.7-21.5 (CH3); 19.3 (C13); 14.3 
(CI4). 
Mlz (ES+): 493 [M+Caf+, 968 [M+Nat 
Elemental analysis: Found C 70.8, H 7.51, N 12.9; C57H73N904.0.5H20 requires C 71.5, H 
7.8, N 13.2. 
• (R-SSS)-(L 8) : 33 
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1H NMR (CDCh, 400 MHz): 8 8.68 (1H, t, J 6.2, HI); 8.57 (IH, t, J 6, H7); 8.20 (IH, d, J 
6, HIO); 8.08 (IH, m, H4); 7.90 (IH, m, J 6, H2); 7.80-7.65 (3H, m, H8H9H3); 7.33-7.I9 
(15H, m, Ph); 6.9 (3H, m, NH); 6.06 5.96 (1H, 2br m, C*H); 5.09 (3H, m, CHMePh); 2.80-
2.50 (I4H, m, ring H, CH2 pendent arms); 2.10 (2H, m, H12); 1.84 (2H, m, H13); 1.43 (9H, 
m, Me arms); 0.89 (3H, t, J7.5, H14). 
13C NMR (CDCh, 75.4 MHz): 8 170.7 170.5, 170.0 (CO); I59.7 (C6); 143.6, 133.4 (C, Ar-
CH); 131.2 (C, Ar-CH); I29.7 (C, Ar-CH); 129.I (C, Ar-CH); I28.8 (C, Ph); 128.3 (C, Ar-
C); 127.4 (C, Ph) ; 126.6 (C, Ph) ; 125.5 (C, Ar-C); 124.1 (2C, Ar-CH); 123.8 (C, Ar-CH); 
122.9 (C, Ar-CH); 122.4 (2C, Ar-CH); 59.6, 59.45, 57.46, 57.3 (4CH2CO); 51.3-49.7 
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(Cring); 47.1 (C*HNH).; 39.1 (Cll); 25.6 (C12); 22.3-21.9 (CH3); 19.3 (C13); 14.3 
(C14). 
Mlz (ES+) : 493 [M+Ca]2+, 968 [M+Nat 
Elemental analysis: Found C 70.4, H 7.9, N 12.8; Cs1H73N904.H20 requires C 70.85, H 
7.82, N 13.04. 
• (S-SSS)-(L7) : 34 
1H NMR (CDCb, 400 MHz): o 8.65 (1H, d, J 6.2, H1); 8.55 (lH, d, J 6, H7); 8.30 (lH, d, J 
6, HlO); 8.08 (t, J 3, H4); 7.86 (t, 1H, J 6, H2); 7.72 (m, 3H, H8H9H3); 7.28-7.14 (m, 17H, 
Ph, NH); 6.94 (br., 2H, NH); 6.06 (br., 1H, C*H); 5.15-4.85 (m, 3H, CHMePh); 2.88 (m, 
8H, CH2); 2.60 (br. m, ring H); 2.10 (m, 2H, H12); 1.84 (m, 2H, H13); 1.22 (m, 9H, Me 
arms); 0.89 (t, 3H, J7.5, H14). 
13C NMR (CDCb, 75.4 MHz): o 170.0 169.9 (CO); 160.0 (C6); 143.3, 133.3 (C, Ar-CH); 
131.2 (C, Ar-CH); 129.7 (C, Ar-CH); 129.1 (C, Ar-CH); 128.9 (C, Ph); 128.0 (C, Ar-C); 
127.6 (C, Ph) ; 126.6 (C, Ph) ; 125.6 (C, Ar-C); 124.1 (2C, Ar-CH); 122.8 (C, Ar-CH); 122.4 
(2C, Ar-CH);; 59.6, 59.5, 59.1, 58.9 (4CH2CO); 53.6-53.1 (Cring); 49.5, 48.5, 48.4 
(C*HNH); 38.7 (C11); 25.6 (C12); 21.6 21.5 (CH3); 19.3 (C13); 14.2 (C14). 
Mlz (ES+): 493 [M+Ca]2+, 968 [M+Nat 
Elemental analysis: Found C 70.7, H 7.7, N 12.8; C57H73N90 4.H20 requires (C 70.8, H 
7.82, N 13.0). 
The Eu(III) and Yb(III) complexes were prepared by stirring each of the isomeric ligands with 
one equivalent of the appropriate lanthanide triflate salt in dry CH3CN (1-2 ml) at 80°C 
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overnight. The CH3 CN was then removed under vacuum and the oily residue taken up into a 
mixture of methanol (1 ml) and purite water (10 ml). The solvents were removed by 
lyophilisation to give the complexes as pale yellow solids. 
1H NMR (CD30D, 300 MHz): 8 29.7, 28.9, 28.6, 28.1, 26.9 (4H, Hax); 11.13, 10.59, 10.06, 
9.96, 9.42 (4H, H'eq); 8.30, 8.10, 7.91, 7.66, 7.47(4H, Heq); ~1.76, ~1.85, ~2.15, -2.44 (4H, 
NHamide); -6.69, -6.64, -7.08 (4H, CH'2Nring); -7.76, -7.86 (4H, Hax'); -13.4, -13.5, -13.9, -
14.2, -14.7, -15.1 (4H, CH2Nring). 
M/z (ES+) : 366 [M-H]3+, 549 [M-Hf+, 624 [M-0Tfj2+ 
HR-ESMS (m/z): Found 623.7181 C60H7!F9N9013S3Eu requires [M-(OTf)2]2+, 623.7181. 
1H NMR (CD30D, 200 MHz): 8 110.4, 108.3, 106.6, 104.1, 103.3 (4H, Hax); 20.1, 19.4, 
18.7, 18.1 (4H, H'eq); 16.5, 14.4, 12.8, 12.1 (4H, Heq); -13.5, -14.2, -14.8, -15.0 (4H, 
NHamide); -27.1, -27.7, -28.4,-28.9 (4H, CH'2Nring); -35.5, -36.2, -37.2, -38.2 (4H, Hax');-
64.3, -65.3, -66.3, -67.7, -68.4 (4H, CH2Nnng). 
M/z (ES+) : 373 [M-H]3+, 559 [M-H]2+, 634 [M-0Tfj2+ 
HR-ESMS (m/z): Found 634.2268 C6oH71F9N9013S3 Yb requires [M-0Tfz]2+, 634.2269. 
1H NMR (CD30D, 300 MHz): 8 29.6, 28.4, 28.3, 27.6, 26.7 (4H, Hax); 10.63, 10.14, 9.51, 
8.92 (4H, H'eq); 8.14, 7.89, 7.70, 7.45, 7.21 (4H, Heq); -2.26, -2.60, -2.94, -3.53 (4H, 
NHamide); -7.11, -7.24, -7.48 (4H, CH'2Nring); -8.05,-8.22 (4H, Hax'); -13.88, -14.6, -15.2,-
15.5 ( 4H, CH2Nring). 
M/z (ES+) : 366 [M-H]3+, 549 [M-Hf+, 624 [M-0Tfj2+ 
HR-ESMS (m/z): Found 623.7183 C6oH71F9N9013S3Eu requires [M-(OTf)2]2+, 623.7181. 
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1H NMR (CD30D, 200 MHz): 8 112.6, 110.6, 108.7, 106.1, 101.1 (4H, Hax); 21.1, 20.0, 
18.9, 18.6 (4H, H' eq); 17.2, 14.8, 13.08, 12.4 (4H, Heq); -13.5, -14.2, -14.8, -15.0 (4H, 
NHamide);-27.2, -28.5, -30.6, -31.9 (4H, CH' zNnng) ;-35.7, -36.3, -37.3, -38.4 (4H, Hax'); -65.0, 
-66.1, -66.7, -68.4, -69.1(4H, CHzNring). 
M/z (ES+) : 373 [M-H]3+, 559 [M-H]2+, 634 [M-0Tf]2+ 
HR-ESMS (m/z) : Found 634.2268 C6oH71F9N9013S3 Yb requires (M-0Tf2]2+, 634.2269. 
1H NMR (CD30D, 300 MHz): 8 28.2, 27.3, 26.9, 26.5, 25.4 (4H, Hax); 9.58, 9.42, 8.56, 
8.10 (4H, H'eq); 7.84, 7.75, 7.40, 7.27(4H, Heq); -0.94, -1.17, -1.49 (4H, NI-Iamide); -2.17,-
2.3, -3.36, -3.67 (4H, CH'zNring); -8.2, -8.3, -8.5, -8.9, -9.4, -9.9 (4H, Hax'); -14.8, -14.9, -
15.1, -15.4, -15.6, -15.8, -16.3, -16.5 (4H, CH2Nnng). 
M/z (ES+) : 366 (M-H]3+, 549 [M-H]2+, 624 (M-0Tf]2+ 
HR-ESMS (m/z) : Found 1394.3887 C60H71F9N9013S3151Eu requires [M-OTf]+, 1394.3869. 
1H NMR (CD30D, 200 MHz): 8 110.5, 108, 106, 104, 99.5 (4H, Hax); 20.6, 19.2, 18.4, 17.9 
(4H, H'eq) ;14.9, 14.2, 13.4, 12.4(4H, Heq); -13.9, -14.2, -14.5, -14.7 (4H, NI-Iamide); -26.8,-
27.4, -28.3, -28.6 (4H, CH'zNnng); -35.3, -35.9, -37.8, -38.4 (4H, Hax'); -64.0, -65.1, -66.0,-
68.1 ( 4H, CHzNring). 
Mlz (ES+) : 373 [M-H]3+, 559 [M-H]2+, 634 [M-0Tf]2+ 
HR-ESMS (m/z): Found 1417.4044 C6oH71F9N9013S3Yb requires [M-OTf]+, 1417.4058. 
1H NMR (CD30D, 300 MHz): 8 29.8, 28.9, 28.5, 28.1, 26.9 (4H, Hax) ;11.3, 11.26, 10.42, 
10.06, 9.96 (4H, H'eq) ;8.28, 8.09, 7.95, 7.51, 7.27(4H, Heq) ;-1.72, -1.80, -2.21, -2.45 (4H, 
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Nilanude) ;-6.76, -6.91, -7.08, -7.12 (4H, CH'zNring) ;-7.62, -7.68, -7.97 (4H, Hax·) ;-13.5, -
13.74, -13.98, -14.24, -14.75, -15.13 (4H, CH2Nring). 
M!z (ES+) : 366 [M-H]H, 549 [M-H]2+, 624 [M-0Tf]2+ 
HR-ESMS (m/z) : Found 1394.3863 C6oH11F9N9013S3 151Eu requires [M-OTt]+, 1394.3869. 
1H NMR (CD30D, 200 MHz): o 110.6, 108.3, 106.8, 104.3, 99.5 (4H, Hax); 20.6, 19.4, 
18.4, 17.9 (4H, H'eq) ;14.5, 14.2, 13.4, 12.4(4H, Heq); -9.0, -9.26, -10.3,-10.6 (4H, Nllamide); 
-26.2, -27.4, -28.8,-29.2 (4H, CH'zNring); -34.2, -34.6, -35.6,-37.3 (4H, Hax·); -60.4, -62.0.,-
64.1, -64.6 (4H, CHzNnng} 
M!z (ES+): 373 [M-H]3+, 559 [M-H]2+, 634 [M-0Tf]2+ 
HR-ESMS (m/z): Found 1417.4040 C6oH71F9N9013S3Yb requires [M-OTf]+, 1417.4058. 
6-Methylphenanthridine 43 
9 
Phenanthridine (1.09 g, 6.08 mmol) was dissolved in dry THF (50 ml) under argon and the 
solution cooled to -78°C. Methyllithium (solution 1.0 M in THF, 12 ml) was added dropwise 
with stirring. After the addition was complete the yellow-green solution was stirred at -78°C 
for 1 h then warmed to room temperature. The reaction was quenched with KOH solution (3 
M, 30 ml) and the solution extracted with CH2C}z (50 mL). The organic layer was washed 
with water (100 ml), dried (Na2S04) and the solvent removed under vacuum. The oily residue 
was re-dissolved in CH2C}z (50 ml) and stirred with excess Mn02 (1 g) overnight. The 
mixture was tilted through a bed of celite and the filtrate evaporated to dryness under vacuum 
to give the title compound (1.11 g, 96%) as an orange oil. 
1H NMR (CDCh, 200 MHz): o 8.61 (lH, d, J 8.0, H1), 8.53 (1H, d, J 8.0, H7), 8.20 (lH, d, J 
8.0, H4) 8.09 (lH, d, J 8.0, HlO), 7.56-7.87 (4H, m, H2H3H8H9), 3.04 (3H, s, CH3). 
M/z (ES+): 195 [M+Ht 
1,; 1 
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6-Bromomethylphenanthridine 44 
9 
6-Methylphenanthridine 43 (1.4 g, 7.18 mmol) was dissolved in a mixture ofCC14 (10 ml) 
and CHCh (50 ml). N-Bromosuccinimide (1.5 g, 8.42 mmol, 1.1 eq.) and a catalytic amount 
of benzoyl peroxide were added and the resultant orange solution stirred at reflux for 5 hrs. 
The solution was cooled, filtered (to remove residual succinimide) and the solvent removed 
under vacuum. The residue was purified by chromatography over silica (CH2Ch/hexane; 3:1, 
Rf0.3) to afford the title compound (1.6 g, 82%) as a pale yellow solid, mp. 107-108°C. 
1H NMR (CDCh, 200 MHz): cS 8.67 (IH, d, J 8.0, H1), 8.56 (IH, d, J 8.0, H7), 8.36 (lH, d, J 
8.0, H4) 8.18 (lH, d, J 8.0, RIO), 7.89 (IH, t, H2), 7.80-7.72 (3H, m, H3H8H9), 4.98 (2H, s, 
CH2Br). 
13C NMR (CDCh, 75.4 MHz): cS 156.2 (C6), 142.8 (4°C), 133.6 (Cquatem.), 131.1, 130.3, 
129.1, 127.8, 127.6, 126.5, 124.6 (Cquatem.), 124.2 (Cquatem.), 122.8, 122.2 (C aromatic), 
32.3 (CH2). 
M/z (ES+) : 272/274 [M+Ht, 295/297 [M+Nat 
Elemental analysis: Found C, 61.6; H, 3.96; N, 5.01. C,~wBrN requires C, 61.6; H, 
3.70,; N, 5.15%. 
1-( 6'-Methylphenanthridine )-1, 4, 7, 1 0-tetraazacyclododecane 45 
6-Bromomethylphenanthridine (220 mg, 0.809 mmol), cyclen (443 mg, 2.57 mmol, 3.2 eq.) 
and caesium carbonate (805 mg, 2.47 mmol) were stirred in acetonitrile (3 ml) overnight 
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under argon at room temperature. The solvent was removed under vacuum and the residue 
taken up into CHC13 (20 ml) and washed with purite water (3 x 30 ml), dried (Na2S04), 
filtered and the solvent removed under vacuum to give a pale yellow oil (230 mg, 78%) which 
was used without purification, m. p. 60-61 °C. 
1H NMR (CDCIJ, 200 MHz): 8 8.53 (lH, d, J 8.2, HI), 8.49-8.43 (2H, m, H7H4), 8.05 (lH, 
d, J 8.2, HIO), 7.73 (IH, t, J 8.2, H2), 7.64-7.52 (3H, m, H3H8H9), 4.26 (2H, s, CH2), 2.37-
2.76 (16H, m, ring CH2). 
13C NMR (CDCh, 75.4 MHz): 8 158.8 (C6), 143.0, 133.3, 130.1, 130.1, 128.7, 127.3, 127.2, 
127.0, 125.6, 124.6, 122.5, 122.2 (Caromatic), 62.28 (Ar-CH2), 53.09, 47.27, 46.27, 45.45 (C 
ring). 
Mlz (ES+) : 364 [ M+Ht 
HR-ESMS (m/z): [M+Ht found 364.2499; C22H29N5 requires 364.2501. 
1-(6' -Methylphenanthridine)-4, 7,1 0-tris-[(R)-1-(1-phenyl)ethylcarbamoyl-
methyl]-1 ,4, 7,1 0-tetraazacyclododecane L9 46 
1-(6'-Methylphenanthridine)-1,4,7,10-tetraazacyclododecane (0.2 g, 0.554 mmol), (R)-N-2-
chloroethanoyl-1-phenylmethylamine (0.34 g, 1.72 mmol, 3.1 eq.) and caesium carbonate 
(550 mg, 1.68 mmol) were stirred overnight in a mixture of CH3CN (2 ml) and CH2Ch (2 ml) 
at 60°C under argon. The solvent was removed under vacuum and the residue taken up into 
CH2Ch (20 ml), washed with purite water (70 ml), dried (Na2S04), filtered and evaporated to 
dryness to afford compound 46 (340 g, 73%) as an orange oily residue. 
1 (;1 
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1H NMR (CDCI3, 200 MHz): o 8.56 (lH, d, J 8, H1), 8.48 (1H, d, J7.2, H7), 8.30 (1H, d, J 
8, H4), 8.00 (1H, d, J 8, H10), 7.75 (1H, t, J7.7, H2), 7.67-7.50 (3H, m, H3H8H9), 7.26-6.80 
(18H, m, Ph, amide NH), 5.08-4.85 (3H, m, C*H), 3.88-3.91 (4H, m, pendent anns CH2), 
2.40-2.83 (20H, m, ring H, pendant arm CH2), 1.33-1.43 (6H, m, CH3), 1.24 (3H, d, J 6.8, 
CH3). 
M/z (ES+): 444 [M]2+, [M+Ca]2+, 847 [M+Ht, 869 [M+Nat 
HR-ESMS (m/z): Found [M+Ht 847.5011. C52H62N80 3 requires 847.5023. 
The Eu(III) complex was prepared by stirring compound 46 (L9) with 1 equivalent of 
Eu(OTf)3 in CH3CN (1-2 mL) at 80°C overnight. The CH3CN was then removed under 
vacuum and the oily residue taken up into a mixture of methanol (1 mL) and Purite water (10 
mL) and the solvents removed on the freeze drier to give the complexe as a pale yellow solid. 
1 
H NMR (CD30D, 200 MHz): o 39.4, 36, 25.3, 22.8 (s, 1H each, ring Hax), 16 (br s, 1H, 
phen H), 8.9-0 (30H, aromatic, CH, CH3), 12.7 (lH), 11.5 (3H), 10.2 (1H), -1.3 (2H), -2.1 
(2H), -2.9 (1H), -3.1 (1H), -7.7 (2H), -11.3 (2H), -12.6 (lH), -13.2 (1H), -15.3 (lH), -16.5 
(lH), -18.8 (lH), -20.5 (lH), -20.9 (lH, NCHCO). 
M/z (ES+) : 499 [M+H]2+, 574 [M+OTf]2+. 
HR-ESMS (m/z): Found: [M -(-OTf)3]2+ 499.2038; Cs2~2N8Eu03 requires 499.2040. 
Therefore for monocharged ion, found [M-( -OTf)3t 998.4076 ; requires 998.4075. 
Elemental analysis: Found: C 44.85, H 4.28, N 7.02%. Css~2NsEuF9012S3.2H20 requires 
C 44.6, H 4.4, N 7.55%. 
Conclusion 
The thesis presents the synthesis and characterisation of chirallanthanide complexes and their 
complexation behaviour with selected oligonucleotides and DNA 
In the second chapter the elaboration of complexes exhibiting pH-dependent luminescence 
was undertaken, with an appropriate chromophore chosen to sensitise efficiently the europium 
or terbium ion. The photophysical properties of each proposed chromophore were 
investigated under neutral and acidic conditions, and the ligand bearing a 6-butyl 
phenanthridine chromophore linked to a macrocyclic core was synthesised on this basis. The 
protonation constants for the europium and terbium tri-acetate and tri-phosphinate complexes 
were measured using ligand fluorescence and metal emission changes. The substitution by 
the 6-butyl group allowed the apparent protonation constant to be increased by 1.2 units 
compared to the parent. 
The third and fourth chapters deal with the interaction of well-defmed chiral lanthanide 
complexes with oligonucleotides. Fundamental aspects of the recognition process were 
evaluated. An intercalative binding mode was defined for several complexes, to which 
systematic structural or electronic variations were effected. Thus the different factors that 
may influence the binding of a given complex were studied: its helicity, the length of the 
linking arm, the degree of steric hindrance, the electron deficiency of the intercalative unit 
and the choice of the complexed lanthanide ion. 
Firstly the helicity at the metal centre was shown to determine the strength and the 
stereoselectivity of the binding. This was demonstrated for the complexes [LnL1] 4+, [LnL3] 3+, 
and [LnL5-8] 3+. For the tetracationic L 1 complexes, the~ isomer showed the greatest affinity 
for [(CG)6] 2, while for the tricationic complexes L3 and L5-8, the A isomer was found to bind 
more strongly. The tuning of the helicity by an additional chiral centre introduced in [LnL5-
8]3+ complexes appeared to enhance the selectivity in binding. 
Secondly, the length of the linking arm between the phenanthridine chromophore and the 
chiral macrocyclic unit was modified both in series of 2-phenanthridyl and 6-phenanthridyl 
complexes. Bringing the element of helicity closer to the intercalative unit was postulated to 
enhance the selectivity of interaction with the DNA helix. Unfortunately, such complexes, 
t.e. [LnL 4t+ and [LnL9] 3+ & [LnL 10] 3+ each possessed considerable inflexibility in their 
structure, which may have inhibited their efficient interaction with the oligonucleotides. 
However, the shortening of the linking arm in the complex [LnL 4] 4+.(H20)2 ( a complex of a 
heptadentate ligand) led to complexation behaviour in which more marked changes occurred 
at the metal centre. The form of the hypersensitive transitions in the Eu emission spectra 
suggested the ligation of a DNA phosphate oxygen in the binding of the complex. 
In addition to the rigidity of the complex, steric inhibition of binding with [LnL 5"8] 3+ may 
have inhibited the phenanthridine chromophore from sliding between the DNA base pairs. 
No evidence for intercalation was found for these tricationic complexes. An electrostatic 
binding mode coupled to some degree of groove binding are more probable interactions, 
given that the phenanthridine-conjugate linked via its 6-position offered only a restricted 
aromatic surface to interact with the nucleic acids. The significant lipophilicity of the 
complex as well as the possibility of stabilising hydrogen bonding interactions, e.g. with the 
phenanthridine nitrogen, may also contribute to the putative groove-binding mode. 
Thirdly the electron deficiency of the phenanthridine moiety served to influence the strength 
and the selectivity of the intercalative binding. A cationic chromophore favoured a charge-
transfer interaction with the more electron-rich base pairs. Intercalative binding occurred 
preferentially to CG base pairs for the tetra- and, to a lesser extent, the tri-cationic 
phenanthridine complexes, [LnL 1 ] 4+ and [LnL 3]3+. 
Finally the choice of the lanthanide ion europium and ytterbium gave rise to distinctly 
different behaviour in the binding of [LnL 1] 4+, [LnL3] 3+, and [LnL5-8] 3+ with the 
oligonucleotides used in this study. A tentative suggestion for the difference relates to the 
acidity of the water molecule bound to the lanthanide. This is likely to be more acidic in 
ytterbium complex, and therefore may affect the binding to the duplex through a differential 
hydrogen-bonding interaction. 
The studies carried out with the complexes studied herein are preliminary in nature 
and certainly not exhaustive! Further work may embrace the development of reactive 
complexes, in which either singlet oxygen is produced by a DNA-bound Tb complex, or 
wherein hydrolytic cleavage is facilitated by cooperative intercalation and phosphate oxygen-
Ln(III) binding. 
Appendix 
Determination of apparent binding constants 
1. Representative data set for titration of A-[YbL Ia]4+ with [(CG)6h 
Data handling using intrinsic methods to determine the concentration of bound 
complex (see part 3.1.4): 
1h7 
10 
9 y = 49,785x + 0,1181 
8 
R2 = 0,9998 
7 
6 
y 5 
4 
3 
2 
1 
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0 0,05 0,1 0,15 0,2 
X 
Intrinsic method for determination of a 
slope = Lot I a with Lot= 24.4 J,lM 
hence a= 0.490 
So the concentration of bound complex can determined: 
where rj is variation of fluorescence 
2. Handling of data using McGhee/von Hippel approach 
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McGhee van Hippel plot with all data 
1.-;0 
K value (x = 0; K = t) was fairly insensitive to the fitted value of n. The major error seems to 
be associated with determination of n': e.g. at low values oft, n' can be 4 or 4.5, with little 
change inK. 
3~--------------------------------------~ 
2,5 
2 
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X 
y = -1 ,2032x + 5,6098 
R2 = 0,9663 
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2,5 3 3,5 4 4,5 5 
r 
McGhee-von Hippel plot- approximation of the central portion of 'curve' 
The value forK is 5.6 J..tM-'.duplex-1, with 4-4.5 complexes bound to the duplex of (CG)6. 
Obviously an additionnal approximation, but iterative least squares fitting gives values forK, 
n ' which are within 10-15% ofthe value given here. 
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